Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
  • Curriculum.
  • Publications.
  • Projects.
  • Presentations.
  • Advised theses.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Brodmann Marianne |

Presentations at scientific and public conferences

Brodmann, M One-Year Results of the DEEPER LIMUS Trial: The Bare Temporary Spur Stent System in Combination With a Sirolimus- Coated Balloon
JACC-CARDIOVASC INTE. 2024; 17(4): S33-S33. [Poster]
Web of Science

 

Gütl, K; Schweiger, L; Hafner, F; Douschan, P; Kovacs, G; Meinitzer, A; Moazedi-Fürst, F; Brodmann, M; Jud, P Predictive role of endothelial dysfunction for disease complications in patients with limited cutaneous systemic sclerosis.
2. Sklerodermie-Tag; JUN 27, 2024; Graz, Austria. 2024. [Poster]

 

Manzi, M; Deloose, KR; Schmidt, A; Scheinert, D; Zeller, T; Maene, L; van den Heuvel, D; Lansink, W; Palena, LM; Sbarzaglia, P; Brodmann, M; Lichtenberg, M The MicroStent HEAL Registry: Interim 6-Month Outcomes
J VASC SURG. 2024; 79(4): 44S-45S. [Poster]
Web of Science

 

Schweiger, L; Hafner, F; Meinitzer, A; Brodmann, M; Dejaco, C; Jud, P Association of clinical, imaging and laboratory parameters with adverse effects of glucocorticoid therapy in patients with giant cell arteritis.
53. Jahrestagung der Deutschen Gesellschaft für Angiologie – Gesellschaft für Gefäßmedizin e.V. 8. DGA-Interventionskongress; SEPT 19-21, 2024; Leipzig, Germany. 2024. [Poster]

 

Schweiger, L; Raggam, RB; Toth-Gayor, G; Jud, P; Avian, A; Nemecz, V; Gütl, K; Brodmann, M; Gary, T Risikostratifizierung mittels kardialer Biomarker bei PatientInnen mit peripherer arterieller Verschlusserkrankung (pAVK)
VASCMED; OCT 17-19, 2024; Linz, Austria. 2024. [Poster]

 

Guetl, K; Schweiger, L; Brodmann, M Patency Rates Following Vessel Preparation with the ULTRASCORE Scoring Balloon in Femoropopliteal Arteries - A Prospective Pilot Study
; OCT 12-14, 2023; Milan, ITALY. 2023. [Poster]

 

Manzi, M; Deloose, K; Schmidt, A; Zeller, T; Scheinert, D; van den Heuvel, D; Maene, L; Lansink, W; Palena, M; Sbarzaglia, P; Brodmann, M; Lichtenberg, M The MicroStent HEAL Post Market Registry: Interim Results of BTK Revascularization and Major Amputation Prevention
J AM COLL CARDIOL. 2023; 82(17): B106-B106. [Poster]
Web of Science

 

Schweiger, L; Guetl, K; Raggam, R; Brodmann, M; IVUS-guided decision making for optimized treatment in below the knee arterial disease
IX ESVM Congress 2023; OCT 12-14, 2023; Milan, ITALY. 2023. [Poster]

 

Toth, GG; Brodmann, M; Schnur, SK; Bartus, S; Vrsalovic, M; Krestianinov, O; Kala, P; Bil, J; Gil, R; Di Serafino, L; Kanovsky, J; Paolucci, L; Barbato, E; Mangiacapra, F; Ruzsa, Z Intentional Coronary Revascularization Versus Conservative Therapy in Patients, Who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia: The INCORPORATE Randomized Clinical Trial
J AM COLL CARDIOL. 2023; 82(17): B81-B81. [Poster]
Web of Science

 

Guetl, K; Nemecz, V; Schweiger, L; Rief, P; Tang, WC; Patel, K; Brodmann, M Standard balloon angioplasty versus Serranator serration balloon angioplasty for the treatment of below-the-knee artery disease
ISET; JAN 16-19, 2022; Miami Beach. 2022. [Poster]

 

Gutl, K; Raggam, R; Gary, T; Kleinhapl, J; Aschauer, M; Muster, V; Jud, P; Rief, P; Brodmann, M Atypical iliac vein compression syndrome (AIVCS) due to a vertebral spondylophyte
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 3):220-221. [Poster]
Web of Science

 

Muster, V; Gütl, K; Schweiger, L; Silbernagel, G; Schmid, F; Brodmann, M A case of an aneurysm spurium of a side branch of the popliteal artery following a proximal fracture of the lower leg and treatment with an external fixator
LINC 2022; JUN 6-9, 2022; Leipzig. 2022. [Oral Communication]

 

Muster, V; Jud, P; Gült, K; Prüller, F; Schweiger, L; Gary, T; Brodmann, M; Raggam, RB Pulmonary cement embolism after kyphoplasty: Clinical and laboratory aspects of pro-coagulant effects
ISTH 2022; JULY 9-13, 2022; London, UK. 2022. [Poster]

 

Muster, V; Jud, P; Gütl, K; Prüller, F; Schweiger, L; Gary, T; Brodmann, M; Raggam, RB Pulmonary cement embolism after kyphoplasty: Clinical and laboratory aspects of pro-coagulant effects.
GTH 2022; MÄRZ 1-4, 2022; Leipzig, Deutschland. 2022. [Poster]

 

Muster, V; Raggam, RB; Urbanic-Purkart, T; Gütl, K; von Campe, G; Brodmann, M; Gary, T Prevalence of asymptomatic venous thromboembolism in patients with primary brain tumor.
Doctoral Day 2022; FEB 10, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

 

Muster, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gutl, K; Rabensteiner, J; Pruller, F; von Campe, G; Rief, M; Brodmann, M; Gary, T Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: a prospective study
THROMB RES. 2022; 213: S16-S17.-11th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); MAY 27-29, 2022; Bergamo, ITALY. [Poster]
Web of Science

 

Muster, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gutl, K; Rabensteiner, J; Pruller, F; von Campe, G; Rief, M; Brodmann, M; Gary, T LOWER-EXTREMITY DEEP VEIN THROMBOSIS AND BLEEDING COMPLICATIONS IN PRIMARY BRAIN TUMOR PATIENTS: A PROSPECTIVE STUDY
NEURO-ONCOLOGY. Meeting Abstracts. 2022; 24(S2):-17th Meeting of the European-Association-of-Neuro-Oncology; SEP 15-18, 2022; Vienna, AUSTRIA. Doi: 10.1093/neuonc/noac174.190 [Poster]
Web of Science FullText FullText_MUG

 

Muster, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gütl, K; Rabensteiner, J; Prüller, F; von Campe, G; Rief, M; Brodmann, M; Gary, T Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: A prospective study
ICTHIC 2022; MAI 27-29, 2022; Bergamo, ITALY. 2022. [Oral Communication]

 

Nemecz, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gütl, K; Rabensteiner, J; Prüller, F; vonCampe, G; Rief, M; Brodmann, M; Gary, T Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: A prospective study
EANO 2022; Sept 15-18, 2022; Vienna, Austria. 2022. [Poster]

 

Parikh, S; Zeller, T; Shishehbor, M; Werner, M; Brodmann, M; Parise, H; Holden, A; Lichtenberg, M; Kashyap, V; Pietras, C; Tirziu, D; Ardakani, S; Beschorner, U; Krishnan, P; Niazi, K; Wali, A; Lansky, A Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Patients With Diabetes Mellitus: Results of the Randomized Chocolate Touch Study
J AM COLL CARDIOL. 2022; 80(12): B84-B84. [Poster]
Web of Science

 

Prietl, B; Odler, B; Kirsch, AH; Artinger, K; Eigner, M; Schmaldienst, S; Pfeifer, V; Stanzer, S; Eberl, A; Raml, R; Rosenkranz, A; Brodmann, M; Eller, P; Pieber, T; Eller, K CHRONIC INFLAMMATION MIGHT PROTECT HAEMODIALYSIS PATIENTS FROM SEVERE COVID-19
NEPHROL DIAL TRANSPL. 2022; 37: I106-I106. [Poster]
Web of Science

 

Rief, M; Raggam, R; Rief, P; Metnitz, P; Stojakovic, T; Reinthaler, M; Brodmann, M; März, W; Scharnagl, H; Silbernagel, G; Comparison of two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations
-. 2022; -Docday2022; FEB 10, 2022; Graz, AUSTRIA. [Onlinepräsentation]

 

Rief, Martin; Raggam, Reinhard; Rief, Peter; Metnitz, Philipp; Stojakovic, Tatjana; Reinthaler, Markus; Brodmann, Marianne; März, Winfried; Scharnagl, Hubert; Silbernagel, G; Comparison of two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations
VMAC 2022; MAR 17-19, 2022; Augsburg, GERMANY. 2022. [Onlinepräsentation]

 

Brodmann, M Final long-term mortaliyt results of paclitaxel coated DCBs from the ILLUMINATE RCTs
LINC 2021 (virtual); Jänner 25-29, 2021; Virtual. 2021. [Oral Communication]

 

Brodmann, M Paclitaxel or sirolimus what should I choose at the end of 2021 to treat my patients?
Paris Vascular Insights 2021; Oktober 21-23, 2021; Paris, Frankreich. 2021. [Oral Communication]

 

Brodmann, M What adequate and ideal lipid levels should we strive for in PAD patients: How to get there?
VEITHsymposium 2021; November 15-19, 2021; Orlando, Florida, USA (virtual). 2021. [Oral Communication]

 

Brodmann, M How and why to measure foot perfusion during endo treatments and when is the angiosome concept helpful, when not?
VEITHsymposium 2021; November 15-19, 2021; Orlando,Florida, USA (virtual). 2021. [Oral Communication]

 

Brodmann, M Update on the Global RANGER II RCT comparing Ranger DCBs with POBA
VEITHsymposium 2021; November 15-19, 2021; Florida, USA (Virtual). 2021. [Oral Communication]

 

Brodmann, M Prizer Studie: Bringen Dual-Layer Stents Vorteile in der Peripherie?
50. Jahrestagung der Deutschen Gesellschaft für Angiologie ; September 30-Oktober 2, 2021; Berlin, Deutschland. 2021. [Oral Communication]

 

Brodmann, M Advancements in Adjunctive Therapy for Severely Calcified Iliac Disease: Intravascular Lithotripsy and Other Options
NY Endovascular Summit 2021; October 15-16, 2021; New York, USA (Virtual). 2021. [Oral Communication]

 

Brodmann, M DES in Real-World Lesions: What is the Data?
NY Endovascular Summit 2021; October 15-16, 2021; New York, USA (virtual). 2021. [Oral Communication]

 

Brodmann, M Optimizing dissection repair above and below the knee: pooled analyses from the Tack Optimized Balloon Angioplasty (TOBA) studies
CIRSE 2021 SUMMIT; September 25-28, 2021; Online. 2021. [Oral Communication]

 

Brodmann, M The cost of endovascular limb preservation vs amputation
CIRSE 2021 SUMMIT; September 25-28, 2021; Online. 2021. [Oral Communication]

 

Brodmann, M IN.PACT global study 5-year outcomes: sex and diabetics subgroups
CIRSE 2021 SUMMIT; September 25-28, 2021; Online. 2021. [Oral Communication]

 

Brodmann, M Limus vs Taxol: What is the Difference and When Will the Answer Come Out from the Shadows?
AMP Europe 2021; October 10-12, 2021; Lugano, Switzerland. 2021. [Oral Communication]

 

Brodmann, M BIOLUX P-III Passeo 18-Lux All-comers Registry: 24 month Results in Below-the-Knee Arteries
AMP Europe 2021; October 10-12, 2021; Lugano, Switzerland. 2021. [Oral Communication]

 

Brodmann, M The cost of endovascular limb preservation vs amputation
AMP Europe 2021; October 10-12, 2021; Lugano, Switzerland. 2021. [Oral Communication]

 

Brodmann, M 2-Year Results of the COMPARE Head-to-Head RCT Comparing the Ranger DCB to the IN.PACT DCB in Complex Fempop Lesions
AMP 2021; August 10-14, 2021; Chicago (Virtual). 2021. [Oral Communication]

 

Brodmann, M Optimizing Protection for Patients with Symptomatic Chronic PAD
ISET 2021; May 9-11, 2021; Miami, Florida (Virtual). 2021. [Oral Communication]

 

Brodmann, M Antithrombotische Therapie nach peripheren Interventionen/Operationen
11. Frankfurter Gerinnungstage; Sept 3-4, 2021; Frankfurt am Main. 2021. [Oral Communication]

 

Brodmann, M Ranger DCB bei komplexen Läsionen
3. Internationaler interdisziplinärer Kongress zur kritischen Extremitätenischämie; Juni 11/12, 18/19, 2021; Düsseldorf (Virtual). 2021. [Oral Communication]

 

Brodmann, M Haben wir in der DACH Region einen adäquaten und weitestgehend konformen Standard in der Wundtherapie?
3. Internationaler interdisziplinärer Kongress zur kritischen Extremitätenischämie; Juni 11/12, 18/19, 2021; Düsseldorf (Virtual). 2021. [Oral Communication]

 

Brodmann, M CO2 Angiographie: Sicherheit für Hochrisikopatienten mit schwerer Niereninsuffizienz
3. Internationaler interdisziplinärer Kongress zur kritischen Extremitätenischämie; Juni 11/12, 18/19, 2021; Düsseldorf (Virtual). 2021. [Oral Communication]

 

Brodmann, M Sind die rezenten CLTI Guidelines hilfreich oder verwirrend in unserer Praxis?
3. Internationaler interdisziplinärer Kongress zur kritischen Extremitätenischämie; Juni 11/12, 18/19, 2021; Düsseldorf (Virtual). 2021. [Oral Communication]

 

Brodmann, M Gibt es ein sogenanntes palliatives Setting für CLTI Patienten oder müssen wir das in Analogie zur Onkologie aufsetzen?
3. Internationaler interdisziplinärer Kongress zur kritischen Extremitätenischämie ; Juni 11/12, 18/19, 20221; Düsseldorf (Virtual). 2021. [Oral Communication]

 

Brodmann, M After peripheral endovascular therapy, DAPT remains the preferred option over dual-pathway antithrombotic treatment-CON
ESC 2021; August 29,2021; Virtual. 2021. [Oral Communication]

 

Brodmann, M Early clinical experience with the SoundBite 14P Crossing System
Paris Vascular Insights 2021; Oktober 21-23, 2021; Paris, Frankreich. 2021. [Oral Communication]

 

Brodmann, M Can Tack Improve Outcome sin Lower Limb PTA- Results from the TOBA Trials
VERVE 2021; Dezember 2-4, 2021; Sydney, Australien (virtual). 2021. [Oral Communication]

 

Brodmann, M Welche Veränderungen in der Betreuung und Behandlung von COVID Patienten sind eingetreten und absehbar?
Hygienetagung BHB (Barmherzige Brüder) Österreich; Dezember 1, 2021; Online. 2021. [Science to Public]

 

Brodmann, M The Spur Stent System (Reflow Medical): A Temporary Stent With Spikes To Penetrate The Arterial Wall And Facilitate DCB Drug Delivery: How Does It Work And Results To Date
VEITHsymposium; November 15-19, 2021; Orlando, Florida, USA (virtual). 2021. [Oral Communication]

 

Brodmann, M Endovascular treatment of common femoral artery lesions?- a word of caution
10. Munich Vascular Conference (MAC); Dezember 1-3, 2021; Online. 2021. [Oral Communication]

 

Brodmann, M Lithoplastie-new kid on the block oder echter Hoffnungsträger?
35. Gefäßmedizinisches Symposium Berlin; November 4-6, 2021; Berlin, Deutschland. 2021. [Oral Communication]

 

Brodmann, M DCB-Stellenwert von Paclitaxel oder Sirolimus
ÖGIA-Live-Webinar; Dezember 9, 2021; Online. 2021. [Oral Communication]

 

Brodmann, M Angiologie: What´s new, what´s hot
52. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; September 23-24, 2021; Salzburg. 2021. [Oral Communication]

 

Brodmann, M Endovaskuläre Revaskularisation am Unterschenkel unter Beachtung des Angiosomkonzeptes - Pro
37.Jahrestagung der Deutschen Gesellschaft für Gefäßchiurgie und Gefäßmedizin ; Oktober 13-16,2021; Mannheim, Deutschland. 2021. [Oral Communication]

 

Brodmann, M How and When I Utilize Intravascular Lithotripsy throughout the Spectrum of Endovascular Interventions
VIVA 2021; October 5-7, 2021; Las Vegas, USA (virtual). 2021. [Oral Communication]

 

Brodmann, M IS DCB at the Frontier of Below-the-Knee Intervention: The European Experience
NY Endovascular Summit 2021; October 15-16, 2021; New York, USA (Virtual). 2021. [Oral Communication]

 

Brodmann, M How does the scientific evidence inform my long lesion strategy?
CIRSE 2021 SUMMIT; September 25-28, 2021; Online. 2021. [Oral Communication]

 

Brodmann, M Follow up of PAD patients in general, after endovascular therapy and especially in CLI
The 29th Slovak Angiological Congress; September 23-25, 2021; Low Tatra, Slowakei (Virtual). 2021. [Oral Communication]

 

Brodmann, M Selution DCB update: PRESTIGE and design of the Selution BTK IDE
AMP Europe 2021; October 10-12, 2021; Lugano, Switzerland. 2021. [Oral Communication]

 

Brodmann, M Update on DISRUPT
AMP Europe 2021; October 10-12, 2021; Lugano, Switzerland. 2021. [Oral Communication]

 

Brodmann, M Thrombose und Lungenembolie-wie und wie lange antikoagulieren?
3.Grazer Herzkreislauftage; September 17-19,2021; Graz. 2021. [Oral Communication]

 

Brodmann, M Limus vs Taxol: When Will the Answer Come Out from the Shadows?
AMP 2021; August 10-14, 2021; Chicago (Virtual). 2021. [Oral Communication]

 

Brodmann, M ILLUMINATE 5 Year Data Series
AMP 2021; August 10-14, 2021; Chicago (Virtual). 2021. [Oral Communication]

 

Brodmann, M Interventionelle Therapieoptionen beim DFS
VASCMED 2021; September 9-10, 2021; Graz. 2021. [Oral Communication]

 

Brodmann, M PTX-Die Ruhe nach dem Sturm? Übersetzung der akutellen Evidenzlage in die tägliche Praxis
VASCMED 2021; September 9-10, 2021; Graz. 2021. [Oral Communication]

 

Brodmann, M Neue Standards in der endovaskulären Therapie peripherer Gefässe: low dose DCB und DES
VASCMED 2021; September 9-10, 2021; Graz. 2021. [Oral Communication]

 

Brodmann, M COMPARE Trial Update and the use of Ranger in Long Lesions
ISET 2021; May 9-11, 2021; Miami, Florida (virtual). 2021. [Oral Communication]

 

Brodmann, M Managing of CLI wounds
ISET 2021; May 9-11, 2021; Miami, Florida (Virtual). 2021. [Oral Communication]

 

Brodmann, M Chocolate Touch Balloon, Experience and Rationale
VINNOVA (Vascular Innovation Conference); April 10-11, 2021; Virtual, China. 2021. [Oral Communication]

 

Brodmann, M Kritische Extermitätenischämie und Revaskularisation
Angiologie-Was Sie schon immer wissen wollten, aber sich nicht getraut haben zu fragen?; März 23, 2021; Virtual. 2021. [Oral Communication]

 

Brodmann, M New insights from Ranger DCB in challenging lesions and demographics
LINC 2021 (virutal); Jänner 25-29, 2021; Virtual. 2021. [Oral Communication]

 

Brodmann, M A pilot study examining the performance and safety of the temporary spur stent system in infrapopliteal arteries: first-time use with a Limus-coated balloon (DEEPER LIMUS)
LINC 2021 (virtual); Jänner 25-29, 2021; Virtual. 2021. [Oral Communication]

 

Brodmann, M Interventions in heavily calcified lesions
Angiologic Summer Academy 2021; Juni 4-5, 2021; Berin (Virtual). 2021. [Oral Communication]

 

Brodmann, M Still endovascular first for effective PAD treatment?
7th ESVM/VLMM Congress ; Sept 1-4, 2021; London (Virtual). 2021. [Oral Communication]

 

Brodmann, M A Single-Center, Single-Arm Pilot Study Examining the Performance and Safety of the Temporary Spur Stent System In Infrapopliteal Arteries: First-Time Use with a Limus-Coated Balloon (DEEPER LIMUS)
Charing Cross 2021; April 19-22, 2021; Virtual, London UK. 2021. [Oral Communication]

 

Brodmann, M Management of calicified lesions in the femoral popliteal
CRT 2021; April 10, 2021; Virtual, Washington DC. 2021. [Oral Communication]

 

Brodmann, M Imaging techniques to determine tissue perfusion in critical limb ischemia
LINC 2021 (Virtual); Jänner 25-29, 2021; virtual. 2021. [Oral Communication]

 

Brodmann, M Paclitaxel safety with CLTI
LINC 2021 (virtual); Jänner 25-29, 2021; virtual. 2021. [Oral Communication]

 

Brodmann, M STEP Up with SELUTION SLR
LINC 2021 (virtual); Jänner 25-29, 2021; Virtual. 2021. [Oral Communication]

 

Brodmann, M Interventionelle Therapie der pAVK
23.Kardiologie Kongress Innsbruck 2021; März 4, 2021; Online. 2021. [Onlinepräsentation]

 

Brodmann,M TOBA Evidence to date-below the knee
The Need to treat dissection-European perspective; Jän 20, 2021; Online. 2021. [Onlinepräsentation]

 

Brodmann,M Review of Lutonix™ Drug Coated Balloon Clinical Program and Independent Safety Analysis
Charing Cross 2021; April 19-22, 2021; Virtual, London, UK. 2021. [Keynote lecture]

 

Brodmann,M Intravascular Lithotripsy; Pros and cons of Atherectomy and Lithotripsy for severe infrainguinal arterial occlusive disease
Veith Online Webinar; FEB 12, 2021; Online Veith Symposium Webinar. 2021. [Onlinepräsentation]

 

Eichinger, S; Eischer, L; Sinkovec, H; Gressenberger, P; Gary, T; Brodmann, M; Heinze, G; Kyrle, PA Identification of Patients with Unprovoked Venous Thromboembolism and a Low Risk of Recurrence Estimated By the Vienna Prediction Model: A Prospective Cohort Management Study
BLOOD. 2021; 138: Doi: 10.1182/blood-2021-150934 [Poster]
Web of Science FullText FullText_MUG

 

Eischer L, Šinkovec H, Gressenberger P, Gary T, Brodmann M, Heinze G, Kyrle PA, Eichinger S Management of Patients with Venous Thromboembolism and a High Recurrence Risk Estimated by the Vienna Prediction Model.
Res Pract Thromb Haemost. 2021; 5 (Suppl 2). 2021; -ISTH 2021 Congress; July 17-21, 2021; Philadelphia, USA;. [Oral Communication]
FullText

 

Guetl, K; Muster, V; Gressenberger, P; Raggam, RB; Brodmann, M; Gary, T Paraneoplastic deep vein thrombosis in pre-existing full-dose anticoagulation with dabigatran: a case report
THROMB RES. 2021; 200: S38-S39. [Onlinepräsentation]
Web of Science

 

Jud, P; Schweiger, L; Brodmann, M A rare sign mimicking a rare vascular disease: Standing waves.
Abstractband der 50. Jahrestagung der Deutschen Gesellschaft für Angiologie – Gesellschaft für Gefäßmedizin e.V. und 5. DGA-Interventionskongress. 2021; 50: 1-45.-50. Jahrestagung der Deutschen Gesellschaft für Angiologie – Gesellschaft für Gefäßmedizin e.V. und 5. DGA-Interventionskongress; SEP 30-OCT 2, 2021; Berlin, GERMANY. [Poster]

 

Jud, P; Verheyen, N; Dejaco, C; Szolar, D; Thonhofer, R; Brodmann, M; Hafner F Prevalence of aortic dilatation according to age-, sex-, and body-surface adjusted cut-off values in giant cell arteritis.
Abstractband der 50. Jahrestagung der Deutschen Gesellschaft für Angiologie – Gesellschaft für Gefäßmedizin e.V. und 5. DGA-Interventionskongress. 2021; 50: 1-45.-50. Jahrestagung der Deutschen Gesellschaft für Angiologie – Gesellschaft für Gefäßmedizin e.V. und 5. DGA-Interventionskongress; SEP 30-OCT 2, 2021; Berlin, GERMANY. [Poster]

 

Metzner, T; Leitner, DR; Dimsity, G; Gunzer, F; Opriessnig, P; Mellitzer, K; Beck, A; Sourij, H; Stojakovic, T; Deutschmann, H; Arz, WM; Landmesser, U; Brodmann, M; Reishofer, G; Scharnagl, H; Toplak, H; Silbernagel, G SHORT-TERM EFFECTS OF INTENSIVE LDL-CHOLESTEROL LOWERING WITH ALIROCUMAB ON VASCULAR STRUCTURE AND FUNCTION
ATHEROSCLEROSIS. 2021; 331: E228-E228. [Poster]
Web of Science

 

Muster, V; Gutl, K; Schweiger, L; Gressenberger, P; Raggam, RB; Brodmann, M; Gary, T A case of normal range D-dimer levels in a patient with deep vein thrombosis and active cancer
THROMB RES. 2021; 200: S34-S35. [Onlinepräsentation]
Web of Science

 

Muster, V; Jud, P; Gütl, K; Prüller, F; Schweiger, L; Gary, T; Brodmann, M; Raggam, RB. Pulmonalarterienembolie mit Knochenzement nach Kyphoplastie.
VascMed2021; SEP 9-10, 2021; Graz, Austria.. 2021. [Keynote lecture]

 

Aziz, F; Reichardt, B; Sourij, C; Dimai, HP; Reichart, D; Kohler, G; Brodmann, M; Sourij, H Incidence, mortality, and trends of major lower extremity amputations in individuals with diabetes in Austria - evidence from the Austrian Health Insurance.
WIEN KLIN WOCHENSCHR. 2020; 132: S346-S347.ÖDG. [Poster]
Web of Science

 

Brodmann, M Lessons from Ranger SFA II RCT (Ranger DCB vs PTA)
LINC 2020; Jan 28-31, 2020; Leipzig, GERMANY. 2020. [Oral Communication]

 

Brodmann, M How do I consent my patients to a paclitaxel coated device?
CIRSE 2020; SEP 12-15, 2020; München, Germany. 2020. [Oral Communication]

 

Brodmann, M Tackling vascular calcium- Innovative forum.
CIRSE 2020; SEP 12-15, 2020; München, Germany. 2020. [Oral Communication]

 

Brodmann, M Alternative treatments- Complex femoro-popliteal lesions.
CIRSE 2020; SEP 12-15, 2020; München, Germany. 2020. [Oral Communication]

 

Brodmann, M Latest updates on Lutonix® DCB: Global IDE trial and BTK registry , Lutonix BD Symposium.
CIRSE 2020; SEP 12-15, 2020; München, Germany. 2020. [Oral Communication]

 

Brodmann, M Die endovaskulären Therapieoptionen bei Gefäßpatienten.
2. Grazer Herzkreislauftage; SEP 11-13, 2020; Graz, Austria. 2020. [Oral Communication]

 

Brodmann, M ILLUMENATE Trial Update: 4-Year ILLUMENATE Global Stellarex DCB Data.
TCT Connect 2020; OKT 14-18, 2020; New York, USA. 2020. [Onlinepräsentation]

 

Brodmann, M DCB or POBA below the knee..?? this is the final answer.
i-MEET 2020; SEPT 16-18, 2020; Nizza, Frankreich. 2020. [Oral Communication]

 

Brodmann, M Gibt es ein sogenanntes palliatives Setting für CLI Patienten oder müssen wir dies in Analogie zur Onkologie aufsetzen?
2. Internationaler Kongress zur kritischen Extremitätenischämie; Jun 4, 2020; Düsseldorf, Germany. 2020. [Oral Communication]

 

Brodmann, M Adäquates Follow up nach BTK Interventionen.
Jahrestagung DGA 2020; Sept 10-12, 2020; Kempten, Deutschland. 2020. [Oral Communication]

 

Brodmann, M Drug Coated Balloons: How to COMPARE Design and Data.
CIRSE 2020; SEP 12-15, 2020; München, Germany. 2020. [Oral Communication]

 

Brodmann, M Pacliatxel-How it should be used in PAD patients.
CIRSE 2020; SEP 12-15, 2020; München, Germany. 2020. [Oral Communication]

 

Brodmann, M Pedal Artery Angioplasty: Patient Selection, Technique, and Results - When Should It Be Added to the Treatment of Multilevel Disease Above the Ankle?
Veith Symposium Webinar: Frontiers of Limb Salvage; SEP 25, 2020; New York, USA. 2020. [Onlinepräsentation]

 

Brodmann, M DCB IDE below-the-knee six-month results with in-depth look at diabetics.
LINC LIVE 2020; BD Satellite Symposium; NOV 4, 2020; Leipzig, Germany. 2020. [Onlinepräsentation]

 

Brodmann, M 12-Month Results of the COMPARE RCT (Full Cohort) Comparing the Ranger DCB with the In.Pact DCB for Treating Complex Fempop Lesions.
AMP 2020; AUG 12-15, 2020; Chicago, USA. 2020. [Oral Communication]

 

Brodmann, M Lutonix BTK IDE Study: 12-Month Results & Interim Safety Analyses at Three Years
AMP 2020; AUG 12-15, 2020; Chicago, USA. 2020. [Oral Communication]

 

Brodmann, M Long SFA de novo lesion.
i-MEET 2020; SEPT 16-18, 2020; Nizza. 2020. [Oral Communication]

 

Brodmann, M Covid-19 und die Auswirkungen auf das tägliche Leben im Spital- besonders bei PAVK Patienten.
COVID-19 und Angiologie; MAI 29, 2020; Graz. 2020. [Onlinepräsentation]

 

Brodmann, M Sind die rezenten CLTI Guidelines hilfreich oder verwirrend in unserer täglichen CLI Praxis?
2. Internationaler Kongress zur kritischen Extremitätenischämie; Jun 4, 2020; Düsseldorf, Germany. 2020. [Oral Communication]

 

Brodmann, M Paclitaxel or Other Stents--Is Sirolimus the Future or Not?
VIVA and the VEINS 2020; NOV 7-8, 2020; Las Vegas. 2020. [Oral Communication]

 

Brodmann, M Studienergebnisse von Dissektion Repair Devices.
Jahrestagung DGA 2020; Sept 10.12, 2020; Kempten, Deutschland. 2020. [Oral Communication]

 

Brodmann, M Brauchen wir einen palliativmedizinischen Ansatz bei der Behandlung von Patienten mit kritischer Extremitätenischämie?
Jahrestagung DGA 2020; Sept 10-12, 2020; Kempten, Deutschland. 2020. [Oral Communication]

 

Brodmann, M Aktuelle Langzeitdaten zur Mortalität und Effektivität aus dem Illuminate DEB Studienprogram.
Jahrestagung DGA 2020; Sept 10-12, 2020; Kempten, Deutschland. 2020. [Oral Communication]

 

Brodmann, M PAD III Data (IVL) in context, optimal PTA.
VIVA 2020; Nov 7-8, 2020; Las Vegas. 2020. [Oral Communication]

 

Brodmann, M Behandlungsoptionen im PAVK Krankheitsverlauf im Licht neuer Daten "Voyager PAD".
ICA 2020/ÖGG2020; OKT 7-9, 2020; Wien, Austria. 2020. [Oral Communication]

 

Brodmann, M What is new in peripheral arterial disease?
Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease; NOV 20-22, 2020; Vilnus, Litauen. 2020. [Oral Communication]

 

Brodmann, M Assessing the clinical utility of real-time tissue oxygen monitoring for endovascular revascularization procedures.
AMP Europe 2020; OCT 12-14, 2020; Lugano, Schweiz. 2020. [Oral Communication]

 

Brodmann, M COMPARE Head-to-Head RCT 12-Month Results: Low Dose Ranger DCB vs Higher Dose In.PACT DCB in Complex SFA Lesions.
AMP Europe 2020; OCT 12-14, 2020; Lugano, Schweiz. 2020. [Oral Communication]

 

Brodmann, M Preserving the Native Vessel for Future Treatment Options.
LINC Live Case Webinar; Sept 16, 2020; Leipzig, Germany. 2020. [Onlinepräsentation]

 

Brodmann, M Protecting the patinet undergoing lower extremity revascularisation for symptomatic PAD.
ESC 2020; Aug 31, 2020; Amsterdam, Niederlande. 2020. [Oral Communication]

 

Brodmann, M The latest results from the IN.PACT Admiral clinical program.
China IN.PACT Workshop; Jul 31, 2020; Maastricht, Niederlande. 2020. [Onlinepräsentation]

 

Brodmann, M Why are we so excited about DCB for In-stent restenosis?
CRT 2020 (Cardiovascular Research Technologies); FEb 22-25, 2020; Washington DC. 2020. [Oral Communication]

 

Brodmann, M Wenn die Beine eine Pause brauchen: Die unterschätzte Gefahr der Schaufensterkrankheit.
MINI MED Med Campus Graz; JAN 9, 2020; Med Campus Graz. 2020. [Science to Public]

 

Brodmann, M Paclitaxel-coated balloon treatment in patients with in-stent restenosis-24 month results of the real-world all-comers registry BIOLUX P-III.
LINC 2020; Jan 28-31,2020; Leipzig, GERMANY. 2020. [Oral Communication]

 

Brodmann, M New approaches to optimize interventional Outcomes and to assess success of recanalisation.
LINC 2020; Jan 28-31, 2020; Leipzig, GERMANY. 2020. [Oral Communication]

 

Brodmann, M Diagnostic Performance potential of periprocedural tissue Oxygen Monitoring to assess functional success of endovascular revascularisation.
LINC 2020; Jan 28-31, 2020; Leipzig, GERMANY. 2020. [Oral Communication]

 

Brodmann, M Assessing the clinical utility of on-table tissue oxygen monitoring for endovascular procedures.
LINC 2020; Jan 28-31,2020; Leipzig, GERMANY. 2020. [Oral Communication]

 

Brodmann, M First time data release: IN.PACT global study 150 mm cohort: Outcomes through 3 years.
LINC 2020; Jan 28-31,2020; Leipzig, GERMANY. 2020. [Oral Communication]

 

Brodmann, M Eximo Medical´s B Laser up to date clinical data.
LINC 2020; Jan 28-31, 2020; Leipzig, GERMANY. 2020. [Oral Communication]

 

Brodmann, M Lutonix Drug Coated Ballon clinical program overview and published Independent safety analysis results
LINC 2020; Jan 28-31,2020; Leipzig, GERMANY. 2020. [Oral Communication]

 

Brodmann M How to optimize lower limb revascularization results.
China PVI Live Webinar; Aug 22, 2020; Online. 2020. [Onlinepräsentation]

 

Brodmann,M RANGER II SFA: Randomized Trial of RANGER DCB vs PTA in the SFA.
LINC 2020; Jan 28-31, 2020; Leipzig, GERMANY. 2020. [Poster]

 

Guetl, K; Reiter, C; Muster, V; Portugaller, RH; Tiesenhausen, K; Gressenberger, P; Brodmann, M; Gary, T Symptomatic Venous Aneurysm of the Internal Jugular Vein Presenting with Thrombotic Inclusions in Von Willebrand Disease Typ I - A Case Report.
Research and Practice in Thrombosis and Haemostasis (RPTH). 2020; 4(S1):-International Society of Thrombosis and Haemostasis; JUL 12-14, 2020; Carrboro, USA (virtual). [Poster]

 

Gütl, K; Avian, A; Muster, V; Gressengerber, P; Rief, P; Hafner, F; Jud, P; Raggam, R; Seinost, G; Brodmann, M; Gary, T Prediction of chronic limb threatening ischaemia in lower extremity artery disease.
4. DGA-Interventionskongress und 49. Jahrestagung der Deutschen Gesellschaft für Angiologie – Gesellschaft für Gefäßmedizin e.V.; SEPT 10-12, 2020; Kempten, GERMANY. 2020. [Poster]

 

Jud, P; Gütl, K; Muster, V; Gary, T; Seinost, G; Gressenberger, P; Pregartner, G; Neuwirth, R; Portugaller, RH; Brodmann, M; Hafner, F Catheter directed thrombolysis in hypothenar hammer syndrome – a case series and review of the literature.
4. DGA-Interventionskongress und 49. Jahrestagung der Deutschen Gesellschaft für Angiologie – Gesellschaft für Gefäßmedizin e.V.; SEPT 10-12, 2020; Kempten, GERMANY. 2020. [Poster]

 

Jud, P; Meinitzer, A; Aliabadi, A; Moazedi-Fürst, F; Brodmann, M; Hafner, F Evaluation of arginine metabolites in patients with limited systemic sclerosis.
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie & Rehabilitation; NOV 26-28, 2020; Vienna, AUSTRIA. 2020. [Poster]

 

Jud, P; Moazedi-Fürst, F; Brodmann, M; Hafner, F Endothelial dysfunction in patients with limited systemic sclerosis.
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie & Rehabilitation. 2020; -Jahrestagung der Österreichischen Gesellschaft für Rheumatologie & Rehabilitation; NOV 26-28, 2020; Vienna, AUSTRIA. [Poster]

 

Muster, V; Jud, P; Gütl, K; Tomka, M; Baumann, A; Anelli-Monti, M; Srekl-Filzmaier, P; Portugaller, RH; Brodmann, M; Gary, T Acute Leriche Syndrome in a 55-Year-Old Woman with Recurrent Central Pulmonary Embolism: A Case Report.
Research and Practice in Thrombosis and Haemostasis (RPTH). 2020; 4(5):-ISTH 2020; JULI 12-14, 2020; virtuell, Carborro, NC, USA. [Poster]

 

Zsilavecz, V; Ablasser, K; Rech, L; Stangl, V; Kaufmann, F; Reichel, K; Eller, P; Schilcher, G; Reisinger, AC; Muster, V; Brodmann, M; Gütl, K; Krause, R; Pieber, T; Zirlik, A; Wallner, M; Rainer, PP; Cardiovascular Characteristics and Intra-Hospital Outcome of COVID-19 Inpatients at a Tertiary Referral Centre.
2. Grazer Herzkreislauftage; SEP 11-13, 2020; Graz, AUSTRIA. 2020. [Poster]

 

Zsilavecz, VW; Ablasser, K; Rech, L; Stangl, V; Kaufmann, F; Reichel, KT; Eller, P; Schilcher, G; Reisinger, A; Muster, V; Brodmann, M; Gutl, K; Krause, R; Pieber, T; Zirlik, A; Wallner, M; Rainer, P Cardiovascular characteristics and intra-hospital outcome of COVID-19 inpatients at a tertiary referral centre.
WIEN KLIN WOCHENSCHR. 2020; 132: S182-S183. [Poster]
Web of Science FullText

 

Brodmann, M Long term safety data: data Analysis of the LEVANT 2 studies
Charing Cross 2019; April 15-18, 2019; London, Great Britain. 2019. [Keynote lecture]

 

Brodmann, M Lates experience with a minimal metal solution Technology for focal sealing of dissections
Charing Cross 2019; April 15-18, 2019; London, Great Britain. 2019. [Oral Communication]

 

Brodmann, M DCB only vs Bail out Stenting outcomes 24 month, a sub-analysis of Biolux P III
Charing Cross 2019; April 15-18, 2019; London, Greta Britain. 2019. [Oral Communication]

 

Brodmann, M Are there any Treatment algorithms for patients with PAD, or is it just a fight of vascular surgeons against endovascular specialists?
CRT 19 (Cardiovascular Research Technologies); March 2-5, 2019; Washington DC, USA. 2019. [Keynote lecture]

 

Brodmann, M Characterizing the relationship between Oxygen measured by subcutaneius microsensors during revascularisation procedures and wound healing in CLI patients
LINC; JAN 22-25, 2019; Leipzig, Germany. 2019. [Oral Communication]

 

Brodmann, M What is intravascular lithotripsy and when to use it?
LINC; JAN 22-25, 2019; Leipzig, Germany. 2019. [Oral Communication]

 

Brodmann, M Critical limb ischemai: Have we made improvement in classifying These patients in a better way?
LINC; JAN 22-25, 2019; Leipzig, Germany. 2019. [Oral Communication]

 

Brodmann, M Clinical evidence and toxicity from the paclitaxel DCB below the knee
CRT 19 (Cardiovascular Research Technologies); March 2-5, 2019; Washington DC, USA. 2019. [Oral Communication]

 

Brodmann, M Total IN.PACT1 year results: Imaging and propensity analysis
LINC; JAN 22-25, 2019; Leipzig, Germany. 2019. [Oral Communication]

 

Brodmann, M Adequate wound care after successful endovascular Treatment, a keystone for success
Charing Cross 2019; April 15-18, 2019; London, Great Britain. 2019. [Keynote lecture]

 

Brodmann, M Safety and feasibility of intravascular lithotripsy for Treatment of common femoral artery stenosis
Charing Cross 2019; April 15-18, 2019; London, Great Britain. 2019. [Oral Communication]

 

Brodmann, M TOBA II trial one year results
Charing Cross 2019; April 15-18, 2019; London, Great Britain. 2019. [Oral Communication]

 

Brodmann, M Appropriate follow-up of patients after endovascular procedures
Charing Cross 2019; April 15-18, 2019; London, Great Britain. 2019. [Oral Communication]

 

Brodmann, M Polypharmazie beim antikoagulierten Patienten-worauf ist zu achten?
10. Thrombosedialog; March 29-30, Austria; Fuschl am See. 2019. [Oral Communication]

 

Brodmann, M Lithoplasty for BTK
CRT 19 (Cardiovascular Research Technologies); March 2-5, 2019; Washington DC, USA. 2019. [Oral Communication]

 

Brodmann, M Why is intravascular ultrasound so underrespresented in PAD procedures?
CRT 19 (Cardiovascular Research Technologies); March 2-5, 2019; Washington DC, USA. 2019. [Oral Communication]

 

Brodmann, M Safety and feasibility of intravascular lithotripsy for treatment of common femoral artery stenoses
LINC; JAN 22-25, 2019; Leipzig, Germany. 2019. [Oral Communication]

 

Brodmann, M 24 months Outcomes of patients presenting with critical limb ischemia within the BIOLUX P-III registry- a real world clinical Trial treating atherosclerotic arteries with a paclitaxel covered balloon
LINC 2019; JAN 22-25, 2019; Leipzig, Germany. 2019. [Oral Communication]

 

Brodmann, M 24 month results of ISR patients treated with a paclitaxel covered balloon in the real-world BIOLUX P III all comers registry
Charing Cross 2019; April 15-18, 2019; London, Great Britain. 2019. [Oral Communication]

 

Brodmann, M Gerinnung to go, ein pharmakologischer Überblick
Gerinnung to go, ein pharmakologischer Überblick; April 3, 2019; Graz. 2019. [Oral Communication]

 

Brodmann, M An evaluation of drug eluting Technologies for BTK treatment
LINC; JAN 22-25, 2019; Leipzig, Germany. 2019. [Oral Communication]

 

Brodmann, M Novel laser-based atherectomy catheter. Results from the Eximo Medical B Laser IDE Study
LINC; JAN 22-25, 2019; Leipzig, Germany. 2019. [Oral Communication]

 

Brodmann, M Peripheral CTO crossing with the SoundBite active wire
LINC; JAN 22-25, 2019; Leipzig, Germany. 2019. [Keynote lecture]

 

Brodmann, M DCB IDE below-the-knee six-month results with in-depth look at Diabetic patients
TCT 2019 - Transcatheter Cardiovascular Therapeutics; SEP 25-29, 2019; San Francisco, USA. 2019. [Oral Communication]

 

Brodmann, M TOBA III: 12-Month Results
TCT 2019 - Transcatheter Cardiovascular Therapeutics; SEP 25-29, 2019; San Francisco, USA. 2019. [Oral Communication]

 

Brodmann, M Notfalldiagnostik Pulmonalarterienembolie
50.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 19-21, 2019; Salzburg, AUSTRIA. 2019. [Keynote lecture]

 

Brodmann, M LEAD: when to revascularise?Percutaneous revascularization of LEAD: state of the art
ESC Congress 2019, World Congress of Cardiology; August 31-September 4, 2019; Paris, FRANCE. 2019. [Oral Communication]

 

Brodmann, M How Patient with Paclitaxel exposure resent published on JACC confirming that IN.PACT DCB is safe and effective in treating fem-pop disease_ WEBINAR
WEBINAR Milano; JULI 25, 2019; Mailand, ITALY. 2019. [Keynote lecture]

 

Brodmann, M PE,DVT and SVT: current management
ESC Joint Educational Training Programme: Antithrombotic therapies:Clinical challenges and future directions; JUNI 12-14, 2019; Sophia Antiplois, FRANCE. 2019. [Keynote lecture]

 

Brodmann, M Mikro-Sauerstoffmessung
Nationaler interdisziplinärer Kongress zur kritischen Extremitätenischämie; JUNI 13-14, 2019; Düsseldorf. 2019. [Oral Communication]

 

Brodmann, M Ergebnisse der CLI Subgruppe aus dem BIOLUX-III DCB Register
Nationaler interdisziplinärer Kongress zur kritischen Extremitätenischämie; Juni 13-14, 2019; Düsseldorf. 2019. [Oral Communication]

 

Brodmann, M LEVANT: 5-Year Safety Results of the Lutonix™ Randomized Controlled Trials for Femoropopliteal Arterial Lesions
VERVE 2019; DEC 5-7, 2019; Sydney, AUSTRALIA. 2019. [Oral Communication]

 

Brodmann, M Should we treat Foot vessels or is such treatment fanciful or harmful? How should we monitor? What is the end point? And when is open surgery better?
VEITH 2019; NOV19-23, 2019; New York, USA. 2019. [Oral Communication]

 

Brodmann, M Strategies for Optimizing Acute Results of BTK Intervention
VIVA 2019; NOV 4-7, 2019; Las Vegas, USA. 2019. [Poster]

 

Brodmann, M What about DCB and increased mortality?
Triple-I Meeting; OKT 24-25, 2019; Berlin, GERMANY. 2019. [Oral Communication]

 

Brodmann, M Applying Serration Technology to CLI: The Serranator Device
AMP Europe, 2019; OKT 2-4, 2019; Lugano, SWITZERLAND. 2019. [Oral Communication]

 

Brodmann, M Newest Stem Cell Therapies are Effective in Treating Lower Extremity Ischemia
TCT 2019 - Transcatheter Cardiovascular Therapeutics; SEP 25-29, 2019; San Francisco, USA. 2019. [Oral Communication]

 

Brodmann, M DES in BTK/CLI: cost-effective compared to POBA?
CIRSE 2019; SEP 7-11, 2019; Barcelona, SPAIN. 2019. [Oral Communication]

 

Brodmann, M Let Evidence Guide Your Practice: Safe, Effective and Durable Treatment Options using DCB
CIRSE 2019; SEP 7-11, 2019; Barcelona, SPAIN. 2019. [Oral Communication]

 

Brodmann, M Are there Alternatives to Paclitaxel?
VERVE 2019; DEC 5-7, 2019; Sydney, AUSTRALIA. 2019. [Oral Communication]

 

Brodmann, M Clinical Trial Endpoints That Make Sense
VIVA 2019; NOV 4-7, 2019; Las Vegas, USA. 2019. [Oral Communication]

 

Brodmann, M Scoring, Serration, Lithoplasty, Atherectomy: Which One to Use in the Calcified Lesion?
VIVA 2019; NOV 4-7, 2019; Las Vegas, USA. 2019. [Oral Communication]

 

Brodmann, M Calcium Tools: Lithoplasty, Eximo, Serration, Scoring
VIVA 2019; NOV 4-7, 2019; Las Vegas, USA. 2019. [Oral Communication]

 

Brodmann, M What Role Does DCB Play In CLI Patients?
VIVA 2019; NOV 4-7, 2019; Las Vegas, USA. 2019. [Oral Communication]

 

Brodmann, M The EndovascularCLI Treatment Algorithm
VIVA 2019; NOV 4-7, 2019; Las Vegas, USA. 2019. [Oral Communication]

 

Brodmann, M Deep vein arterialization by endovascular approach
Triple-I Meeting; OKT 24-25, 2019; Berlin, GERMANY. 2019. [Oral Communication]

 

Brodmann, M Deep Venous arterialisation: When, Why and How?
Triple-I Meeting; OKT 24-25, 2019; Berlin, GERMANY. 2019. [Oral Communication]

 

Brodmann, M How Can We Improve Treatment for Patients with PAD? Insights from COMPASS
European Society for Vascular Medicine Congress 2019; OKT 10-12, 2019; Ljubljana, SLOVENIA. 2019. [Oral Communication]

 

Brodmann, M To stent or not to stent?
European Society for Vascular Medicine Congress 2019; OKT 10-12, 2019; Ljubljana, SLOVENIA. 2019. [Oral Communication]

 

Brodmann, M Endovascular treatment of femoro-popliteal lesion: presently the optimal choice
European Society of Vascular Medicine Congress 2019; OKT 10-12, 2019; Ljubljana,SLOVENIA. 2019. [Oral Communication]

 

Brodmann, M Appropriate follow-up of patients after endovascular procedures
AMP Europe 2019; OKT 2-4, 2019; Lugano, SWITZERLAND. 2019. [Oral Communication]

 

Brodmann, M Compare Pilot RCT: 2 –year Results from Head to Head Study of Ranger DCB vs IN.PACT DCB in complex SFA lesions
AMP Europe 2019; OKT 2-4, 2019; Lugano, SWITZERLAND. 2019. [Oral Communication]

 

Brodmann, M Real World Correlation Between RF Class at Time and Presentation and its Associated Morbidity and Mortality
AMP Europe 2019; OKT 2-4, 2019; Lugano, SWITZERLAND. 2019. [Oral Communication]

 

Brodmann, M Increased outward force of self-expanding BMS in the SFA could be a significant risk factor for restenosis at 12 months
CIRSE 2019; SEP 7-11, 2019; Barcelona, SPAIN. 2019. [Oral Communication]

 

Brodmann, M Why I believe a 6 month follow-up is good enough for CLI patients
DCB Summit Barcelona; JUNI 11-12, 2019; Barcelona, SPAIN. 2019. [Oral Communication]

 

Brodmann, M COMPARE Pilot RCT: 2-Year Results from Head to Head Study of Ranger DCB vs IN.PACT DCB in complex lesions
AMP 2019; August 14-17, 2019; Chicago, USA. 2019. [Oral Communication]

 

Brodmann, M How Best to Define and Treat “No Option” CLI Patients
VERVE 2019; DEC 5-7, 2019; Sydney, AUSTRALIA. 2019. [Oral Communication]

 

Brodmann, M Final Results of the Ranger II Pivotal Trial
VERVE 2019; DEC 5-7, 2019; Sydney, AUSTRALIA. 2019. [Oral Communication]

 

Brodmann, M Drug eluting technology: What was the Impact of the JAHA Meta-analysis 1-Year Later?
VERVE 2019; DEC 5-7, 2019; Sydney, AUSTRALIA. 2019. [Oral Communication]

 

Brodmann, M The Real World Global Registry Confirms The Value Of The IN.PACT DCB For Treating More Complex SFA Lesions Including In Stent Restenosis (ISR)
VEITH 2019; NOV 19-23, 2019; New York, USA. 2019. [Oral Communication]

 

Brodmann, M Drug Eluting Balloon BTK-Update: What Role Does DCB Play In CLI Patients?
6. PVI Excellence Circle; NOV 14,2019; Wien, AUSTRIA. 2019. [Oral Communication]

 

Brodmann, M Optimal Antithrombotics in CLI & COMPASS Trial Update
AMP EUROPE 2019; OCT 2-4, 2019; Lugano, SWITZERLAND. 2019. [Oral Communication]

 

Brodmann, M pAVK 2019-Was gibt es Neues?
1. Grazer Herzkreislauftage ; SEP 13-15, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

 

Brodmann, M PTX Controversy and treatment options for lower limb endovascular treatment
1. Grazer Herzkreislauftage; SEP 13-15, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

 

Brodmann, M Etablierte/neue Verfahren zur Objektivierung der Extremitätenperfusion vor und nach Revaskularisation
DGA 2019; SEP 12-12, 2019; Leipzig, GERMANY. 2019. [Oral Communication]

 

Brodmann, M Lutonix Data update: Update on the BTK Global Registry& IDE Trial
DCB Summit Barcelona; JUNI 11-12, 2019; Barcelona, SPAIN. 2019. [Oral Communication]

 

Brodmann, M Disrupting Critical Limb Ischemia with Intravascular Lithothripsy
AMP 2019; August 14-17, 2019; Chicago, USA. 2019. [Keynote lecture]

 

Brodmann, M The importance of dissection identification in optimizing Patient outcomes
AMP 2019; August 14-17, 2019; Chicago, USA. 2019. [Keynote lecture]

 

Brodmann, M Summarizing the TOBA Evidence from Above and Below the knee clinical trial data
VERVE 2019; DEC 5-7, 2019; Sydney, AUSTRALIA. 2019. [Oral Communication]

 

Brodmann, M Why I believe a 6 month follow up is good enough for CLI patients?
VEITH 2019; NOV 19-23, 2019; New York, USA. 2019. [Oral Communication]

 

Brodmann, M Compass and Voayger PAD are trying to answer our open questions for secondary prophylactic treatment in patients with PAD
Charing Cross 2019; April 15-18, 2019; London, Great Britain. 2019. [Oral Communication]

 

Brodmann, M Long-term safety of Low dose Stellarex drug coated balloon
CRT 19 (Cardiovascular Research Technologies); March 2-5, 2019; Washington DC, USA. 2019. [Oral Communication]

 

Brodmann, M Why we are excited about DCB for In-stent restenosis?
CRT 19 (Cardiovascular Research Technologies); March 2-5, 2019; Washington DC, USA. 2019. [Oral Communication]

 

Brodmann, M Stellarex DCB: safely treat the complex patient
CRT 19 (Cardiovascular Research Technologies); March 2-5, 2019; Washington DC, USA. 2019. [Oral Communication]

 

Brodmann, M Update Optimize BTK Trial
Nationaler interdisziplinärer Kongress zur kritischen Extremitätenischämie; JUNI 14-14, 2019; Düsseldorf. 2019. [Oral Communication]

 

Brodmann, M The geriatric Patient in the age of modern endovascular Treatment options
Charing Cross 2019; April 15-18, 2019; London, Great Britain. 2019. [Oral Communication]

 

Brodmann, M Comparison of Overall LTX BTK IDE six month Outcomes to Global Registry
Charing Cross 2019; April 15-18, 2019; London, Great Britain. 2019. [Oral Communication]

 

Brodmann M An Overview of BTK Outcomes
ISET; JAN 27-30, 2019; Hollywood, Florida, USA. 2019. [Oral Communication]

 

Brodmann M Saver Registry Update
ISET; JAN 27-30, 2019; Hollywood, Florida, USA. 2019. [Oral Communication]

 

Brodmann M, IN.PACT Trial Update
AMP 2019; August 14-17, 2019; Chicago, USA. 2019. [Oral Communication]

 

Brodmann, M Drug coated balloons bei PAVK, below the knee
Angiologische Sommerakademie; JUNI 20-22, 2019; Wien, Austria. 2019. [Keynote lecture]

 

Brodmann,M Antithrombotic therapies in pregnancy
ESC Joint Educational Training Programme: Antithrombotic therapies:Clinical challenges and future directions; JUNI 12-14,2019; Sophia Antipolis, FRANCE. 2019. [Keynote lecture]

 

Brodmann,M Newest Stem Cell Therapies are Effective in Treating Lower Extremity Ischemia
VEITH 2019; NOV 19-23, 2019; New York, USA. 2019. [Oral Communication]

 

Brodmann,M Appropriate follow up of patients after endovascular procedures
DCB Summit Barcelona; JUNI 11-12, 2019; Barcelona, SPAIN. 2019. [Oral Communication]

 

Brodmann,M Benefit and Risk Profile of Paclitaxel-Coated Peripheral Devices
20. Unionstagung der Schweizerischen Gesellschaften für Gefässkrankheiten; NOV 13-15, 2019; Luzern, SWITZERLAND. 2019. [Oral Communication]

 

Brodmann,M Medical Therapy for CLI. A comprehensive Update on latest Treatments including Therapy iniation time
AMP Europe 2019; OCT 2-4, 2019; Lugano, SWITZERLAND. 2019. [Oral Communication]

 

Brodmann,M Drug-coated balloons in 2019
CIRSE 2019; SEP 7-11, 2019; Barcelona, SPAIN. 2019. [Oral Communication]

 

Brodmann,M Distinguishing between class effect and device/brand-specificfeatures:how to decide what deserves adoption?
CIRSE 2019; SEP 7-11, 2019; Barcelona, SPAIN. 2019. [Keynote lecture]

 

Brodmann,M What is the Role of Open Vascular Surgery in PAD in 2020:An Overview of Proposed Indications
VERVE 2019; DEC 5-7, 2019; Sydney, AUSTRALIA. 2019. [Oral Communication]

 

Brodmann,M; NOAK´s und Arteriosklerose, macht eine solche Verbindung Sinn?
Bezirksärztetreffen Wartberg; Mai 9, 2019; Wartberg. 2019. [Keynote lecture]

 

Brodmann,M Which Atherectomy device is best and why? A European perspective and Shockwave based technology with a Jack Hammer Effect to facilitate CTO Wire Crossing: Soundbite How it works
VEITH 2019; NOV 19-23, 2019; New York, USA. 2019. [Oral Communication]

 

Gressenberger, P; Muster, V; Gütl, K; Raggam, R; Brodmann, M; Tiesenhausen, K; Gary, T Recurrent venous thromboembolism in a patient with a venous aneurysm of the left femoral vein.
The Venous Symposium ; APR 11-13, 2019; New York, USA . 2019. [Poster]

 

Guetl, K; Horina, A; Muster, V; Mangge, H; Gressenberger, P; Brodmann, M; Wimmer, G; Seinost, G The Effect of Periodontal Treatment on Endothelial Function in Patients with Severe Periodontitis and Symptomatic Lower Extremity Artery Disease - A Randomized Controlled Trial.
European Society of Vascular Medicine (ESVM); OCT 10-12, 2019; Ljubljana, SLOVENIA. 2019. [Poster]

 

Guetl, K; Raggam, RB; Muster, V; Vujic, J; Gressengerber, P; Avian, A; Hafner, F; Wehrschuetz, M; Brodmann, M; Gary, T The White Blood Cell Count to Mean Platelet Volume Ratio: A Novel Marker for Prediction of Chronic Limb Threatening Ischemia in Lower Extremity Artery Disease
European Society of Vascular Medicine (ESVM); OCT, 10-12, 2019; Ljubljana, SLOVENIA. 2019. [Poster]

 

Gütl, K; Raggam, RB; Muster, V; Vujic, J; Avian, Alexander; Hafner, F; Wehrschuetz, M; Brodmann, M; Gary, T The White Blood Cell Count to Mean Platelet Volume Ratio: A Novel Marker for Critical Limb Ischemia in Lower Extremity Artery Disease
Angiologische Sommerakademie; JUN 20-22, 2019; Vienna, AUSTRIA. 2019. [Poster]

 

Shammas, NW; Chandra, P; Brodmann, M; Weinstock, B; Sedillo, G; Cawich, I; Micari, A; Lee, A; Metzger, C; Palena, LM; Rundback, J Acute and 30-Day Safety and Effectiveness Evaluation of Eximo Medical's B-Laser, a Novel Atherectomy Device, in Subjects Affected With Infrainguinal Peripheral Arterial Disease: Results of the EX-PAD-03 Trial
JACC-CARDIOVASC INTE. Abstract Book CRT19. 2019; 12(4):S24-S25.-CRT19; MAR 2-5, 2019; Washington, USA. Doi: 10.1016/j.jcin.2019.01.095 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Brodmann, M ESC Guidelines pAVK.
Österreichische Kardiologische Gesellschaft Jahrestagung 2018 „Under pressure – das Herz im gesellschaftlichen Wandel“; JUN 6-9, 2018; Salzburg, AUSTRIA. 2018. [Oral Communication]

 

Brodmann, M DCB in SFA: Level 1 evidence review.
CIRSE; SEP 22-25, 2018; Lissabon, PORTUGAL. 2018. [Oral Communication]

 

Brodmann, M DCB + Focal scaffolding - the new concept for optimized BTK angioplasty?
Veith 2018; Nov 13-17, 2018; New York. 2018. [Oral Communication]

 

Brodmann, M Comparative SFA Technologies
VIVA 2018; NOV 5-8, 2018; Las Vegas. 2018. [Oral Communication]

 

Brodmann, M NOAKs und Arteriosklerose: Macht so eine Verbindung Sinn?
Thrombovision Kärnten 2018; OCt 12, 2018; Klagenfurt. 2018. [Oral Communication]

 

Brodmann, M PAD 5: Update on periprocedural and log-term platelet inhibition and anticoagulation in PAD - " Cardiovascular outcomes after lower extremity endovascular or surgical revascularization - the EUCLID trial"
8 th Munich Vascular Conference; Dec 6-8, 2018; Munich, Germany. 2018. [Oral Communication]

 

Brodmann, M Combination of Atherectomy (with stealth 360 device from CSI) and DCB for treating calcified Occlusions in BTK Arteries: How the device works and preliminary results
Veith 2018; Nov 13-17, 2018; New York, USA. 2018. [Oral Communication]

 

Brodmann, M The Biolux Paseo-18 Lux DCB: Advanges And Good Patency in Diffcult fempop lesions
Veith 2018; Nov 13-17, 2018; New York, USA. 2018. [Oral Communication]

 

Brodmann, M Drug Eluting Update
5. PVI Excellence Circle; NOV 29, 2018; Vienna, Austria. 2018. [Oral Communication]

 

Brodmann, M Shockwave energy to facilitate guidewire crossing of difficult and calcified CTOs: Early Clinical experience and preautions.
Veith 2018; Nov 13-17, 2018; New York. 2018. [Oral Communication]

 

Brodmann, M PAD1: Innovative imaging and below-the-knee-treatment modalities - "Early results from a RCT on below-the-knee drug-eluting balloons "
8th Munich Vascular Conference; Dec 6-8, 2018; Munich, Germany. 2018. [Oral Communication]

 

Brodmann, M Update on the Value of Track Assisted Balloon Angioplasty (TOBA): Results of the TOBA-ALTO and BASS trials for above knee and below the knee lesions: Do the tacks improve PTA patency
Veith 2018; Nov 13-17, 2018; New York. 2018. [Oral Communication]

 

Brodmann, M BTK-Intervention: Aktueller Stand und Zukunftsvision.
47. Jahrestagung der Deutschen Gesellschaft für Angiologie - Gesellschaft für Gefäßmedizin e.V. ; Sept 12-15, 2018; Münster, DEUTSCHLAND. 2018. [Oral Communication]
FullText

 

Brodmann, M What Kind of Drug Do we Need to treat BTK Arteries in CLI Patients
Veith 2018; Nov 13-17, 2018; New York. 2018. [Oral Communication]

 

Brodmann, M Neue Perspektiven durch aktuelle Studienergebnisse - Hokusai VTE Cancer.
ÖGIM; SEP 20-22, 2018; Salzburg, AUSTRIA. 2018. [Oral Communication]

 

Brodmann, M Interim results of a multicenter, controlled trial comparing 4 F vs 6 French femoral access site complications for ambulatory endovascular treatment of PAD.
CIRSE; SEP 22-25, 2018; Lissabon, PORTUGAL. 2018. [Oral Communication]

 

Brodmann, M Antithrombotic therapy in a 50 year old patient with intermittent claudication.-Conclusion and take home message.
ESC; AUG 25-29, 2018; Munich, GERMANY. 2018. [Oral Communication]

 

Brodmann, M Patient recruitment and retention challenges
LINC; JAN 30 - FEB 2, 2018; Leipzig, GERMANY. 2018. [Oral Communication]

 

Brodmann, M ILLUMENATE EU RCT: 2-year results with the Stellarex DCB in femoropopliteal lesions.
LINC; JAN 30 - FEB 2, 2018; Leipzig, GERMANY. 2018. [Oral Communication]

 

Brodmann, M Cancer assoziierte Therapie und ESC Guidelines PAVK 2017.
Cancer assoziierte Therapie und ESC Guidelines PAVK 2017.; JAN 25,2018; Graz, AUSTRIA. 2018. [Keynote lecture]

 

Brodmann, M Endovascular first: Möglichkeiten und Grenzen dieser Therapie.
Österreichische Kardiologische Gesellschaft Jahrestagung 2018 „Under pressure – das Herz im gesellschaftlichen Wandel“; JUN 6-9, 2018; Salzburg, AUSTRIA. 2018. [Oral Communication]

 

Brodmann, M The concept of focal Tack-scaffolding for optimisation of BTK procedural outcomes.
Charing Cross 2018; APR 24-27, 2018; London, Great Britain. 2018. [Oral Communication]

 

Brodmann, M Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries. Twelve-month results of the BIOLUX P-III all-comers registry for the full cohort.
Charing Cross 2018; APR 24-27, 2018; London, Great Britain. 2018. [Oral Communication]

 

Brodmann, M Lithoplasty for preparation of severely calcified lesions.
Charing Cross 2018; APR 24-27, 2018; London, Great Britain. 2018. [Oral Communication]

 

Brodmann, M ILLUMENATE study.
Charing Cross 2018; APR 24-27, 2018; London, Great Britain. 2018. [Oral Communication]

 

Brodmann, M Overview of peripheral intravascular lithotrispy clinical programmes.
Charing Cross 2018; APR 24-27, 2018; London, Great Britain. 2018. [Oral Communication]

 

Brodmann, M Lithoplasty for BTK.
CRT 2018; MAR 3-6, 2018; Washington, USA. 2018. [Oral Communication]

 

Brodmann, M Adventitial drug infusion to prevent restenosis.
LINC; JAN 30 - FEB 2, 2018; Leipzig, GERMANY. 2018. [Oral Communication]

 

Brodmann, M Real-world experience with a Paclitaxel Coated Balloon for the treatment of atherosclerotic infrainguinal arteries. Twelve-month results of the BIOLUX P-III All Comers Registry in diabetic patients.
LINC; JAN 30 - FEB 2, 2018; Leipzig, GERMANY. 2018. [Oral Communication]

 

Brodmann, M Update on the Optimize BTK trial (Atherectomy with the CSI atherectomy catheter in combination with DCB in calcified BTK lesions).
LINC; JAN 30 - FEB 2, 2018; Leipzig, GERMANY. 2018. [Oral Communication]

 

Brodmann, M Arterielle Revaskularisation - katheterbasiert
124. Kongress der Deutschen Gesellschaft für Innere Medizin; APR 14-17, 2018; Mannheim, GERMANY. 2018. [Oral Communication]

 

Brodmann, M Endovascular treatment of chronic vein occlusion.
ESVM & Angio 2018; MAR 18-20, 2018; Praque, CZECH REPUBLIC. 2018. [Oral Communication]

 

Brodmann, M Aktuelle Behandlungskonzepte der pAVK.
Thrombosedialog ; MAR 23-24, 2018; Salzburg, AUSTRIA. 2018. [Oral Communication]

 

Brodmann, M Endpoints in CLI Trials -- Is there Agreement?.
CRT 2018; MAR 3-6, 2018; Washington, USA. 2018. [Oral Communication]

 

Brodmann, M Is there a place for lithoplasty to disrupt calcium and assist drug trasfer with dcb?.
CRT 2018; MAR 3-6, 2018; Washington, USA. 2018. [Oral Communication]

 

Brodmann, M Objective assessment of CLI patients: What about hemodynamic parameters – are they worth anything especially when it comes to end stage no option patients!.
LINC; JAN 30 - FEB 2, 2018; Leipzig, GERMANY. 2018. [Oral Communication]

 

Brodmann, M How to assess procedural success in complex CLI-settings? Initial OMNIA results: unique tool in the assessment and clinical management of CLI.
LINC; JAN 30 - FEB 2, 2018; Leipzig, GERMANY. 2018. [Oral Communication]

 

Brodmann, M Update on TOBA below-the-knee.
LINC; JAN 30 - FEB 2, 2018; Leipzig, GERMANY. 2018. [Oral Communication]

 

Brodmann, M Percutaneous deep venous arterialization with the LimFlow procedure. Presentation and a case example.
LINC; JAN 30 - FEB 2, 2018; Leipzig, GERMANY. 2018. [Oral Communication]

 

Brodmann, M Outcomes of DCB use in real-world patients: 2-year results from the IN.PACT global registry.
LINC; JAN 30 - FEB 2, 2018; Leipzig, GERMANY. 2018. [Oral Communication]

 

Brodmann, M Randomized Trial of DCB vs. PTA: 2-Year Results of IN.PACT Japan Trial.
AMP; AUG 8-11, 2018; Chicago, USA. 2018. [Oral Communication]

 

Brodmann, M Lutonix Global Registry Update.
AMP; AUG 8-11, 2018; Chicago, USA. 2018. [Oral Communication]

 

Brodmann, M Lutonix BTK Update.
AMP; AUG 8-11, 2018; Chicago, USA. 2018. [Oral Communication]

 

Brodmann, M I Have A CLI Patient With All Three Below The Knee Vessel’s Diseased: Can The Angiosome Concept Help In Making A Decision?
Mount Sinai LINC 2018; JUN 12-13, 2018; New York, USA. 2018. [Oral Communication]

 

Brodmann, M DCB Therapy In Infrapopliteal Disease: Clarifying The Murky Waters.
Mount Sinai LINC 2018; JUN 12-13, 2018; New York, USA. 2018. [Oral Communication]

 

Brodmann, M Impact Global Registry Vorstellung
2. DGA Interventionskongress; JUN 8-9, 2018; Hamburg, GERMANY. 2018. [Oral Communication]

 

Brodmann,M SFA/POP Treatment:shaping the future of DCB
GISE 2018; OCT 16-19, 2018; Mailand. 2018. [Keynote lecture]

 

Brodmann,M Tack-Optimized Angioplasty: Ist role in BTK and Early Results
VIVA 2018; NOV 5-8,2018; Las Vegas. 2018. [Oral Communication]

 

Brodmann,M Lessons learned from the IN.Pact DCB Global Registry - Chronic total occlusion (CTO) Cohort: How to make DCB´s work best with CTOs
Veith 2018; Nov 13-17,2018; New York. 2018. [Oral Communication]

 

Gries, A; Gabron, C; Lackner, HK; Gary, T; Brodmann, M; Kolovetsiou-Kreiner, V; Mayer-Pickel, K; Lang, U; Binder, B; Aberer, E; Demel, U; Pichler, A; Horn, S Epidemiology of the Antiphospholipid syndrome – a retrospective study at the University Hospital Graz, Austria
Jahrestagung der Österreichischen Physiologischen Gesellschaft; OKT 4, 2018; Salzburg, AUSTRIA. 2018. [Poster]
FullText

 

Mahmud, E; Hafner, F; Rief, P; Cain, C; Ang, L; Brodmann, M Robotic Peripheral Vascular Intervention with Drug Coated Balloons is Feasible and Reduces Operator Radiation Exposure: Results of the Robotic-Assisted Peripheral Intervention for Peripheral Artery Disease (RAPID) Study II
J AM COLL CARDIOL. 2018; 72(13):B178-B178.-30th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT); SEP 21-25, 2018; San Diego, CA. Doi: 10.1016/j.jacc.2018.08.1608 [Keynote lecture]
Web of Science FullText FullText_MUG

 

Aberer, F; Tripolt, N; Riedl, R; Hutz, B; Url, J; Brodmann, M; Meinitzer, A; Stojakovic, T; Dimsity, G; Hodl, R; Hafner, F; Sourij, H The Effect of Linagliptin on the Endothelial Function and Arginine Bioavailability Ratio in CHD Patients with Early Type 2 Diabetes Mellitus - A Randomized Controlled Trial.
WIEN KLIN WOCHENSCHR. 2017; 129: 162-162. [Oral Communication]
Web of Science

 

Aberer, F; Tripolt, N; Riedl, R; Hutz, B; Url, Jasmin; Brodmann, M; Meinitzer, A; Stojakovic, T; Dimsity, G; Hödl, Ronald; Hafner, F; Sourij, H; Der Einfluss von Linagliptin auf die Endothelfunktion und Arginin-Bioavailability Ratio bei KHK Patienten mit frühem Diabetes mellitus Typ 2 – eine randomisierte kontrollierte Studie.
Wiener klinische Wochenschrift 2017; 128 (Suppl. 4) . 2017; 162-162.-45. ÖDG-Jahrestagung 2017 ; NOV 16-18, 2017; Salzburg, AUSTRIA. [Oral Communication]

 

Brodmann, M Algorithm for the treatment of Calcified SFA Lesions.
LINC MOUNT SINAI; JUN 12-14, 2017; New York, USA. 2017. [Oral Communication]

 

Brodmann, M Minimal footprint Tack placement for dissection repair after below-the-knee balloon angioplasty.
Charing Cross; APR 25-28, 2017; London, UNITED KINGDOM. 2017. [Oral Communication]

 

Brodmann, M NOACs and antiplatelet agents in PAD patients – clinical aspects together with laboratory findings.
3rd Annual Congress of the ESVM and the 23rd IUA EuroChap Congress; MAY 7-9, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M Is There a Place for Lithoplasty to Dirsupt Calcium and Assist Drug Transfer with DCB?.
VERVE; DEZ 7-9,2017; Sydney, AUSTRALIA. 2017. [Oral Communication]

 

Brodmann, M Towards Optimised BTK Results by Preventing Recoil and Sealing Dissections – TOBA BTK.
VERVE; DEZ 7-9,2017; Sydney, AUSTRALIA. 2017. [Oral Communication]

 

Brodmann, M Is There Any Hope Left for DCB in Infrapopliteal Interventions?.
VERVE; DEZ 7-9,2017; Sydney, AUSTRALIA. 2017. [Oral Communication]

 

Brodmann, M Cost Efficacy.
4. PVI Excellence Circle; NOV 23, 2017; Vienna, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M Optical coherence tomography with debulking and drug-coated balloon.
Charing Cross; APR 25-28, 2017; London, UNITED KINGDOM. 2017. [Oral Communication]

 

Brodmann, M Guidelines should reflect the latest clinical data.
Charing Cross; APR 25-28, 2017; London, UNITED KINGDOM. 2017. [Oral Communication]

 

Brodmann, M Lithoplastytechnologie zur Behandlung kalzifizierter SFA und BTK Läsionen: Interimanalye.
11. Arnsberger Gefäßtage; MAR 30- APR 1, 2017; Arnsberg, GERMANY. 2017. [Oral Communication]

 

Brodmann, M Is Drug Delivery BTK Dead? What Lies Ahead?.
VIVA; SEP 11-14, 2017; Las Vegas, USA. 2017. [Oral Communication]

 

Brodmann, M Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries: 12-month results of the BIOLUX P-III allcomers registry.
CIRSE; SEP 16-20, 2017; Copenhagen, DENMARK. 2017.

 

Brodmann, M Impact of calcium on drug-coated balloon: analysis of the long lesion (>15 cm) and CTO imaging cohorts of the IN.PACT Global study.
CIRSE; SEP 16-20, 2017; Copenhagen, DENMARK. 2017.

 

Brodmann, M 4 trials/1.000+ patients: results from the ILLUMENATE SFA program.
LINC 2017; JAN 24-27,2017; Leipzig, Germany. 2017. [Oral Communication]

 

Brodmann, M We want to know where we are when we treat CTOs: OCT guided revascularisation.
LINC 2017; JAN 24-27,2017; Leipzig, Germany. 2017. [Oral Communication]

 

Brodmann, M Towards optimised BTK results by preventing recoil and sealing dissections – TOBA BTK.
LINC 2017; JAN 24-27,2017; Leipzig, Germany. 2017. [Oral Communication]

 

Brodmann, M Identifying Patients before Amputation is Imminent: Learn How to Identify and Treat Patients Earlier to Enhance Limb Preservation.
The Amputation Prevention Symposium; AUG 9-12, 2017; Chicago, USA. 2017. [Oral Communication]

 

Brodmann, M Lower Extremity Post-PTA Dissection Repair in the DCB Era.
The Amputation Prevention Symposium; AUG 9-12, 2017; Chicago, USA. 2017. [Oral Communication]

 

Brodmann, M An Update o nthe ILLUMENATE Trial.
The Amputation Prevention Symposium; AUG 9-12, 2017; Chicago, USA. 2017. [Oral Communication]

 

Brodmann, M The European Experience and the Path Forward.
The Amputation Prevention Symposium; AUG 9-12, 2017; Chicago, USA. 2017. [Oral Communication]

 

Brodmann, M The PRELUDE Study: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator Device.
VIVA; SEP 11-14, 2017; Las Vegas, USA. 2017. [Oral Communication]

 

Brodmann, M ILLUMENATE European Randomized Trial: Two-Year Results.
VIVA; SEP 11-14, 2017; Las Vegas, USA. 2017. [Oral Communication]

 

Brodmann, M Safety and performance of the Shockwave Medical Lithoplasty® System in treating calcified, stenotic, infrapopliteal arteries.
CIRSE; SEP 16-20, 2017; Copenhagen, DENMARK. 2017. [Oral Communication]

 

Brodmann, M Current and Future Strategies for Femoropopliteal Calcification.
VIVA; SEP 11-14, 2017; Las Vegas, USA. 2017. [Oral Communication]

 

Brodmann, M Two-year results from the IN.PACT global studies and outcomes in patients with diabetes.
CIRSE; SEP 16-20, 2017; Copenhagen, DENMARK. 2017. [Oral Communication]

 

Brodmann, M The Cost of Vascular Care in the U.S; Insights from the REACH Registry and How we Compare Globally.
VIVA; SEP 11-14, 2017; Las Vegas, USA. 2017. [Oral Communication]

 

Brodmann, M BTK Calcified Disease Treated with Lithoplasty: Experience from Austria.
C3; JUN 27-30, 2017; Orlando, FLORIDA. 2017. [Oral Communication]

 

Brodmann, M New DCB Trials for BTK Disease in CLI: Overview.
C3; JUN 27-30, 2017; Orlando, FLORIDA. 2017. [Oral Communication]

 

Brodmann, M Produktpräsentation: Keine Angst vor NOAK‘s.
Grazer Fortbildungstage; OCT 9-14, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M Was ist gesichert, was ist obsolet? ...bei NOAK‘s.
Grazer Fortbildungstage; OCT 9-14, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M ESC Guidelines 2017 on peripheral arterial disease.
ÖGIM; SEP 21-23, 2017; Salzburg, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M Upper and lower extremities arteries.
ESC Congress; AUG 26-30, 2017; Barcelona, SPAIN. 2017. [Oral Communication]

 

Brodmann, M In.Pact Global Complex lesion data.
3rd Annual Congress of the ESVM and 23rd IUA EuroChap Congress; MAY 7-9, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M Lebensbegleitende Medikation - Herausforderung für Arzt und Patient? Antikoagulation und Compliance.
Antikoagulation im Dialog; MAY 5-6, 2017; Salzburg, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M Twelve-month duplex patency and MRA following OCT-guided atherectomy: single-centre prospective case series.
Charing Cross; APR 25-28, 2017; London, UNITED KINGDOM. 2017. [Oral Communication]

 

Brodmann, M Lutonix BTK Studie und Register: Eine neue Hoffnung für den DCB bei BTK Interventionen?.
11. Arnsberger Gefäßtage; MAR 30- APR 1, 2017; Arnsberg, GERMANY. 2017. [Oral Communication]

 

Brodmann, M Update Guidelines der Thromboembolischen Embolie.
Thrombovision Süd 2017; Mar 18 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M Tasks of a study nurse.
LINC; JAN 24-27,2017; Leipzig, Germany. 2017. [Oral Communication]

 

Brodmann, M The common femoral artery – an anatomical region still reserved for treatment by the surgeons?
LINC; JAN 24-27,2017; Leipzig, Germany. 2017. [Oral Communication]

 

Brodmann, M Thrombolytic therapy of distal upper extremity occlusions (hypothenar hammer syndrome): A therapeutic option for a rare disease.
LINC 2017; JAN 24-27,2017; Leipzig, Germany. 2017. [Oral Communication]

 

Brodmann, M DCB use in the SFA: Budget impact analysis and reimbursement in Austria.
LINC 2017; JAN 24-27,2017; Leipzig, Germany. 2017. [Oral Communication]

 

Brodmann, M Is There a Role for Direct Oral Anticoagulants After Treatment for PAD?.
VERVE; DEZ 7-9,2017; Sydney, AUSTRALIA. 2017. [Oral Communication]

 

Brodmann, M The Soundbite Guidewire as a New CTO Guidewire for Crossing Calcified CTO´s.
VERVE; DEZ 7-9,2017; Sydney, AUSTRALIA. 2017. [Oral Communication]

 

Brodmann, M Shockwave Lithoplasty May be an Option for Treatment of the Common Femoral Artery.
VERVE; DEZ 7-9,2017; Sydney, AUSTRALIA. 2017. [Oral Communication]

 

Brodmann, M Perkutane Arterialisation tiefer Venen bei "No-Option" CLI.
Gefäßmedizinisches Symposium; NOV 9-11, 2017; Berlin, GERMANY. 2017. [Oral Communication]

 

Brodmann, M Lithoplasty: A solution for calcified lesions?.
LINC 2017; JAN 24-27,2017; Leipzig, Germany. 2017. [Oral Communication]

 

Brodmann, M Real World Value of the In.Pact Admiral DCB (Medtronic) for Fem-Pop Lesions: From the IN.Pact Global Registry: What else does it tells us
VEITH; NOV 14-18, 2017; New York, USA. 2017. [Oral Communication]

 

Brodmann, M How to get involved in clinical research – Perspective from the site.
LINC 2017; JAN 24-27,2017; Leipzig, Germany. 2017. [Oral Communication]

 

Brodmann, M A real-world look at treatment effects of IN.PACT Admiral DCB: 12-month results from the IN.PACT Global Study full clinical cohort.
LINC 2017; JAN 24-27,2017; Leipzig. 2017. [Oral Communication]

 

Brodmann, M PAVK Guidelines 2017
ESC Update 2017; SEP 26, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M Kompression nach Revaskularisation?.
1. Grazer Wundtagung; OCT 20-21, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M CAVK
ÖGIM; SEP 21-23, 2017; Salzburg, AUSTRIA. 2017. [Oral Communication]

 

Brodmann, M Outcomes following subintimal recanalization of chronic total occlusions: a subset analysis of the IN.PACT global CTO imaging cohort.
CIRSE; SEP 16-20, 2017; Copenhagen, DENMARK. 2017.

 

Brodmann, M Lower extremity artery disease: women are special.
ESC Congress; AUG 26-30, 2017; Barcelona, SPAIN. 2017. [Oral Communication]

 

Brodmann, M Revascularisation for claudicants, the evidence is out there! PRO.
ESC Congress; AUG 26-30, 2017; Barcelona, SPAIN. 2017. [Oral Communication]

 

Brodmann, M Impact Trial Update.
LINC Mount Sinai; JUN 12-14, 2017; New York, USA. 2017. [Oral Communication]

 

Brodmann, M What Have We Learned From Past DCB BTK Studies?.
LINC Mount Sinai; JUN 12-14, 2017; New York, USA. 2017. [Oral Communication]

 

Brodmann, M. Antikoagulation und Compliance.
Thrombosedialog; Mar 10-11, 2017; Sheraton Fuschlsee-Salzburg. 2017. [Oral Communication]

 

Brodmann, M. TACK optimierte Ballonangioplastie der SFA und BTK: Vorläufige Studienergebnisse.
11. Arnsberger Gefäßtage; MAR 30- APR 1, 2017; Arnsberg, GERMANY. 2017. [Oral Communication]

 

Brodmann, M; Muck, PE; Recht, M Advantages and limitations of the OCT guidedatherectomy device (Panthera and ocelot systems from avinger) in the treatment of Iliac and lower extremity arterial lesions: concepts, indications and results.
VEITH; NOV 14-18, 2017; New York, USA. 2017.

 

Brodmann, M; Tepe, G; Holden, A Shockwave Lithoplasty - Indications and Results: Use in Combination with DCBs and other Treatments.
VEITH; NOV 14-18, 2017; New York, USA. 2017.

 

Brodmann, M; Wissgott, C; Bosiers, M; Zeller, T; Jaff, MR 2-Year results of the tack optimized balloon angiography (TOBA) trial for fem-pop and btk lesions demonstrates safety, efficacy and cost effectiveness of tack device (intact vascular) in repairing focal PTA dissections.
VEITH; NOV 14-18, 2017; New York, USA. 2017.

 

Brodmann, M; Zeller, T Passeo-18 lux DCBs; the latest 1-year results in CLI patients
VEITH; NOV 14-18, 2017; New York, USA. 2017.

 

Jud, P; Adelsmayr, G; Schmid, F; Deutschmann, H; Brodmann, M; Hafner, F Antegrade access of deep femoral artery collateral vessel and retrograde superficial femoral artery recanalization
Angiologische Sommerakademie 2017; JUN 15-17, 2017; Vienna, AUSTRIA. 2017. [Poster]

 

Brinton, T; Brodmann, M; Werner, M; Tepe, G; Holden, A; Scheinert, D; Wolf, F; Torsello, G; Lansky, A; Jaff, M; Zeller, T TCT-777 Safety and Performance of the Shockwave Medical Lithoplasty® System in treating calcified peripheral vascular lesions: 6-Month Results from the two-phase DISRUPT PAD Study.
J Am Coll Cardiol. . 2016; 68(18S):B314-B314.-Transcatheter Cardiovascular Therapeutics (TCT); OCT 29- Nov 2, 2016; Washington, US. Doi: 10.1016/j.jacc.2016.09.808 [Oral Communication]
Web of Science FullText FullText_MUG

 

Brinton, TJ; Illindala, U;Brodmann, M; Werner, M; Tepe, G; Holden, A; Scheinert, D; Torsello, G; Wolf, F; Zeller, T; Lithoplasty for the treatment of calcified SFA lesions: The Disrupt PAD study program
CIRSE 2016; SEP 10-14, 2016; Barcelona, SPAIN. 2016. [Oral Communication]

 

Brodmann, M Dickes Bein - Abklärung und Therapie.
47. Jahrestagung ÖGIM; SEP 22-24,2016; Salzburg, AUSTRIA. 2016. [Oral Communication]

 

Brodmann, M The use of shockwave lithotripsy for particularly calcified femoropopliteal lesions.
VERVE Symposium ; DEZ 1-3, 2016; Sydney, AUSTRALIA. 2016. [Oral Communication]

 

Brodmann, M Theory and evidence to support use of the stellarex balloon.
VERVE Symposium; DEZ 1-3, 2016; Sydney, AUSTRALIA. 2016. [Oral Communication]

 

Brodmann, M Will the Results from Basil 2 and Best-CLI Change the Treatment Pradigm Back Toward open surgery for CLI?
VERVE Symposium; DEZ 1-3, 2016; Sydney, AUSTRALIA. 2016. [Oral Communication]

 

Brodmann, M TCT-786 6-month Duplex Patency and MRA following OCT guided Atherectomy: Single Center Prospective Case Series.
J Am Coll Cardiol. . 2016; 68(18S):B318-B318.-Transcatheter Cardiovascular Therapeutics ; OCT 29- Nov 2, 2016; Washington, US. Doi: 10.1016/j.jacc.2016.09.817 [Oral Communication]
Web of Science FullText FullText_MUG

 

Brodmann, M Could it be better that different drugs will give better results treating arterial disease below-the-knee.
VERVE Symposium; DEZ 1-3, 2016; Sydney, AUSTRALIA. 2016. [Oral Communication]

 

Brodmann, M Critical Limb Ischaemia: The Acute Coronary Syndrome of the Leg
ESC Conggress; AUG 27-31,2016; Rom, ITALY. 2016. [Oral Communication]

 

Brodmann, M How to manage calcified lesions and in-stent restenosis.
EuroPCR; MAY 17-20, 2016; Paris, FRANCE. 2016. [Oral Communication]

 

Brodmann, M Session evaluation and key learnings.
EuroPCR; MAY 17-20, 2016; Paris, FRANCE. 2016. [Oral Communication]

 

Brodmann, M PAD; the urgency for CV protection?.
European Society for Vascular Medicine ; May 8-10, 2016; Rom, Italy. 2016. [Oral Communication]

 

Brodmann, M Non-invasive and invasive diagnostics, endovascular therapies for aortic aneurysms, arterial and venous disease including varicosis, deep vein thrombosis and pulmonary embolism.
Vascular Medicine / Angiology in Europe - Quo Vadis?; APR 5-7, 2016; Hamburg, GERMANY. 2016. [Oral Communication]

 

Brodmann, M ILLUMINATE: an update on the Stellarex drug-coated balloon clinical programme
EuroPCR; MAY 17-20, 2016; Paris, FRANCE. 2016. [Oral Communication]

 

Brodmann, M Endovascular therapy of PTS.
European Society for Vascular Medicine ; May 8-10, 2016; Rom, Italy. 2016. [Oral Communication]

 

Brodmann, M Shockwave Lithoplasty: Innovation bei kalzifizierten Läsionen
10. Arnsberger Gefäßtage; APR 14-16, 2016; Arnsberg-Herdringen, GERMANY. 2016. [Oral Communication]

 

Brodmann, M Studienlage DCB im Unterschenkel
10. Arnsberger Gefäßtage; APR 14-16, 2016; Arnsberg-Herdringen, GERMANY. 2016. [Oral Communication]

 

Brodmann, M DISRUPT PAD 2: 30-day Follow -up on the Use of Lithoplasty(r) for the Treatment of de Novo Calcified SFA/Popliteal Disease.
CRT 2016; FEB 20-23, 2016; Washington, USA. 2016. [Oral Communication]

 

Brodmann, M What kind of vessel preparation is best before DCB usage for peripheral interventions.
CRT 2016; FEB 20-23, 2016; Washington, USA. 2016. [Oral Communication]

 

Brodmann, M Conquering Restenosis - Use of DCB and other Future Therapies.
CRT 2016; FEB 20-23, 2016; Washington, USA. 2016. [Oral Communication]

 

Brodmann, M DCB for Peripheral Application: Show me the Data I - DCB for SFA Lesions.
CRT 2016; FEB 20-23, 2016; Washington, USA. 2016. [Oral Communication]

 

Brodmann, M Real Life Daten nach den ersten Jahren mit DOAKs.
Thrombovision SÜD 2016; FEB 27, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

 

Brodmann, M Ich bevorzueg Clopidogrel wegen der besseren Wirksamkeit.
12. Königsberger Gefäßdialog; Nov 5, 2016; Bad Schönau, AUSTRA. 2016. [Oral Communication]

 

Brodmann, M BTK - reasons for DCB failure.
3rd International DEB Symposium ; OCT 14-15, 2016; Berlin, GERMANY. 2016. [Oral Communication]

 

Brodmann, M Differences and similiarities in all the DCB registries and RCTs: All DCBs and all studies are not equal.
VEITH Symposium; NOV 15-19, 2016; New York, USA. 2016. [Oral Communication]

 

Brodmann, M Tack Optimized Balloon Angioplasty in the SFA and BTK Arteries: Concept, How ot works and 1-year Results: The TOBA-BTK Trial.
VEITH Symposium; NOV 15-19, 2016; New York, USA. 2016. [Oral Communication]

 

Brodmann, M IMage Guided Directional Atherectomy with the Pantheris-Lumivascular System (from Avinger) Using OCT (Optimal Coherence Tomography) Guideance: Howit Works Advantages, Limitations and results.
VEITH Symposium; NOV 15-19, 2016; New York, USA. 2016. [Oral Communication]

 

Brodmann, M 2-Year Results with the Stellarex DCB in treating occlusive lesions: What makes it different: from the Illumenate trials
VEITH Symposium; NOV 15-19, 2016; New York, USA. 2016. [Oral Communication]

 

Brodmann, M Current Status, Value and Limitations of DCBs in Fempop Occlusive Disease: Update on the IN.Pact GLobal registry an the LEVANT II pf the Lutonix DCB (Bard): Are the benfits over POBA sustained.
VEITH Symposium; NOV 15-19, 2016; New YYork, USA. 2016. [Oral Communication]

 

Brodmann, M Gender-Based Vessel Disease.
3. PVI Excellence Circle; Nov 10, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]

 

Brodmann, M DCB Alone or in Combination with Adjunctive Therapies?.
Vascular Interventional Advances; SEP 18-22,2016; Las Vegas, USA. 2016. [Oral Communication]

 

Brodmann, M Intraluminal Versus Subintimal CTO Crossing: Does it Matter?
Vascular Interventional Advances; SEP 18-22,2016; Las Vegas, USA. 2016. [Oral Communication]

 

Brodmann, M Is Calcium Really such a Bad Thing? The Shocking Truth!
Vascular Interventional Advances; SEP 18-22,2016; Las Vegas, USA. 2016. [Oral Communication]

 

Brodmann, M Therapy of chronic limb ischaemia
CIRSE 2016; SEP 10-14, 2016; Barcelona, SPAIN. 2016.

 

Brodmann, M Tech Talks: Seeing Is Believing with Oct-guided Atherectomy.
CVC; JUL 18-21, 2016; Chicago. 2016. [Oral Communication]

 

Brodmann, M ILLUMENAE European Radnomized Clinicl Trial: 12-Month final results for the Stellarex Drug Coated Balloon.
The Amputation Prevention Symposium; AUG 10-13,2016; Chicago, USA. 2016. [Oral Communication]

 

Brodmann, M How do you choose your DCB? Do you flip a coin or follow the data? Learn from a global expert.
The Amputation Prevention Symposium; AUG 10-13,2016; Chicago, USA. 2016. [Oral Communication]

 

Brodmann, M Complex Endovascular Techniques III
CVC 2016; JUL 18-21, 2016; Chicago. 2016. [Oral Communication]

 

Brodmann, M Shock and Awe... Long Cto Crossings - Case-based Discussions and Lessons from Master Operators: Case #2 - Sfa Ctos.
CVC 2016; JUL 18-21, 2016; Chicago. 2016. [Oral Communication]

 

Brodmann, M Explaining the Discreoancy Between Low Patency and Higher Limb Salvage Rates After Revascularization for CLI: Does Perfusion Matter or Not?.
CCVVC 2016; JUN 14-17,2016; New York, USA. 2016. [Oral Communication]

 

Brodmann, M Shockwave Lithoplastie-eine Therapie für kalzifizierter Stenosen.
17. Dreiländertagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Angiologie; SEP 7-10,2016; Dresden, GERMANY. 2016. [Oral Communication]

 

Brodmann, M Drug-coated balloons for in-stent restenosis
Charing Cross; APR 26-29, 2016; London, UK. 2016. [Oral Communication]

 

Brodmann, M Minimally invasive testing: are you a eliever or a non-believer? What does the data say vs. clinical experinece?.
The Amputation Prevention Symposium; AUG 10-13,2016; Chicago, USA. 2016. [Oral Communication]

 

Brodmann, M Complex Endovascular Techniques II.
CVC; JUL 18-21, 2016; Chicago. 2016. [Oral Communication]

 

Brodmann, M Does the angiosome concept have an impact in diabetic feet?.
European Society for Vascular Medicine ; May 8-10, 2016; Rom, Italy. 2016. [Oral Communication]

 

Brodmann, M Popliteal and BTK trifurcation occlusion in dialyzed diabetic Rutherford 5
European Society for Vascular Medicine ; May 8-10, 2016; Rom, Italy. 2016. [Oral Communication]

 

Brodmann, M Einfach und individuelle Therapie bei VTE geht das?.
47. Jahrestagung ÖGIM; SEP 22-24,2016; Salzburg, AUSTRIA. 2016. [Oral Communication]

 

Brodmann, M Total Cardiovascular Risk Evaluation and Manangement in Patiens with PAD.
The 4th International Conference on PreHypertension, Hypertension & Cardio Metabolic Syndrome; Mar 3-6, 2016; Venice, ITALY. 2016. [Oral Communication]

 

Brodmann, M. Tibials and DCB: What is the latest, What is to come and What we learned from the past?.
The Amputation Prevention Symposium; AUG 10-13,2016; Chicago, USA. 2016. [Oral Communication]

 

Gary, T; Raggam, R; Avian, A; Hafner, F; Brodmann, M White blood cell count to mean platelet volume: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients
WIEN KLIN WOCHENSCHR. 2016; 128: S380-S381. [Oral Communication]
Web of Science

 

Gary, T; Raggam, R; Avian, A; Sareban, M; Brodmann, M Mean platelet volume: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients
WIEN KLIN WOCHENSCHR. 2016; 128: S380-S380. [Poster]
Web of Science

 

Gries, A; Gabron, C; Lackner, HK; Gary, T; Brodmann, M; Kolovetsiou-Kreiner, V; Mayer-Pickel, K; Lang, U; Binder, B; Aberer, E; Demel, U; Pichler, A; Horn, S; Epidemiology of the Antiphospholipid syndrome with particular reference to sex
Tag des Zentrums für Physiologische Medizin; MAR 31, 2016; Graz, AUSTRIA. 2016. [Poster]

 

Gries, A; Gabron, C; Lackner, HK; Gary, T; Brodmann, M; Pichler, A; Binder, B; Aberer, E; Mayer-Pickel, K; Demel, U; Horn, S; Kolovetsiou-Kreiner, V; Lang, U Epidemiology of the Antiphospholipidsyndrome with particular reference to sex - a retrospective study at the University Hospital Graz, Austria
10th International Congress on Autoimmunity ; APR 6-10, 2016; Leipzig, GERMANY. 2016. [Poster]

 

Hafner, F; Adelsmayr, G; Rief, P; Schmid, F; Deutschmann, H; Brodmann, M Antegrade access and retrograde SFA recanalization:the potential impact of profunda femoris artery and its collateral vessels
JACC, Volume 68, Issue 18, Supplement. 2016; -Transcatheter Cardiovascular Therapeutics Abstracts, Twenty-Eighth Annual Symposium Transcatheter Cardiovascular Therapeutics; OCT 29 - NOV 2, 2016; Washington D.C., USA. [Oral Communication]

 

Hafner, F; Peter, R; Schmid, F; Gary, T; Brodmann, M Thrombolysis in Hypothenar Hammer Syndrome a case series
WIEN KLIN WOCHENSCHR. 2016; 128: S379-S380. [Poster]
Web of Science

 

Jud, P; Gary, T; Hafner, F; Ghanim, N; Brodmann, M Peripheral artery occlusive disease due to cystic medial degeneration Erdheim-Gsell: A case report
WIEN KLIN WOCHENSCHR. Wiener Klinische Wochenschrift. 2016; 128(S5):S380-S380.-47. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEPT 22-24, 2016; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Pietzsch, JB; Geisler, BP; Jaff, MR; Zeller, T; Brodmann, M; y ECONOMIC ANALYSIS OF ENDOVASCULAR INTERVENTIONS FOR THE TREATMENT OF FEMOROPOPLITEAL PERIPHERAL ARTERY DISEASE IN AUSTRIA.
VALUE HEALTH. VALUE IN HEALTH19: A690-A690. NEW YORK: ELSEVIER SCIENCE INC; Doi: 10.1016/j.jval.2016.09.1973
Web of Science FullText FullText_MUG

 

Rief, P; Raggam, R; Avian, A; Hafner, F; Sareban, M; Wehrschütz, M; Brodmann, M; Gary, T Mean platelet volume: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
17. Dreiländertagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Angiologie; SEP 7-10, 2016; Dresden, GERMANY. 2016. [Oral Communication]

 

Rief, P; Raggam, R; Avian, A; Hafner, F; Sareban, M; Wehrschütz, M; Brodmann, M; Gary, T White blood cell count to mean platelet volume: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
17. Dreiländertagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Angiologie; SEP 7-10, 2016; Dresden, GERMANY. 2016. [Oral Communication]

 

Riel, LP; Charlebois-Ménard, M; Bérubé, S; Despatis, MA; Brodmann, M; Benko, A; Thérasse, E; Dion, S; Brouillette, M Ex-vivo CTO Crossing with a Novel Shock Wave-energized Guidewire.
Amputation Prevention Symposium (AMP); AUG 10-13, 2016; Chicago, USA. 2016. [Poster]

 

Riel, LP; Charlebois-Ménard, M; Dion, S; Rinfret, S; Tanguay, JO; Clavet, MÉ; Bertrand, MJ; Geoffroy, P; Berube, S; Despatis, MA; Brodmann, M; Thérèse, É; Benko, A; Guy, LG; LeClerc, G; Chagnon, M; Brouillette, M TCT-839 Acute safety and technical performance evaluation of a novel CTO-crossing device based on a shock wave-energized guidewire.
J Am Coll Cardiol. . 2016; 68(18S):B339-B339. Doi: 10.1016/j.jacc.2016.09.868 [Keynote lecture]
Web of Science FullText FullText_MUG

 

Brodmann, M Evaluation of a robotic system for femoropopliteal interventions
Charing Cross; APR 28- MAI 1,2015; London, UK. 2015. [Keynote lecture]

 

Brodmann, M DCB in BTK INtervention: Summary of the Evidence from 2 failes RCTs IN.PACT DEEP and Biolux P-II.
TCT 2015; OCT 11-15, 2015; San Francisco, USA. 2015. [Keynote lecture]

 

Brodmann, M SPAF-ACADEMY
SPAF-ACADEMY ; JUN 12,2015; Graz, AUSTRIA. 2015. [Keynote lecture]

 

Brodmann, M DCB vs. DES: Extrapolated Data and Its Relevance to Tibial Revascularization.
The Amputation Prevention Symosium; AUG 12-15, 2015; Chicago. 2015. [Keynote lecture]

 

Brodmann, M How important is vessel patency and how to achieve it.
European Society for Vascular Medicine; Mai 10-12,2015; Berlin-Potsdam, GERMANY. 2015. [Keynote lecture]

 

Brodmann, M DFS-aus Sicht der Angiologie.
Jahrestagung Steirische Diabetes Gesellschaft; Jun 13, 2015; Graz, AUSTRIA. 2015. [Keynote lecture]

 

Brodmann, M Interaktionen von Xa-Inhibitoren
17. Kardiologie-Kongress; Mär 05.07, 2015; Innbruck. 2015. [Keynote lecture]

 

Brodmann, M Behandlung in der Akutphase der venösen Thromboembolie
ÖGIM; SEP 24-26, 2015; Salzburg, AUSTRIA. 2015. [Keynote lecture]

 

Brodmann, M Angiologie - Top news aus 2014.
ÖGIM; SEPT 24-26, 2015; Salzburg, AUSTRIA. 2015. [Keynote lecture]

 

Brodmann, M Evidence-basierte Kathetertherapie
16. Unionstagung der Schweizerischen Gesellschaft für Gefäßkrankheiten; OCT 28-30, 2015; Bern, SCHWEIZ. 2015. [Keynote lecture]

 

Brodmann, M Pre-Recorded Case: Complications in a Complex CLI INtervention.
The Amputation Prevention Symposium; AUG 12-15, 2015; Chicago, USA. 2015. [Keynote lecture]

 

Brodmann, M European Update on Limb Salvage Tools.
The Amputation Prevention Symposium; AUG 12-15, 2015; Chicago, USA. 2015. [Keynote lecture]

 

Brodmann, M Shockwave in peripheren Arterien
VASCMED 2015; OCT 22-24,2015; Innsbruck. 2015. [Keynote lecture]

 

Brodmann, M Recanalisation of long chronic total occlusions of SFA: Indications and limitations.
European Society of Vascular Medicine; Mai 10-12,2015; Berlin-Potsdam, GERMANY. 2015. [Keynote lecture]

 

Brodmann M; Complications in the cath lab and what we learned from it
LINC; JAN 27-30, 2015; Leipzig. 2015. [Keynote lecture]

 

Brodmann M; DCB are still a valid option to solve the challenge of BTK vessel patency: Lutonix trials are continuing
LINC; JAN 27-30, 2015; Leipzig. 2015. [Keynote lecture]

 

Brodmann M; Hypertonie aus angiologischer Sicht
10. Kardiovaskuläres Symposium Wilhelminenberg; JAN 24, 2015; Wien. 2015. [Oral Communication]

 

Brodmann, M; Burket, MW; Jaff, MR; Clinical outcomes of the Bioflex-I study: utilization of self-expanding stents in the iliac arteries
CIRSE; SEP 26-30, 2015; Lissabon, Portugal. 2015. [Keynote lecture]

 

Brodmann, M; Zeller, T; Bosiers, M; Peeters, P; Schulte,KL; Scheinert, D; Beschorner, U; Pilger, E Paclitaxel-coated balloon for the treatment of infrapopliteal arteries: 12-month results from the BIOLUX P-II randomized trial
CIRSE ; SEP 26-30, 2015; Lissabon, Portugal. 2015. [Keynote lecture]

 

Gary, T; Pichler, M; Rief, P; Hafner, F; Brodmann, M The AST/ALT Ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease Patients
WIEN KLIN WOCHENSCHR. 2015; 127(17-18):721-721. [Poster]
Web of Science

 

Hafner, F; Hackl, G; Ghanim, L; Mandl, J; Urdl, H; Fessler, J; Ghanim, N; Gary, T; Brodmann, M Survival in giant cell arteritis – a cohort based analysis
Zeitschrift für Gefäßmedizin. 2015; 12(3):18-19.-VASCMED 2015; 2. Kongress des Österreichischen Verbandes für Gefäßmedizin; OCT 22-24, 2015; Innsbruck; AUSTRIA. [Oral Communication]

 

Hafner, F; Mandl, J; Hackl, G; Rief, P; Ghanim, L; Fessler, J; Ghanim, N; Urdl, H; Brodmann, M Survival in giant cell arteritis – a cohort based analysis
Zeitschrift für Gefäßmedizin. 2015; -Sailer Symposium; JUN 18-19, 2015; Graz, AUSTRIA. [Poster]

 

Kirsch, AH; Kirsch, A; Artinger, K; Schabhüttl, C; Goessler, W; Klymiuk, I; Gülly, I; Fritz, W; Frank, S; Wimmer, R; Brodmann, A; Anders, HJ; Pramstaller, Rosenkranz, AR; Eller, K; Eller P; Heterogeneous susceptibility for uremic media calcification and concomitant inflammation within the arterial tree
Jahrestagung der österreichischen Gesellschaft für Nephrologie; OCT 1-3, 2015; Alpbach, Österreich. 2015. [Oral Communication]

 

Königsbrügge, O; Brodmann, M; Hoke, M Grau ist alle Theorie - was lernen wir aus der Praxis? Antikoagulation - Fallbeispiele
Thrombosedialog; Mär 20-21, 2015; St. Wolfgang. 2015. [Keynote lecture]

 

Mahmud, E; Schmid, F; Kalmar, P; Deutschmann, HA; Brodmann, M RAPID (Robotic-Assisted Peripheral Intervention for peripheral arterial Disease) Study
J AM COLL CARDIOL. 2015; 66(15):B329-B330.-27th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT); OCT 11-15, 2015; San Francisco, CA. Doi: 10.1016/j.jacc.2015.08.1117 [Oral Communication]
Web of Science FullText FullText_MUG

 

Rief, P; Hackl, G; Hafner, F; Brodmann, M; Gary, T The relationship of glycosylated hemoglobin (HbA1c) and reobstruction in the superficial femoral artery after percutaneous transluminal angioplasty
59th Annual Meeting of the Society of Thrombosis and Hemostasis Research; Feb 24-27, 2015; Düsseldorf, Germany. 2015. [Poster]

 

Rief, P; Hackl, G; Hafner, F; Raggam, RB; Wölfler, A; Brodmann, M; Gary, T VTE during Pressence of acquired Inhibitor to Coagulation factor V - A case report
Z f Gefäßmedizin. 2015; -Sailersymposium; Jun 18-19, 2015; Graz. [Oral Communication]

 

Rief, P; Hackl, G; Hafner, F; Raggam, RB; Wölfler, A; Brodmann, M; Gary, T; Venous thromboembolism during concomitant presence of acquired inhibitor to coagulation factor V – A case report
10. Sailersymposium 2015; Jun 18-20, 2015; Graz, Austria. 2015. [Poster]

 

Rief, P; Hackl, G; Hafner, F; Raggam, Reinhard Bernd; Wölfler, Albert; Brodmann, Marianne; Gary, Thomas Erworbene, idiopathische Hemmkörper-Hämophilie gegen Faktor V – Ein Fallbericht
VASCMED 2015; Oct 22-24, 2015; Innsbruck, Austria. 2015. [Oral Communication]

 

Rief, P; Hafner, F; Eller, P; Hackl, G; Brodmann, M; Gary, T Graz CLI Score: a risk score for critical limb ischemia in peripheral arterial occlusive disease patients
EUR HEART J. 2015; 36: 697-698.-Congress of the European-Society-of-Cardiology (ESC); AUG 29-SEP 02, 2015; London, ENGLAND. [Poster]
Web of Science

 

Rief, P; Pichler, M; Hafner, F; Gerger, A; Eller, P; Hackl, G; Brodmann, M; Gary, T De Ritis Score und CLI
Z f Gefäßmedizin. 2015; -Sailersymposium; Jun 18-19, 2015; Graz. [Poster]

 

Belaj, K; Stockmair, P; Hackl, G; Rief, P; Hafner, F; Eller, P; Brodmann, M; Gary, T Risk Score for Occurrence of Critical Limb Ischemia in Patients with Peripheral Arterial Occlusive Disease
Zeitschrift für Gefäßmedizin. 2014; -Sailersymposium; Jun 12-13; Graz. [Poster]

 

Belaj, K; Stockmair, P; Hackl, G; Rief, P; Hafner, F; Eller, P; Brodmann, M; Gary, T Graz CLI Score
DGA; Hamburg. 2014. [Oral Communication]

 

Brodmann, M Thromboembolie_Lyse und Cavaschirm
Venalpina 2014; JAE-FEB 25-1,2014; Seefeld. 2014. [Keynote lecture]

 

Brodmann, M Fem-pop In-stent restenosis_Is there a role for DCB
CRT 2014; FEB 22-24,2014; Washington. 2014. [Keynote lecture]

 

Brodmann, M; Neue Aspekte in der Therapie der PAE
Jahrestagung der ÖKG; MAI 28-30, 2014; Salzburg. 2014. [Keynote lecture]

 

Brodmann, M; IN.PACT SFARandomized Trial of IN.PACT Admiral DCB vs. PTA for the Treatment of Atherosclerotic Lesions in the SFA and/or PPA1-year Primary Outcomes
Euro PCR 2014; MAI 20-23, 2014; Paris. 2014. [Keynote lecture]

 

Brodmann, M; European Update on Limb Salvage Tools
AMP The CLI Meeting; AUG 14-16, 2015; Chicago, USA. 2014. [Keynote lecture]

 

Brodmann, M; The Value of Randomized Trials and Registries
AMP-The CLI Meeting; AUG 14-16, 2015; Chicago, USA. 2014. [Keynote lecture]

 

Brodmann, M; Poba-DEB-Stnet-DES: Studienlage und persönliche Anwendung in der Praxis
Excellence Circle; OCT 9, 2015; Wien. 2014. [Keynote lecture]

 

Brodmann, M; INPACT SFA Randomized trial one year results
Medtronic Academia Medical Education; OCT 17-18, 2015; Istanbul, Turkei. 2014. [Keynote lecture]

 

Brodmann, M; Venöse Thromboembolie VTE_Update
Fortbildung LKH Fürstenfeld; OCT 23, 2015; LKH Fürstenfeld. 2014. [Keynote lecture]

 

Brodmann, M; Renale Denervation zur Behandlung der Hypertonie-Ja-ich will nicht auf Dauer viele Antihypertensiva schlucken
Zeitschrift für Gefäßmedizin. 2014; 4: -Königsbergergefäßdialog; NOV 7-8, 2014; Bad Schönau. [Keynote lecture]

 

Brodmann, M; Tack-it Dissection Repair: Full Metal Jacket No More
TCT ; SEP 13-17, 2014; Washington. 2014. [Keynote lecture]

 

Brodmann, M; DEB are changing the treatment paradigm in Europe!
VIVA; NOV 4-7,2014; Las Vegas, USA. 2014. [Keynote lecture]

 

Brodmann, M; Drug eluting Balloons work better than expected-Long SFA Disease
VIVA; NOV 4-7,2014; Las Vegas, USA. 2014. [Keynote lecture]

 

Brodmann, M; Thrombolytische Therapie bei PAE
Sailersymposium 2014; JUN 13-14, 2014; Graz. 2014. [Keynote lecture]

 

Brodmann, M; The Value of Randomized Trials and Registries
PAD Masterclass Paris; SEP 12, 2015; Paris. 2014. [Keynote lecture]

 

Brodmann, M; Akuttherapie und Sekundärprophylaxe tiefer Venenthrombosen und Lungenembolien
ÖGIA Jahrestagung; OCT 10-11, 2015; Innsbruck. 2014. [Keynote lecture]

 

Brodmann, M; The angiosome concept: Pro
CIRSE; SEP 13-17, 2014; Glasgow, UK. 2014. [Keynote lecture]

 

Brodmann, M; Controvery Analysis-Drug eluting Balloon
VIVA; NOV 4-7,2014; Las Vegas, USA. 2014. [Keynote lecture]

 

Brodmann, M; DOAC bei VTE: Daten und Fakten
Sailersymposium 2014; JUN 13-14, 2014; Graz. 2014. [Keynote lecture]

 

Brodmann, M; Ein dickes Bein kann tödlich sein- akutelles zur Therapie der venösen Thromboembolie
Thrombosedialog Fuschl; MAE 28-29,2014; Fuschl am See. 2014. [Keynote lecture]

 

Brodmann, M; BTK Applications and Lutonix BTK Clinical Trial
Charing Cross Meeting 2014; APR 5-8, 2014; London, UK. 2014. [Keynote lecture]

 

Brodmann, M; DCB for below the knee are dead man walking
First International Live Course on DCB Angioplasty; MAI 30-31, 2014; Mailand, Italien. 2014. [Keynote lecture]

 

Brodmann, M; The future Role of DCB
Drug Coated Balloon Summit; SEP 4, 2015; Brüssel. 2014. [Keynote lecture]

 

Brodmann, M; Advantages and Limitations of the Tack Endovascular System™ for Minimizing Dissection After Plain Old Balloon Angioplasty (POBA) and Leaving Minimal Metal Behind: The TOBA Study
VEITH Meeting; NOV 18-22, 2014; New York, USA. 2014. [Keynote lecture]

 

Brodmann, M; IN.PACT DEB Clinical Evidence in SFA
DCB Medtronic Faculty Education Program Irland; DEC 5-6, 2014; Galway, Irland. 2014. [Keynote lecture]

 

Brodmann, M; Drug eluting.. Die Lösung des Problems der Restenose?
ÖGIA Jahrestagung; OCT 10-11, 2015; Innsbruck. 2014. [Keynote lecture]

 

Brodmann, M; Novel anticoagulants, what does a cardiologist need to know about DVT
ESC Conference 2014; AUG 30-SEP 2, 2015; Barcelona. 2014. [Keynote lecture]

 

Brodmann, M; Unmet Technical Needs and Opportunities for the Development of Next Generation Technologies
TCT; SEP 13-17, 2014; Washington, DC, USA. 2014. [Keynote lecture]

 

Brodmann, M; Critical Limb Ischemia and the role of DCBs below the knee
TCT 2014; SEP 13-17, 2014; Washington, DC; USA. 2014. [Keynote lecture]

 

Brodmann, M; Patient mit DM +sein hohes CV Risiko
MED NETZWERK; OCT 23, 2015; Graz. 2014. [Keynote lecture]

 

Brodmann, M; DISRUPT PAD: A Single Arm Study Evaluating the Safety and Effectiveness of Lithoplasty for Treatment of Calcified SFA/Popliteal LesionsLate Breaking Clinical Trial
VIVA; NOV 4-7,2014; Las Vegas, USA. 2014. [Keynote lecture]

 

Brodmann, M; Antikoagulation heute: Was muß ich für die Praxis beachten?
Herbstkongress Kardiologie ; OCT 21,2015; Graz. 2014. [Keynote lecture]

 

Brodmann, M; Aktuelle DEB Studien Fokus BTK
Biotronik Meeting LMU München; JUN 27,2014; München. 2014. [Keynote lecture]

 

Brodmann, M; Therapie der pAVK-primär konservativ? Nein-rekanalisiert besser als okkludiert
ÖGIM ; SEP 25-27, 2015; Salzburg. 2014. [Keynote lecture]

 

Brodmann, M; Klinisch orientierte Übersicht über DOAC´s_VTE
Thrombovision 2014; OCT 4, 2014; Wien. 2014. [Keynote lecture]

 

Brodmann M; Role of DCBs in treating critical limb ischemiaand the enrollment update on-going Lutonix BTK clinical trial
LINC 2015; JAN 27-30, 2015; Leipzig. 2014. [Keynote lecture]

 

Brodmann,M From evidence to practice:how DEBs fit my daily work
LINC 2014; JAE 28-31,2014; Leipzig. 2014. [Oral Communication]

 

Brodmann,M Multidisciplinary appraoch to CLI Management
CRT 2014; FEB 22-24,2014; Washington. 2014. [Keynote lecture]

 

Brodmann,M Biolux BII-A randomized clinical trial of DEBvs PTA for infrapopliteal disease: 6 months angiographic follow up
LINC 2014; JAE 28-31,2014; Leipzig. 2014. [Keynote lecture]

 

Brodmann,M The SHOCKWAVE lithoplasty concept for calcified lesions-initial clinical experience
LINC 2014; JAE 28-31,2014; Leipzig. 2014. [Oral Communication]

 

Brodmann,M BTK Applications and Lutonix BTK clinical trial
LINC 2014; JAE 28-31,2014; Leipzig. 2014. [Oral Communication]

 

Brodmann,M Vom Symptom zur Diagnose
10.Kardiovaskuläres Symposium Schloß Wilhelminenberg; JAEn 25, 2013; Wien. 2014. [Oral Communication]

 

Brodmann,M Ein dickes Bein kann tödlich sein
Ärzetkammerfortbildung Bezirk Weiz; FEB 5,2014; Weiz. 2014. [Oral Communication]

 

Brodmann,M Complications in the cath lab and what the team learned from it
LINC 2014; JAE 28-31,2014; Leipzig. 2014. [Oral Communication]

 

Brodmann,M; Perioperatives Vorgehen bei DOACs
Weiterbildung Unfallchirurgie; 2014. [Oral Communication]

 

Brodmann,M; Improving Outcome in CLI Interventions: Is there a Future for DCB?
VEITH Meeting; NOV 18-22, 2014; New York, USA. 2014. [Keynote lecture]

 

Brodmann,M; Klinisch orientierte Übersicht über DOAC´s_VTE
Bezirksfortbildung Langenwang; DEC 4, 2014; Langenwang. 2014. [Keynote lecture]

 

Brodmann,M; Gary,T; Hafner,F; Seinost,G; Eller,P; Hackl,G; Deutschmann,H;Pilger,E; Drug eluting ballooning versus primary old balloon angioplasty (POBA) in femorpopliteal stent reobstructions- a non-randomized controlled pilot trial
LINC 2014; JAE 28-31;2014; Leipzig. 2014. [Poster]

 

Brodmann,M;Dorr,A;Gary,T;Deutschmann,H;Pilger,E;Eller,P; Differentiation of Superficial Femoral Artery restenosis by optical coherence tomography (OCT)
LINC 2014; JAE 28-31,2014; Leipzig. 2014. [Poster]

 

Gary, T; Belaj, K; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Haas, E; Eller, P; Brodmann, M Elevated blood urea nitrogen is associated with CLI in PAOD patients
EUR HEART J. 2014; 35: 631-631.-Congress of the European-Society-of-Cardiology (ESC); AUG 30-SEP 03, 2014; Barcelona, SPAIN.
Web of Science

 

Gary, T; Belaj, K; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Haas, E; Eller, P; Brodmann, M BUN und CLI
DGA; Hamburg. 2014. [Poster]

 

Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Pilger, E; Brodmann, M BUN und CLI
DGA; Hamburg. 2014. [Oral Communication]

 

Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich H; Eller, P; Pilger, E; Brodmann, M NLR und PLR und der Zusammenhang mit der kritischen Extremitätenischämie
DGA ; Hamburg. 2014. [Keynote lecture]

 

Gary, T; Rief, P; Belaj, K; Hackl, G; Brodmann, M Elevated blood urea nitrogen is associated with critical limb ischemia
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):562-562. [Poster]
Web of Science

 

Gary,T; Belaj,K; Froehlich,H; Hafner,F; Eller,P; Brodmann,M A high Essen Stroke Risk Score is associated with a high risk for critical limb ischemia in peripheral arterial occlusive disease patients
Hämostaseologie. 2014; -GTH; Feb 12-15, 2013; Wien. [Poster]

 

Hackl, G; Belaj, K; Hafner, F; Rief, P; Brodmann, M The value of FDG-PET in the diagnosis of thromboangiitis obliterans-a case series
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):562-563. [Poster]
Web of Science

 

Hackl, G; Gary, T; Belaj, K; Hafner, F; Rief, P; Pilger, E; Deutschmann, H; Brodmann, M Exoseal in antegrade procedures in peripheral arterial disease patients
LINC 2014; JAN 28-31, 2014; Leipzig. 2014. [Poster]

 

Hafner, F; Belaj, K; Gary, T; Hackl, G; Brodmann, M Aortic aneurysm giant cell arteritis-the value of D-Dimer
WIEN KLIN WOCHENSCHR. 2014; 126(17-18): 561-561. [Poster]
Web of Science

 

Hafner, F; Haas, E; Hackl, G; Gary, T; Belaj, K; Fessler, J; Rief, P; Thonhofer, R; Szolar, D; Brodmann, M Aortic aneurysm in Giant Cell Arteritis – the value of D-Dimer
German medical science. 2014; -42. Kongress der Deutschen Gesellschaft für Rheumatologie; SEP 17-20, 2014; Düsseldorf, GERMANY. [Poster]
FullText

 

Kovacs, G; Avian, A; Wutte, N; Hafner, F; Fuerst, F; Aberer, E; Brodmann, M; Graninger, W; Foris, V; Tscherner, M; Kqiku, X; Olschewski, A; Olschewski H Hemodynamic Follow-Up Of Patients With Systemic Sclerosis.
2014: A4697, 10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A4697. 2014; -American Thoracic Society; May 16-21, 2014; San Diego, USA. [Poster]
FullText

 

Mihaljevic, R; Rief, P; Hackl, G; Belaj, K; Hafner, F; Seinost, G; Brodmann, M; Pilger, E Diabetes mellitus type 2 in patients with PAD (peripheral arterial disease) stage II-IV: single center disease registry
WIEN KLIN WOCHENSCHR. 2014; 126: S186-S187.-Österreichische Diabetes Gesellschaft; NOV 20-22, 2014; Salzburg, Austria. [Poster]
Web of Science

 

Mihaljevic R, Rief P, Hackl G, Belaj K, Hafner F, Seinost G, Brodmann M, Pilger E Diabetes mellitus type 2in patients with PAD stage II-IV: singel center disease registry
Wiener Klinische Wochenschrift. 2014; Supplement 4, 2014: 186-187.-ÖDG; NOV 20-22, 2014; Salzburg. [Poster]

 

Ribitsch,W;Schilcher,G;Quehenberger,F;Pilz,St;Portugaller,RH;Truschnig-Wilders,M;Zweiker,R;Brodmann,M;Rosenkranz, AR;Horina,JH Diagnostic Accuracy of Urinary Neutrophil Gelatinase Associated Lipocalin (uNGAL) for the Early Detection of Contrast Induced Nephropathy – The ANTI-CIN Study.
Abstract Supplement,J Am Soc Nephrol 25, 2014. 2014; 25: A135--Kidney Week 2014, American Society of Nephrology; NOV 11-16,2014; Philadelphia, USA. [Poster]

 

Ribitsch,W;Schilcher,G;Quehenberger,F;Pilz,St;Portugaller,RH;Truschnig-Wilders,M;Zweiker,R;Brodmann,M;Rosenkranz,AR;Horina,JH Diagnostischer Wert von neutrophilem Gelatinase-assoziiertem Lipocalin (NGAL) in der Früherkennung der Kontrastmittelnephropathie bei Hochrisikopatienten nach intraarterieller Angiographie-Ergebnisse der ANTI-CIN Studie
Journal für Hypertonie. 2014; 18(3):110-128.-Jahrestagung der ÖGN & ÖGH; Sep 18-20,2014; Baden, Austria. [Poster]

 

Ribitsch,W;Schilcher,G;Quehenberger,F;Pilz,St;Portugaller,RH;Truschnig-Wilders,M;Zweiker,R;Brodmann,M;Rosenkranz,AR;Horina,JH Neutrophiles Gelatinase assoziiertes Lipocalin (NGAL) - ein geeigneter Marker zur Früherkennung der Kontrastmittelnephropathie bei Hochrisikopatienten nach intraarterieller Angiographie? Ergebnisse der ANTI-CIN Studie.
ABS00113,Abstract-USB-Stick Kongress für Nephrologie 2014-6.Jahrestagung der Deutschen Gesellschaft für Nephrologie. 2014; -6.Jahrestagung der Deutschen Gesellschaft für Nephrologie; Sept. 6-9,2014; Berlin, Germany. [Poster]

 

Rief, P; Belaj, K; Eller, P; Hafner, F; Hackl, G; Brodmann, M; Gary, T HbA1c und Reobstruktion nach PTA der A. femoralis superficialis bei Diabetes mellitus Typ 2
Zeitschrift für Gefäßmedizin. 2014; -Sailersymposium Graz; Jun 12-13, 2014; Graz. [Poster]

 

Rief, P; Belaj, K; Pichler, M; Schilcher, G; Hafner, F; Hackl, G; Eller, P; Brodmann, M; Gary, T Elevated Blood Urea Nitrogen is Associated with CLI in PAOD Patients
Zeitschrift für Gefäßmedizin. 2014; -Sailersymposium; Jun 12-13, 2014; Graz. [Poster]

 

Rief,P; Belaj,K; Smaczny,N; Eller,P; Brodmann,M; Pilger,E Foreign Body Pulmonary Embolism
VASA - Volume 42, Supplement 84 / 2013. 2014; -16.Dreiländertagung der Österreichischen, Schweizerischen und Deutschen Gesellschaft für Angiologie; SEP 15-18, 2013; Graz. [Poster]

 

Scheinert, D; Brodmann, M; Zeller, T; Bosiers, M; Peeters, P; Karl-Ludwig, S; Beschorner, U; Pilger, E BIOLUX P-II: A Randomized Clinical Trial of Passeo-18 Lux Drug Releasing Balloon versus Plain Old Balloon Angioplasty for the Treatment of Infrapopliteal Artery Lesions
J AM COLL CARDIOL. 2014; 64(11):B79-B79.-26th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT); SEP 13-17, 2014; Washington, DC. Doi: 10.1016/j.jacc.2014.07.315 [Oral Communication]
Web of Science FullText FullText_MUG

 

Belaj, K; Gary, T; Pichler, M; Eller, P; Hackl, G; Hafner, F; Gerger, A; Froehlich, H; Pilger, E; Brodmann, M Lymphocyte-to-Monocyte Ratio: A Novel Marker for Critical Limb Ischemia in PAOD Patients
Zeitschrift für Gefäßmedizin 2013. 2013; -Sailersymposium 2013; Jun 20-21, 2013; Graz. [Poster]

 

Belaj, K; Hackl, G; Eller, P; Brodmann, M; Gary, T; Pathomechanism of reobstruction after endovascular treatment of the superficial femoral artery: Impact of inflammatory cells.
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):555-555. [Poster]
Web of Science

 

Belaj, K; Pichler, M; Hackl, G; Eller, P; Brodmann, M; Gary, T Derived Neutrophil-to-Lymphocyte Ratio and its Association with Critical Limb Ischemia in PAOD Patients
Zeitschrift für Gefäßmedizin 2013. 2013; -Sailersymposium 2013; Jun 20-21, 2013; Graz. [Poster]

 

Belaj, K; Pichler, M; Hackl, G; Eller, P; Brodmann, M; Gary, T Pathomechanism of reobstruction after endovascular treatment of the superficial femoral artery: impact of inflammatory cells
J THROMB HAEMOST. .. 2013; 11: 863-863. [Poster]
Web of Science

 

Belaj,K; Hackl, G; Pichler,M; Eller,P; Brodmann,M; Gary,T Derived Neutrophil-to-Lymphocyte Ratio and its association with critical limb ischemia in PAOD patients
VASA - Volume 42, Supplement 84 / 2013. 2013; -16. Dreiländertagung der Österreichischen, Schweizerischen und Deutschen Gesellschaft für Angiologie; SEP 15-18, 2013; Graz. [Oral Communication]

 

Brodmann, M Was ändert sich für den PAVK-und geriatrischen Patienten
24. Grazer Fortbildungstage, Symposium Lipidtherapie in der Angiologie/Akutes Koronarsyndrom; OKT 7-12, 2013; Graz. 2013. [Keynote lecture]

 

Brodmann, M Levant 2 Study Design
TCT 2013; OKT 26-31, 2013; San Francisco. 2013. [Keynote lecture]

 

Brodmann, M Dabigatran als neue Therapeioption bei VTE
16. Dreiländertagung der Österreichischen, Deutschen und Schweizerischen Gesellschaft für Angiologie; SEP 15-18, 2013; Graz. 2013. [Oral Communication]

 

Brodmann, M Therapie und Sekundärprophylaxe der TVT und PE im Umbruch
Thrombovision Steiermark 2013; Jun, 15, 2013; Graz. 2013. [Oral Communication]

 

Brodmann, M Läsionspräparation im klinischen Alltag- Wann macht es einen Sinn
16. Dreiländertagung der Österreichischen, Deutschen und Schweizerischen Gesellschaft für Angiologie; SEP 15-18, 2013; Graz. 2013. [Oral Communication]

 

Brodmann, M State of the Art der TVT Behandlung
AD Board Dabigatran; JUN, 14, 2013; Wien. 2013. [Oral Communication]

 

Brodmann, M Schlaganfallprävention bei VHF: Epidemiologie und Risikobewertung
16. Dreiländertagung der Österreichischen, Deutschen und Schweizerischen Gesellschaft für Angiologie; SEP 15-18, 2013; Graz. 2013. [Oral Communication]

 

Brodmann, M Neues aus der Angiologie
11.Innere Medizin Update Refresher; JUN 11-15,2013; Wien. 2013. [Oral Communication]

 

Brodmann, M; The angiosome concept in clinical practice: Implications for patient-specific recanalisation approaches
LINC 2013; JAN 23-26,2013; Leipzig. 2013. [Oral Communication]

 

Brodmann, M; Silverhawk Atherectomy versus primary old balloon angioplasty (POBA) in femoropopliteal stent reobstructions- a randomized controlled pilot trial
LINC 2013; JAN 23-26,2013; Leipzig. 2013. [Poster]

 

Brodmann, M; Dorr, A; Gary, T; Deutschmann, H; Pilger, E; Eller, P Differentiation of Superficial Femoral Artery Restenosis by Optical Coherence Tomography (OCT)
Zeitschrift für Gefäßmedizin 2013. 2013; -Sailersymposium 2013; Jun 20-21, 2013; Graz. [Poster]

 

Brodmann, M; Dorr, A; Hafner, F; Gary, T; Froehlich, H; Eller, P; Pilger, E, Deutschmann, H Lumbar Artery Aneurysms as a Rare Case of Life Threatening Retroperitoneal Bleeding – Case Report and Literature Review
Zeitschrift für Gefäßmedizin 2013. 2013; -Sailersymposium 2013; Jun 20-21, 2013; Graz. [Poster]

 

Brodmann, M; Gary, T; Hafner, F; Eller, P; Deutschmann, H; Pilger, E Acute Wiiitis Representing as Thrombosis of the Inferior Vena cava and Left Pelvic Veins
Zeitschrift für Gefäßmedizin 2013. 2013; -Sailersymposium 2013; Jun 20-21, 2013; Graz. [Poster]

 

Brodmann, M; Gary, T; Hafner, F; Eller, P; Pilger, E; Acute wiiitis representing as thrombosis of the inferior vena cava and left pelvic veins.
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):554-554. [Poster]
Web of Science

 

Brodmann, M; Hafner, F; Eller, P; Dorr, A; Gary, T; Deutschmann, H; Pilger, E Stenting of the Popliteal Artery – A Single Center Experience with 5 year Follow up
Zeitschrift für Gefäßmedizin 2013. 2013; -Sailersymposium 2013; Jun 20-21, 2013; Graz. [Poster]

 

Brodmann, M; Hafner, F; Gary, T; Eller, P; Pilger, E; Stenting of the popliteal artery: a single center experience with 5 year follow up.
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):554-554. [Oral Communication]
Web of Science

 

Brodmann,M Treating SFA Intervention complicated by dissection: a novel approach using "Tack"
TCT 2013; OKT 26-31,2013; San Francisco. 2013. [Keynote lecture]

 

Brodmann,M Neue Studienergebnisse zur Therapie der venösen Thromboembolie
44.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 26-28, 2013; Salzburg. 2013. [Oral Communication]

 

Brodmann,M Therapie und Sekundärprophylaxe der TVT und PE im Umbruch
44.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 26-28, 2013; Salzburg. 2013. [Oral Communication]

 

Brodmann,M Can OCT be used to help to decide when a post PTA dissection needs to be fixed with a TACK-it or stent
VEITH Meeting 2013; NOV 19-23, 2013; New York. 2013. [Keynote lecture]

 

Brodmann,M New technologies in PVI (DEB, DES, Scaffolds)
Great minds-Euorpean PCI Expert Meeting; MAI-JUN, 31-1,2013; Budapest. 2013. [Oral Communication]

 

Brodmann,M Medikamentöse Primär-und Sekundärintervention in der Gefäßmedizin-ein Studienupdate
Dreiländertagung der Österreichischen, Deutschen und Schweizerischen Gesellschaften für Gefäßchirurgie; SEP 4-7, 2013; Linz. 2013. [Oral Communication]

 

Brodmann,M PAVK und Embolie
Akrale Durchblutungsstörungen, Symposium Hanuschkrankenhaus; OKT 9,2013; Wien. 2013. [Oral Communication]

 

Brodmann,M Neue Antikoagulantien, Kombinationen (SSRI&PPI) und anderes wissenswertes für den Gastroenterologen
46.Jahrestagung und 24. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 13-15, 2013; Graz. 2013. [Oral Communication]

 

Brodmann,M Stenting of the popliteal artery: a single center experience with 5 year follow up
Euro PCR; MAI 21-24, 2013; Paris. 2013. [Oral Communication]

 

Brodmann,M; Rauchen und Atherosklerose
9. Kardiovaskuläres Symposium Schloss Wilhelminenberg; JAE 26, 2013; Wien. 2013. [Oral Communication]

 

Brodmann,M; DCB-limits with calcified lesions
European Lutonix Symposium; NOV 12-13, 2013; Frankfurt. 2013. [Oral Communication]

 

Brodmann,M; DCB in calicfied lesions
Lutonix Sympsoium Frankfurt; JUL 3-4, 2013; Frankfurt. 2013. [Keynote lecture]

 

Brodmann,M; Safety and efficacy of periprocedural antocoagulation with enoxaparin in patients undergoing peripheral endovascular recanalisation
LINC 2013; JAN 23-26, 2013; Leipzig. 2013. [Poster]

 

Brodmann,M; Antikoagulation-NOAK
Gemeinsame Jahrestagung der Österreichischen Gesellschaften für Dermatochirurgie, Phlebologie und dermatologische Angiologie; OKT 25-26,2013; Wels. 2013. [Oral Communication]

 

Brodmann,M; Raynaudphänomen; Pathogenese und Kapillarmikroskopie
Gemeinsame Jahrestagung der Österreichischen Gesellschaften für Dermatochirurgie, Phlebologie und dermatologische Angiologie; OKT 25-26,2013; Wels. 2013. [Oral Communication]

 

Brodmann,M; Dorr, A; Gary,T; Deutschmann,H; Hafner,F; Pilger,E; Eller, P; Differentiation of Superficial Femoral Artey restenosis by OCT
VASA Volume 42. 2013; -16.Dreiländertagung der Österreichischen, Schweizerischen und Deutschen Gesellschaft für Angiologie; SEP 15-18, 2013; Graz. [Oral Communication]

 

Brodmann,M; Gary,T; Hafner,F; Eller, P; Deutschmann, H; Pilger, E Acute wiitis representing as thrombosis of the inferior vena cava and left pelvic veins
VASA - Volume 42, Supplement 84 / 2013. . 2013; -16. Dreiländertagung der Österreichischen, Deutschen und Schweizerischen Gesellschaft für Angiologie; SEP 15-18, 2013; Graz. [Poster]

 

Brodmann,M; Hafner, F; Eller,P; Dorr,A; Gary,T; Deutschmann, H; Pilger,E Stenting of the popliteal artery - a single center experience with 5 year follow up
VASA - Volume 42, Supplement 84 / 2013. . 2013; -16. Dreiländertagung der Österreichischen, Schweizerischen und Deutschen Gesellschaft für Angiologie; SEP 15-18, 2013; Graz. [Poster]

 

Brodmann,M; Hafner,F; Eller,p; Dorr,A; Gary,T;Deutschmann,H;Pilger,E; Stenting of the popliteal artery: a single center experience with a 5 year follow up
CVIR. 2013; -CIRSE; SEP 14-18,2013; Barcelona. [Poster]

 

Deloose, K; Brodmann, M; Gissler, HM; Scheinert, D; Bosiers, M Prospective, Multicenter Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular SystemTM
J AM COLL CARDIOL. . 2013; 62(18):B42-B42.-25th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT); OCT 27-NOV 01, 2013; San Francisco, CA. Doi: 10.1016/j.jacc.2013.08.863 [Poster]
Web of Science FullText FullText_MUG

 

Eller, P; Kirsch, A; Smaczny, N; Sedej, S; Hofmeister, A; Stojakovic, T; Brodmann, M; Pilger, E; Rosenkranz, A; Eller, K Regulatory T-cells modulate ectopic calcification in nephrocalcinosis and dystrophic cardiac calcinosis
EUR HEART J. 2013; 34: 508-508. [Oral Communication]
Web of Science

 

Eller, P; Schneider, P; Pilger, E; Brodmann,M Optic Coherence Tomography of Tack optimized Balloon Angioplasty
VASA, Supplements. 2013; -Dreiländertagung der österreichischen, deutschen und schweizerischen Gesellschaft für Angiologie; Sept 15-18, 2013; Graz, AUSTRIA. [Oral Communication]

 

Gary, T; Belaj, K; Eller, P; Hackl, G; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M Chadasvasc Score and risk for reobstruction after endovascular treatment of the superficial femoral artery: differences between balloon angioplasty and stenting
Journal of Thrombosis and Hemostasis. 2013; -ISTH; Jun 29-Jul 4, 2013; Amsterdam. [Poster]

 

Gary, T; Belaj, K; Eller, P; Hackl, G; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M; CHA(2)DS(2)-VASc score and risk for reobstruction after endovascular treatment of the superficial femoral artery: Differences between balloon angioplasty and stenting.
VASC MED. 2013; 18(3):160-160. [Poster]
Web of Science

 

Gary, T; Belaj, K; Eller, PH; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M CHA2DS2-VASc score and risk for reobstruction after endovascular treatment of the superficial femoral artery: differences between balloon angioplasty and stenting
J THROMB HAEMOST. .. 2013; 11: 387-387. [Poster]
Web of Science

 

Gary, T; Belaj, K; Hackl, G; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M Primary Antiphospholipid Antibody Syndrome - One further Aspect of Thrombophilia in Overweight and Obese Patients with VTE
Hämostaseologie. 2013; -GTH Jahrestagung 2013; Feb 20-23, 2013; München. [Poster]

 

Gary, T; Pichler, M; Belaj, K; Hafner, F; Brodmann, M; Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients.
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):554-555. [Poster]
Web of Science

 

Gary, T; Pichler, M; Belaj, K; Rief, P; Eller, P; Hafner, F; Gerger, A; Froehlich, H; Haas, E; Brodmann, M Lymphocyte to Monocyte Ratio: A novel marker for critical limb ischemia in PAOD patients
Vasa. 2013; -Dreiländertagung Angiologie Graz; Sep 15-18, 2013; Graz. [Oral Communication]

 

Hackl, G; Brodmann, M; Seinost, G Cutaneous Plasmacytoma – a rare case
ZEITSCHRIFT FÜR GEFÄSSMEDIZIN. 2013; -8. Sailersymposium; JUN 20-21, 2013; Graz, Austria. [Poster]

 

Hackl, G; Gary, T; Belaj, K; Hafner, F; Brodmann, M; Risk factors for puncture site complications after endovascular procedures in peripheral arterial disease patients.
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):555-555. [Poster]
Web of Science

 

Hackl, G; Gary, T; Belaj, K; Hafner, F; Eller, P; Brodmann, M Risk factors for puncture site complications after endovascular procedures in peripheral arterial disease patients
VASA - Volume 42, Supplement 84 / 2013. 2013; 42(84):80-81.-16. Dreiländertagung der Österreichischen, Deutschen und Schweizerischen Gesellschaften für Angiologie; SEPT 15-18, 2013; Graz, Austria. [Poster]

 

Hafner, F; Haas, E; Dejaco, C; Gary, T; Froehlich, H; Szolar, D; Thonhofer, R; Brodmann, M AORTIC ANEURYSM RELATED TO GCA - AN OVERESTIMATED RISK?
ANN RHEUM DIS. .. 2013; 72: 495-495. [Poster]
Web of Science

 

Hafner, F; Haas, E; Dejaco, C; Gary, T; Fröhlich, H; Szolar, D; Thonhofer, R; Brodmann, M Aortic Aneurysm in Giant Cell Arteritis - An overestimated Risk?
EULAR Database. 2013; -EULAR; JUN 12-15, 2013; Madrid, SPAIN. [Poster]

 

Hafner, F; Haas, E; Gary, T; Froehlich, H; Hackl, G; Fessler, J; Szolar, D; Thonhofer, R; Brodmann, M Aortic Aneurysm in Giant Cell Arteritis
VASA - European Journal of Vascular Medicine. 2013; 42(S/84):100-100.-16. Jahrestagung der Österreichischen, Deutschen und Schweizerischen Gesellschaften für Angiologie; SEP 15-18, 2013; Graz, AUSTRIA. [Poster]

 

Hafner, F; Kieninger, A; Seinost, G; Haas, E; Hackl, G; Gary, T; Froehlich, H; Belaj, K, Meinitzer, A; Brodmann, M Cardiovascular Risk in Peripheral Arterial Disease: Evaluation of Serologic and Functional Parameters of Endothelial Function
VASA - European Journal of Vascular Medicine. 2013; 42(S/84):29-29.-16. Dreiländertagung der Österreichischen, Deutschen und Schweizerischen Gesellschaft für Gefäßmedizin; SEP 15-18, 2013; Graz, AUSTRIA. [Oral Communication]

 

Kirsch, AH; Kozina, A; Smaczny, N; Gössler, W; Frank, S; Brodmann, M; Pilger, E; Rosenkranz, AR; Eller, K; Eller, P Phosphorus-rich diet specifically induces media calcification in the abdominal aorta
VASA, Supplements. 2013; -Dreiländertagung der österreichischen, deutschen und schweizerischen Gesellschaft für Angiologie; Sept 15-18, 2013; Graz, AUSTRIA. [Poster]

 

Kirsch, AH; Smaczny, N; Riegelbauer, V; Sedej, S; Hofmeister, A; Stojakovic, T; Brodmann, M; Pilger, E; Rosenkranz, A; Eller, K; Eller, P REGULATORY T-CELLS MODULATE NEPHROCALCINOSIS IN MICE.
NEPHROL DIALYSIS TRANSPLANT. 2013; 28: 406-406.-50th European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress; MAY 18-21, 2013; Istanbul, TURKEY. [Poster]
Web of Science

 

Kirsch, AH; Smaczny, N; Riegelbauer, V; Sedej, S; Hofmeister, A; Stojakovic, T; Brodmann, M; Pilger, E; Rosenkranz, A; Eller, K; Eller, P; Regulatory T Cells in Nephrocalcinosis and Dystrophic Cardiac Calcinosis in DBA/2 Mice
Abstract Supplement of the Journal of the American Society of Nephrology. 2013; 315A--Annual Meeting of the American Society of Nephrology.; NOV 5-10, 2013; Atlanta, USA. [Poster]
FullText

 

Kirsch, AH; Smaczny, N; Riegelbauer, V; Sedej, S; Hofmeister, A; Stojakovic, T; Brodmann, M; Pilger, E; Rosenkranz, AR; Eller, K; Eller, P; Regulatory T-cells improve nephrocalcinosis but not dystrophic cardiac calcinosis.
International Students Congress; JUL 4-6, 2013; Graz, AUSTRIA.. 2013. [Oral Communication]

 

Kirsch, AH; Smaczny, N; Riegelbauer, V; Sedej, S; Hofmeister, A; Stojakovic, T; Goessler, W; Brodmann, M; Pilger, E; Rosenkranz, AR; Eller, K; Eller, P; Regulatory T cells in nephrocalcinosis and dystrophic cardiac calcinosis in DBA/2 mice
Jahrestagung der deutschen Gesellschaft für Nephrologie; OCT 5-8, 2013; Berlin, GERMANY. 2013. [Poster]

 

Rief, P; Eller, P; Gary, T; Pilger, E; Brodmann, M; Digital subtraction angiography in outpatient clinic treatment.
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):554-554. [Poster]
Web of Science

 

Seinost, G; Hohl, A; Hirschl, M; Klein-Weigel, P; Groechenig, E; Pessenhofer, H; Hafner, F; Brodmann, M; Pilger, E Searching for subclinical organ damage: oscillometric ABI is a reliable alternative to standard Doppler method.
EuroPrevent 2013; April 18-20, 2013; Rom. 2013. [Poster]

 

Smaczny, N; Kirsch, A; Riegelbauer, V; Sedej, S; Hofmeister, A.; Stojakovic, T.; Goessler, W.; Brodmann, M; Pilger E.; Rosenkranz, A.; Eller, K.; Eller P. Regulatory T cells modulate nephrocalcinosis in mice
Junge Niere ; JUN 14-15, 2013; Regensburg, GERMANY. 2013. [Oral Communication]

 

Smaczny, N; Kirsch, A; Riegelbauer, V; Sedej S; Hofmeister, A; Stojakovic, T; Goessler, W; Brodmann, M; Pilger, E; Rosenkranz, A; Eller K; Eller P; Regulatory T cells modulate nephrocalcinosis in mice
Kongress für Nephrologie 2013 - 5. Jahrestagung der Deutschen Gesellschaft für Nephrologie; OKT 5-8, 2013; Berlin, GERMANY. 2013. [Poster]

 

Belaj, K; Gary,T; Hackl,G; Derler,M; Hafner,F; Fröhlich,H; Pilger,E; Brodmann,M. Erfassung der Lebensqualität von Patienten unter Langzeit-NMH-Therapie versus oraler Antikoagula- tion unter Selbstmessung
Zeitschrift für Gefäßmedizin. 2012; -Sailersymposium; JUN 21-22,2012; Graz. [Poster]

 

Belaj, K; Rodler,C; Steidl,K; Prüller,F; Raggam,R; Hafner,F; Froehlich,H; Pilger,E; Brodmann,M; Gary,T. Intraarterial Platelet Reactivity and its Possible In- fluence on Development of Reobstruction in the Superficial Femoral Artery After Percutaneous Transluminal Angioplasty
Zeitschrift für Gefäßmedizin. 2012; -Sailersymposium; JUN 21-22,2012; Graz. [Poster]

 

Belaj,K; Gary,T; Hackl,G; Bruckenberger,R; Hafner,F; Fröhlich,H; Pilger,E; Brodmann M. Möglicher Zusammenhang zwischen Antiphospho- lipidantikörpern und erhöhtem BMI
Zeitschrift für Gefäßmedizin. 2012; -Sailersymposium; JUN 21-22,2012; Graz. [Oral Communication]

 

Brodmann, M Neue orale Antikoagulantien interdisziplinär-aus der Sicht des Angiologen
43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 20-22,2012; Graz. 2012. [Keynote lecture]

 

Brodmann, M Tiefe Venenthrombose-Update Refresher Allgemeinmedizin
Update Refresher Allgemeinmedizin; Mai 9-12, 2012; Wien. 2012. [Keynote lecture]

 

Brodmann, M Leitlinienkonforme Therapie der pAVK? Nein-für den klinischen Alltag sind sie nicht relevant
8.Königsberger Gefäßdialog; Nov 9-10, 2012; Bad Schönau. 2012. [Oral Communication]

 

Brodmann, M Wie weit gehe ich bei der Revaskularisation des Unterschenkels?
1.Kongress des Verbandes für österreichische Gefäßmedizin (VASCMED); Oct 18-20, 2012; Graz. 2012. [Keynote lecture]

 

Brodmann, M Endovaskuläre Varizentherapie
8.Kardiovaskuläres Symposium Schloss Wilhelminenberg; JAE 21, 2012; Wien. 2012. [Poster]

 

Brodmann, M Nierenarterienstenose-klinische Relevanz
Update Refresher Innere Medizin; Mai 9-12, 2012; Wien. 2012. [Keynote lecture]

 

Brodmann, M Tiefe Venenthrombose
Update Refresher Allgemeinmedizin; Nov 7-10, 2012; Wien. 2012. [Keynote lecture]

 

Brodmann, M Diagnosis of recurrent VTE
XXV World Congress of the International Union of Angiology; Jul 1-5, 2012; Prag. 2012. [Keynote lecture]

 

Brodmann, M Buerger´s disease-when do cardiologists need to think about rare vascular diseases
ESC 2012; Aug 25-29, 2012; Munich. 2012. [Oral Communication]

 

Brodmann, M Rivaroxaban bei VHFA
Sailersymposium; JUN 21-22, 2012; Graz. 2012. [Keynote lecture]

 

Brodmann, M DD des dicken Beins
1.Kongress des Verbandes für österreichische Gefäßmedizin (VASCMED); Oct 18-20, 2012; Graz. 2012. [Oral Communication]

 

Brodmann, M; Dorr, A; Hafner, F; Gary, T; Frohlich, H; Kvas, E; Deutschmann, H; Seinost, G; Pilger, E Safety and efficacy of periprocedural anticoagulation with enoxaparin in patients undergoing peripheral endovascular revascularisation
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):559-559.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; ; ; SEP 20-22, 2012; ; Graz, AUSTRIA. .. [Poster]
Web of Science

 

Brodmann, M; Dorr,A; Hafner,F; Gary,T; Froehlich,H; Kvas,E; Deutschmann,H; Pilger E. Safety and Efficacy of Periprocedural Anticoagula- tion with Enoxaparin in Patients Undergoing Peripheral Endovascular Revascularisation
Zeitschrift für Gefäßmedizin. 2012; -Sailersymposium; JUN 21-22,2012; Graz. [Poster]

 

Brodmann, M; Froehlich,H; Dorr,A; Gary,T; Hafner,F; Deutschmann, H; Portugaller, RH; Pilger,E. Percutaneous Transluminal Angioplasty versus Primary Stenting in Infrapopliteal Arteries in Critical limb Ischemia
Zeitschrift für Gefäßmedizin. 2012; -Sailersymposium; JUN 21-22,2012; Graz. [Poster]

 

Brodmann, M; Frohlich, H; Rief, P; Dorr, A; Hafner, F; Gary, T; Eller, P; Seinost, G; Deutschmann, H; Pilger, E Silverhawk atherectomy versus primary old balloon angioplasty (POBA) in femorpopliteal stent reobstructions- a randomized controlled pilot trial
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):559-560.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; ; ; SEP 20-22, 2012; ; Graz, AUSTRIA.. [Poster]
Web of Science

 

Brodmann, M; Gary, T; Hafner, F; Belaj, K; Tiesenhausen, K; Deutschmann, H; Pilger E. Massive PE caused by internal iliac vein thrombosis with free floating thrombus formation in the inferior vena cava
Hämostaseologie. 2012; -GTH 2012; FEB 1-4,2012; St. Gallen. [Poster]

 

Brodmann, M; Gary, T; Hafner, F; Fröhlich, H; Tiesenhausen, K; Deutschmann, H; Pilger,E Massive pulmonary embolism caused by internal iliac vein thrombosis with free floating thrombus formation in the inferior vena cava
XXV World Congress of the International Union of Angiology; Jul 1-5, 2012; Prag. 2012. [Poster]

 

Brodmann, M; Gary,T; Hafner,F; Tiesenhausen,K; Deutschmann,H; Pilger,E. Massive Pulmonary Embolism Caused by Internal Iliac Vein Thrombosis with Free Floating Thrombus Formation in the Inferior Vena Cava
Zeitschrift für Gefäßmedizin. 2012; -Sailersymposium; JUN 21-22,2012; Graz. [Poster]

 

Brodmann, M; Pief, P; Froehlich, H; Dorr, A; Gary, T; Hafner,F; Eller,P; Deutschmann, H; Pilger,E Neointimaproliferation after Silverhawk atherectomy versus primary old balloon angioplasty (POBA) in femoropopliteal stent reobstructions- a controlled randomized pilot trial
VASA. 2012; 41(S82):34-35.-41. Jahrestagung der DGA ; Sep 12-15, 2012; Mainz. [Oral Communication]

 

Brodmann, M; Rief, P; Fröhlich, H; Dorr, A; Gary,T; Eller,P; Hafner,F; Deutschmann, H; Pilger,E Neointimaproliferation after silverhawk atherectomy versus primary old balloon angioplatsy in femoropopliteal stent reobstructions- a controlled randomized pilot trial
1.Kongress des Verbandes für österreichische Gefäßmedizin (VASCMED); Oct 18-20, 2012; Graz. 2012. [Oral Communication]

 

Brodmann, M; Rief,P; Froehlich,H; Dorr,A; Gary,T; Eller,P; Hafner,F; Deutschmann,H; Pilger E. Silverhawk Atherectomy Versus Primary Old Balloon Angioplasty (POBA) in Femoropopliteal Stent Re- obstructions – a Randomized Controlled PilotTrial
Zeitschrift für Gefäßmedizin. 2012; -Sailersymposium; JUN 21-22,2012; Graz. [Poster]

 

Brodmann,M Drug eluting balloons_new approaches to peripheral arterail disease
ESC 2012; Aug 25-29, 2012; Munich. 2012. [Oral Communication]

 

Brodmann,M Neue Thrombozytenfunktionshemmer-Wirken viel zu gut
7.Sailersymposium; Jun 21-22,2012; Graz. 2012. [Oral Communication]

 

Brodmann,M Kann man Studien überhaupz anhand ihrer Einschlußkriterien vergleichen?
1.Kongress des Verbandes für österreichische Gefäßmedizin (VASCMED); Oct 18-20,2012; Graz. 2012. [Keynote lecture]

 

Brodmann,M Therapie der venösen Thromboembolie
43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 20-22, 2012; Graz. 2012. [Keynote lecture]

 

Brodmann,M Anticoagulation in practice: is there rom for improvement? An update from GARFIELD
Eurothrombosis 2012; Oct 11-13, 2012; Vienna. 2012. [Keynote lecture]

 

Brodmann,M; Deutschmann,H; Dorr,A; Froehlich,H; Gray,T; Hafner,F; Pilger,E Safety and efficacy of periprocedural anticoagulation with enoxaparin in patients undergoing peripheral endovascualr revascularisation
Vasa, European Journal of Vascular Medicine. 2012;. 2012; 41(S 82):72-72.-41. Jahrestagung der DGA; Sep 12-15, 2012; Mainz. [Poster]

 

Brodmann,M; Dorr,A; Hafner,F; Gary,T; Fröhlich,H; Deutschmann,H; Pilger,E Safety and efficacy of periprocedural anticoagulation with enoxaparin in patients undergoing peripheral endovascular revascularisation
1.Kongress des Verbandes für österreichische Gefäßmedizin (VASCMED); Oct 18-20, 2012; Graz. 2012. [Oral Communication]

 

Brodmann,M; Froehlich, H; Dorr, A; Gary,T;Portugaller,H; Deutschmann, H; Pilger,E. Percutaneous transluminal angioplasty versus primary stenting in below the knee arteries in critical limb ischemia
XXV World Congress of the International Union of Angiology; Jul 1-5, 2012; Prag. 2012. [Poster]

 

Cvirn, G; Hoerl, G; Schlagenhauf, A; Tafeit, E; Hofmann, L; Brodmann, M; Juergens, G; Mathew, E; Koestenberger, M; Gary, T Stent implantation in the superficial femoral artery: short thrombelastometry-derived coagulation times identify patients with late in-stent restenosis
Hämostaseologie. 2012; 32(1):A61-A61.-56th Annual Meeting of the "Gesellschaft für Thrombose- und Hämostaseforschung" (GTH) ; FEB 1-4, 2012; St. Gallen, SWITZERLAND. [Poster]

 

Froehlich, H; Hafner, F; Gray, T; Pilger, E; Brodmann M Results of Percutaneus Ultrasound Guided Thrombin Injection in 404 Patients with Postcatherization Pseudo Aneurysm
Circulation. 2012; 126: A15588 . 2012; -Scientific Sessions 2012, American Heart Association; NOV 3-7, 2012; Los Angeles, CA, USA. [Oral Communication]
FullText

 

Gary, T, Belaj, K; Bruckenberger, R; Hackl, G; Hafner, F; Froehlich, H; Pilger,E; Brodmann,M Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism
VASA. 2012; 41(S/82):31-32.-41. Jahrestagung der DGA ; Sep 12-15, 2012; Mainz. [Oral Communication]

 

Gary, T; Belaj, K; Eisner, F; Pichler, M; Brodmann, M Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):559-559.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; ; SEP 20-22, 2012; ; ; Graz, AUSTRIA. . . [Poster]
Web of Science

 

Gary, T; Belaj, K; Hafner, F; Froehlich, H; Brodmann, M Primary antiphospholipid antibody syndrome - one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):561-561.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; ; ; SEP 20-22, 2012; ; Graz, AUSTRIA. . [Poster]
Web of Science

 

Gary, T; Belaj, K; Hafner, F; Froehlich, H; Deutschmann, H; Pilger, E; Brodmann, M. Unusual DVT sites - MR venography in patients with negative CUS and symptomatic PE
Hämostaseologie. 2012; -GTH ; FEB 1-4,2012; St. Gallen. [Poster]

 

Gary, T; Belaj, K; Rodler, C; Pruller, F; Brodmann, M High platelet reactivity induced with collagen predicts development of reobstruction in the superficial femoral artery after percutaneous transluminal angioplasty
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):560-560.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; ; SEP 20-22, 2012; ; Graz, AUSTRIA. . [Poster]
Web of Science

 

Gary, T; Belaj, K; Steidl, K; Pichler, M; Eisner, F; Hafner, F; Froehlich, H; Samonigg, H; Pilger, E; Brodmann, M Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
THROMB RES. 2012; 129: S181-S181.-6th International Conference on Thrombosis and Hemostasis Issues in Cancer; APR 20-22, 2012; Bergamo, ITALY. Doi: 10.1016/S0049-3848(12)70103-2 [Oral Communication]
Web of Science FullText FullText_MUG

 

Gary, T; Belaj, K; Steidl, K; Pichler,M; Eisner, F; Stoeger,H; Hafner, F; Froehlich,H; Samonigg, H; Pilger,E; Brodmann, M Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
1.Kongress des Verbandes für österreichische Gefäßmedizin (VASCMED); Oct 18-20, 2012; Graz. 2012. [Oral Communication]

 

Gary, T; Rodler,C; Belaj,K; Steidl, K; Prüller, F; Raggam, R; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M. High platelet reactivity induced with collagen predicts development of reobstruction in the superficial femoral artery after percutaneous transluminal angioplasty
Zeitschrift für Gefäßmedizin. 2012; -Vascmed Graz; OCT 18-20, 2012; Graz. [Oral Communication]

 

Gary, T; Steidl, K; Belaj, K; Hafner,F; Froehlich,H; Deutschmann, H; Pilger, E; Brodmann,M Unusual deep vein thrombosis sites-MR venography in patients with negative CUS and symptomatic PE
XXV World Congress of the International Union of Angiology; Jul 1-5,2012; Prag. 2012. [Oral Communication]

 

Gary,T; Belaj,K; Bruckenberger,R; Hackl,G; Hafner,F; Froehlich,H; Pilger,E; Brodmann M. Primary Antiphospholipid Antibody Syndrome - One further aspect of thrombophilia in overweight and obese patients with venous thromboembolism
Zeitschrift für Gefäßmedizin. 2012; -Vascmed Graz; OCT 18-20, 2012; Graz. [Oral Communication]

 

Gross, S; Hafner, F; Haas, E; Lipp, R; Brodmann, M Repetitive (18)F-fluorodeoxyglucose positron emission tomography: a predictive value for relapse of giant cell arteritis?
Wiener Klinische Wochenschrift. 2012; 124(15-16):561-561.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 20-22, 2012; Graz, AUSTRIA. [Poster]
Web of Science

 

Gross, S; Hafner, F; Haas, E; Lipp, R; Gary, T; Froehlich, H; Hackl, G; Brodmann, M Repetitive 18-FDG PET and the Relapse-Risk of Giant Cell Arteritis
Zeitschrift für Gefäßmedizin. 2012; 9(3):30-30.-VASCMED 2012, 1. Kongress des Dachverbandes der Gefäßmedizinischen Gesellschaften Österreichs; OCT 18-20, 2012; Graz, AUSTRIA. [Poster]

 

Hafner, F; Fazekas, C; Gary, T; Froehlich, H; Brodmann, M Seasonal Variation of Endothelial Function in Scleroderma Related and Idiopathic Raynaud´s Phenomenon
Zeitschrift für Gefäßmedizin. 2012; 9(2):14-14.-7. Sailersymposium; JUN 21-22, 2012; Graz, AUSTRIA. [Poster]

 

Hafner, F; Fazekas, C; Gary, T; Froehlich, H; Brodmann, M SEASONAL VARIATION OF ENDOTHELIAL FUNCTION IN SCLERODERMA-RELATED AND IDIOPATHIC RP
RHEUMATOLOGY. 2012; 51: 90-90. [Poster]
Web of Science

 

Hafner, F; Kieninger, A; Seinost, G; Fröhlich, H; Gary, T; Hackl, G; Pilger, E; Brodmann, M Flow-Mediated Dilatation and Brachial Intima-Media Thickness: The Long-Term Cardiovascular Risk after Endovascular Treatment in Peripheral Arterial Disease
Zeitschrift für Gefäßmedizin. 2012; 9(3):31-31.-VASCMED 2012, 1. Kongress des Dachverbandes der Gefäßmedizinischen Gesellschaften Österreichs; OCT 18-20, 2012; Graz, AUSTRIA. [Poster]

 

Hafner, F; Kieninger, A; Seinost, G; Hackl, G; Gary, T; Froehlich, H; Pilger, E; Brodmann, M Flow-mediated dilatation and brachial intima-media thickness: the long term cardiovascular risk after percutaneous revascularization in peripharl arterial disease
Vasa, European Journal of Vascular Medicine. 2012; 41(S/82):43-44.-41. Jahrestagung der Deutschen Gesellschaft für Angiologie; SEP 15-15, 2012; Mainz, GERMANY. [Oral Communication]

 

Hafner, F; Kieninger, A; Seinost, G; Meinitzer, A; Brodmann, M Flow-mediated dilatation and brachial intima-media thickness: the long-term cardiovascular risk after percutaneous revascularization of peripheral arteries
Wiener Klinische Wochenschrift. 2012; 124(15-16):562-562.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 20-22, 2012; Graz, AUSTRIA. [Poster]
Web of Science

 

Kieninger, A; Hafner, F; Seinost, G; Froehlich, H; Gary, T; Pilger, E; Brodmann, M Correlation between flow-mediated dilatation and brachial intima-media thickness and the long-term cardiovascular risk after percutaneous revascularization in peripheral arterial disease
International Angiology. 2012; 31(Sup 1):-XXV World Congress of the International Union of Angiology; JUL 1-5; 2012; Prague, CZECH REPUBLIC. [Oral Communication]

 

Kieninger, A; Hafner, F; Seinost, G; Gary, T; Froehlich, H; Pilger, E; Brodmann, M Flow-Mediated Dilatation and Brachial Intima-Media Thickness and the Long-Term Cardiovascular Risk after Percutaneous Revascularization in Peripheral Arterial Disease
Zeitschrift für Gefäßmedizin. 2012; 9(2):14-15.-7. Sailersymposium; JUN 21-22, 2012; Graz, AUSTRIA. [Poster]

 

Kieninger, A; Hafner, F; Seinost, G; Gary, T; Froehlich, H; Pilger, E; Brodmann, M Flow-mediated dilatation and brachial intima-media thickness and the long-term cardiovascular risk after percutaneous revascularization in peripheral arterial disease
EURO PCR 2012. 2012; -EURO PCR; MAY 15-18, 2012; Paris, FRANCE. [Poster]

 

Koenig, C; Wimmer, G; Meinitzer, A; Hafner, F; Gasser, R; Brodmann, M; Pilger, E; Seinost, G Periodontal treatment decreases asymmetrical dimethylarginine (ADMA) concentrations and increases the plasma L-arginine/ADMA ratio in patients with severe periodontitis
EuroPrevent; MAY 3-5, 2012; Dublin. 2012. [Poster]

 

Konig, C; Wimmer, G; Meinitzer, A; Hafner, F; Gasser, R; Brodmann, M; Pilger, E; Seinost, G Periodontal treatment decreases asymmetrical dimethylarginine (ADMA) concentrations and increases the plasma L-arginine/ADMA ratio in patients with severe periodontitis
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):562-562.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; ; SEP 20-22, 2012; ; Graz, AUSTRIA. . [Poster]
Web of Science

 

Leb-Stöger, U; Haas, W; Köhler, G; Brodmann, M; Bock, G; Svehlikova, E; Mader, J; Pilger, E; Pieber, TR. Diabetic foot clinic: Set-up of interdisciplinary cooperation: 1 year of evaluation
EWMA Journal. 2012; 12(2):92-92.-Europaean Wound Management Association (EWMA); May 23-25; Vienna, Austria. [Oral Communication]

 

Salmhofer W, Binder B, Brodmann M Seminar: Beinvenenthrombose: Diagnostik, Therapie und Prophylaxe
8. DermAkademie; 20.-21.4.2012; Graz. 2012. [Oral Communication]

 

Seinost, G; König,C; Wimmer, G; Meinitzer,A; Hafner,F; Gasser, R; Brodmann,M; Pilger,E Peridontal treatment decreases asymmetrical dimethylarginine (ADMA) concentrations and increases the plasma L-arginine/ADMA ratio in patients with severe periodontitis
1.Kongress des Verbandes für österreichische Gefäßmedizin (VASCMED); Okt 18-20, 2012; Graz. 2012. [Poster]

 

Aschauer, M; Obernosterer, A; Brodmann M; Partl, R; Cohnert, T Emergency MRA in patients with critical ischemia at 1.5 and 3.0T
Abstractband des 23rd Annual International Conference on Magnetic Resonance Angiography. 2011; -23rd Annual International Conference on Magnetic Resonance Angiography; SEP 25-28, 2011; Banff, Ablerta, Canada. [Oral Communication]

 

Belaj, K; Gary, T; Brodmann, M; Lipp, R; Deutschmann, H Positive Lung Scintigraphy in a female Patient following a Warden Procedure
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A48-A49.-ÖGIM 2011; [Poster]
Web of Science

 

Belaj, K; Gary,T; Deutschmann, H; Lipp,R; Brodmann, M False positive V/Q Scan suspecting PE in a patient after Warden procedure
Zeitschrift für Gefäßmedizin. 2011; 8(4):15-15.-Jahrestagung der ÖGIA und 6.Sailersymposium; NOV 25-26, 2011; Graz. [Poster]

 

Brodmann, M Plättchenhemmung oder Antikoagulation oder Kombination-wem, wann, was?
International Vascular Workshop ; FEB-MAe 25-4, 2011; Going, Tirol. 2011. [Keynote lecture]

 

Brodmann, M; Therapie der PAVK-State of the Art
Die Gefässe im Fokus; Mai 13-15, 2011; Fuschl, Salzburg. 2011. [Keynote lecture]

 

Brodmann, M; Therapie tiefer Venenthrombosen-kein Stein bleibt auf dem anderen?
Jahrestagung der ÖGIA und 6. Sailersymposium; NOV 25-26, 2011; Graz. 2011. [Keynote lecture]

 

Brodmann, M; Interventionelle Angiologie-aktuelle Studien-ein Update
Jahrestagung der ÖGIA und 6. Sailersymposium; NOV 25-26, 2011; Graz. 2011. [Keynote lecture]

 

Brodmann, M; Die Komplexität von Kollagenosen
22.Grazer Fortbildungstage; OKT 3-8, 2011; Graz. 2011. [Keynote lecture]

 

Brodmann, M; Blutgerinnung 2011 Fokus Thrombogenität bei onkologischen Patienten&Update neuer Substanzen
Symposium am Puls der Zeit; Kardiovaskuläre Erkrankungen heute und morgen; SEP 23-24, 2011; Klagenfurt. 2011. [Keynote lecture]

 

Brodmann, M; Therapie venöser Thromboembolien-kEIN STEIN bleibt auf dem anderen?
Thrombosedialog St Pölten; DEZ 2-3,2011; St Pölten. 2011. [Keynote lecture]

 

Brodmann, M; Frohlich, H; Dorr, A; Gary, T; Deutschmann, H; Portugaller, RH; Pilger, E Percutaneous transluminal Angioplasty versus primary Stent Implantation in the infrapopliteal arteries in Patients with Critical Critical Limb Ischaemia
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A46-A46.-ÖGIM 2011; [Poster]
Web of Science

 

Brodmann, M; Gary, T; Hafner, F; Tiesenhausen, K; Deutschmann, H; Pilger, E Massive Pulmonary Artery Embolism caused by isolated Vena iliaca interna-Thrombosis with free-floating Thrombus in the Vena cava inferior
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A46-A46.-ÖGIM 2011; [Poster]
Web of Science

 

Brodmann, M; Gary, T; Hafner, F; Tiesenhausen, K; Deutschmann, H; Pilger, E; Massive pulmonary embolism caused by internal iliac vein thrombosis with free floating thrombus formation in the vena cava inferior
Zeitschrift für Gefäßmedizin. 2011; 8(4):14-14.-Jahrestagung der ÖGIA und Sailersymposium; NOV 25-26, 2011; Graz. [Poster]

 

Brodmann, M; Gary,T; Hafner, F; Tiesenhausen,K; Deutschmann,H; Pilger,E; Massive pulmonary embolism caused by internal iliac vein thrombosis with free floating thrombus formation in the inferior vena cava
VASA. 2011; . 2011; 40(S 80):76-76.-40. Jahrestagung der Deutschen Gesellschaft für Angiologie;; SEP 7-10; 2011; Frankfurt am Main, GERMANY. . [Poster]

 

Brodmann,M Therapie der akuten Pulmonalembolie
Jahrestagung der Östereichischen Gesellscahft für Pneumonologie; SEP 8-10, 2011; Wien. 2011. [Oral Communication]

 

Brodmann,M Nierenarterienstenose: Wann ist eine endovaskuläre Rekanalisation indiziert
42.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OKT 5-8, 2011; Innsbruck. 2011. [Keynote lecture]

 

Brodmann,M Neue Antithrombotika-die Einsteinstudie
5.Wachauer Venensymposium; JUN 17-19, 2011; Wachau, Niederösterreich. 2011. [Keynote lecture]

 

Brodmann,M Die Akuttherapie der PAE
Wiener Medizinische Wochenschrift 2011. 2011; 8(8):8-9.-Jahrestagung der Österreichischen Gesellschaft für Pneumonologie; SEP 8-10, 2011; Wien. [Keynote lecture]

 

Brodmann,M; Interdisziplinäre Fortbildung Wundmanagement-die arterielle Wunde
Interdisziplinäre Fortbildung Wundmanagement-LKH UNIV Klinikum; NOV 21-23, 2011; Graz. 2011. [Oral Communication]

 

Brodmann,M; Therapeutische Herausforderungen: Der Diabetes Patient
Meet the Experts; OKT 8, 2011; Linz. 2011. [Keynote lecture]

 

Brodmann,M; pAVK Diagnostik und Therapie
Innere Medizi, Update Refresher; Nov-Dez, 30-4, 2011; Vienna. 2011. [Keynote lecture]

 

Brodmann,M; Akute Extremitätenischämie-interventionelle Therapiemöglichkeiten
Jahrestagung ÖGIA und 6.Sailersymposium; Nov 25-26,2011; Graz. 2011. [Oral Communication]

 

Brodmann,M; Dabigatran-Paradigmenwechsel in der Antikoagulation
Jahrestagung der ÖGIA und 6. Sailersymposium; NOV 25-26, 2011; Graz. 2011. [Keynote lecture]

 

Brodmann,M; Therapie der kritischen Exzremitätenischämie, konservativ
Jahrestagung der ÖGIA und 6. Sailersymposium; NOV 25-26, 2011; Graz. 2011. [Keynote lecture]

 

Brodmann,M; Perioperative Thromboseprophylaxe
22. Grazer Fortbildungstage; OKT 3-8, 2011; Graz. 2011. [Oral Communication]

 

Brodmann,M; Froehlich,H; Dorr, A; Gary,T; Pilger, E; Deutschmann, H; Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arteries in critical limb ischemia
40.Jahrestagung der Deutschen Gesellschaft für Angiologie; SEP 7-10, 2011; Frankfurt am Main, Germany. 2011. [Oral Communication]

 

Brodmann,M; Froehlich,H; Dorr,A; Gary,T; Portugaller,RH; Deutschamnn,H; Pilger,E; Perkutane transluminale Angioplastie versus primäre Stentimplantation im Bereich der infrapoplitealen Arterien bei Patienten mit kritsischer Extremitätenischämie
Zeitschrift für Gefäßmedizin. 2011. 2011; 8(4):14-14.-Jahrestagung der Österreichischen Gesellchaft für Internistische Angiologie und 6. Sailersymposium; NOV 25-26, 2011; Graz. [Poster]

 

Fazekas, C; Hafner, F; Gary, T; Froehlich, H; Steidl, K; Brodmann, M Gibt es saisonale Schwankungen der Endothelfunktion bei Patienten mit Raynaud-Phänomen?
Der Internist Volume 52, Supplement 1 / Mai 2011 2011; 52(1):121-121.-117. Kongress der Deutschen Gesellschaft für Innere Medizin; APR 30- MAI 03, 2011; Wiesbaden, GERMANY. [Poster]
FullText

 

Froehlich, H; Hafner, F; Binder, J; Amrein, K; Scharnagl, H; Brodmann, M; Stojakovic, T Simvastatin improves endothelial function in patients with cardiovascular disease but not in patients with peripheral artery disease.
18. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 6-7, 2011; St. Gilgen, AUSTRIA. 2011. [Oral Communication]

 

Froehlich, H; Hafner, F; Binder, J; Amrein, K; Scharnagl, H; Brodmann, M; Stojakovic, T SIMVASTATIN IMPROVES ENDOTHELIAL FUNCTION IN PATIENTS WITH CARDIOVASCULAR DISEASE BUT NOT IN PATIENTS WITH PERIPHERAL ARTERY DISEASE.
ATHEROSCLER SUPPL. 2011; 12(1):173-174.-79th Congress of the European Atherosclerosis Society (EAS); JUN 26-29, 2011; Gothenburg, SWEDEN. Doi: 10.1016/S1567-5688(11)70827-3 [Poster]
Web of Science FullText FullText_MUG

 

Froehlich, H; Hafner, F; Binder, J; Amrein, K; Scharnagl, H; Brodmann, M; Stojakovic, T Simvastatin improves endothelial function in patients with cardiovascular disease but not in patients with peripheral artery disease.
41. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 24-26, 2011; Maikammer, GERMANY. 2011. [Oral Communication]

 

Froehlich, H; Lintner, L; Hafner, F; Steidl, K; Gary, T; Deutschmann, HA; Brodmann, M Elevated Levels of pre-Procedural Lipoprotein(a) are Associated with Restenosis after Carotid Artery Stenting
CIRCULATION. 2011; 124(21): [Poster]
Web of Science

 

Frohlich, H; Hafner, F; Binder, J; Amrein, K; Scharnagl, H; Brodmann, M; Stojakovic, T Simvastatin improves endothelial function in patients with cardiovascular disease but not in patients with peripheral artery disease.
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A54-A54.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); OCT 5-8, 2011; Innsbruck, AUSTRIA. [Poster]
Web of Science

 

Fröhlich, H; Hafner, F; Binder,J; Amrein,K; Scharnagl, H; Brodmann,M; Stojakovic,T Simvastatin imporves endothelial function in patients with cardiovascular disease but not in patinets with peripheral arterial disease
Zeitschrift für Gefäßmedizin 2011. 2011; 8(4):16-16.-Jahrestagung der ÖGIA und 6.Sailersymposium; NOV 25-26, 2011; Graz. [Poster]

 

Frohlich, H; Korinek, J; Hafner, F; Gary, T; Pilger, E; Brodmann, M Comparison of two state-of-art automated oscillometric and standard Doppler-based ankle-brachial index measurements and a novel pulse wave index for peripheral arterial disease diagnosis
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A48-A48.-ÖGIM 2011; [Poster]
Web of Science

 

Fröhlich, H; Korinek, J; Hafner,F; Gary,T; Pilger,E; Brodmann,M Comparison of two state of the art automated oscillometric and standard doppler-based ankel-brachial index measurements an a novel pulse wave index for peripheral arterial disease diagnosis
Zeitschrift für Gefäßmedizin 2011. 2011; 8(4):16-16.-Jahrestagung der ÖGIA und 6.Sailersymposium; NOV 25-26, 2011; Graz. [Poster]

 

Gary, T; Belaj, K; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M Lipid parameters might influence VTE extension
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A45-A45.-ÖGIM 2011; [Poster]
Web of Science

 

Gary, T; Belaj,K; Hafner, F; Froehlich,H; Pilger,E; Brodmann,M; Lipid parameters might influence VTE extension
VASA 2011. 2011; 40(S80):76-76.-40.Jahrestagung der Duetschen Gesellschaft für Angiologie; SEP 7-10,2011; Frankfurt am Main, Germany. [Poster]

 

Gary, T; Steidl, K; Eller, P; Deutschmann, H; Hafner, F; Nagel, B; Brodmann, M Suspected massive Pulmonary Arterial Embolism in a Patient with Pulmonary Atresia and intact Ventricular Septum following a Fontan-Kreutzer Procedure
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A47-A48.-ÖGIM 2011; [Poster]
Web of Science

 

Gary, T; Steidl, K; Hafner, F; Froehlich, H; Deutschmann, H; Pilger, E; Brodmann, M Unusual deep vein thrombosis-sites - MR venography in patients with negative CUS and symptomatic PE
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A45-A45.-ÖGIM 2011; [Poster]
Web of Science

 

Gary, T; Steidl, K; Hafner, F; Froehlich,H; Deutschmann, H; Pilger, E; Brodmann, M; Unusual Deep vein thrombosis sites-MR venography in patients with negative CUS and sympotmatic PE
Zeitschrift für Gefäßmedizin. 2011; 8(4):15-15.-Jahrestagung der ÖGIA und 6 Sailersymposium; NOV 25-26, 2011; Graz. [Poster]

 

Gary,G; Starz,I; Belaj,K; Hafner,F; Froehlich,H; Pilger,E; Brodmann,M Hyperlipidemia is associated with a higher PAP in patients after pulmonary embolism
Hämostasiologie 2011. 2011; 31(1):5-5.-55. Jahrestagung der Gesellschaft für Thrombose-und Hämostaseforschung; FEB 16-19, 2011; Wiesbaden, Germany. [Oral Communication]

 

Gary,T; Belaj, K; Hafner, F; Froehlich,H; Pilger,E; Brodmann,M Lipid parametres might influence VTE extension
Zeitschrift für Gefäßmedizin. 2011. 2011; 8(4):14-14.-Jahrestagung ÖGIA und Sailersymposium; NOV 25-26, 2011; Graz. [Poster]

 

Gary,T; Steidl, K; Eller,P; Deutschmann, H; Hafner,F; Nagel,B; Brodmann, M; Suspected massive pulmonary embolism in a patient with pulmonal atresia and intact ventricular septum after Fontan-Kreutzer Procedure
Zeitschrift für Gefäßmedizin. 2011; 8(4):14-14.-Jahrestagung der ÖGIA und 6.Sailersymposium; NOV 25-26, 2011; Graz. [Poster]

 

Haas, E; Hafner, F; Froehlich, H; Gary, T; Steidl, K; Brodmann, M Hat die Steroidtherapie einen Einfluss auf die endotheliale Funktion bei Riesenzellarteriitis?
Der Internist2011; Vos 52, Suppl. 1: 122-122.-117. Kongress der Deutschen Gesellschaft für Innere Medizin; APR 30- Mai 3, 2011; Wiesbaden, GERMANY. [Poster]
FullText

 

Hafner, F; Froehlich, H; Gary, T; Henoekl, K; Steidl, K; Pilger, E; Brodmann, M Akut aufgetretene Extremitätenischämie nach Varizensklerosierung, ein Fallbericht
Wiener Klinische Wochenschrift. 2011; 123(17):A47-A47.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin, ÖGIM 2011; OCT 5-8, 2011; Innsbruck, AUSTRIA. [Poster]
Web of Science

 

Hafner, F; Froehlich, H; Gary, T; Henoekl, K; Steidl, K; Pilger, E; Brodmann, M Ausgeprägtes Ischämiesyndrom des Fußes nach Varizensklerosierung, ein Fallbericht
Vasa, European Journal of Vascular Medicine. 2011; 40(S/81):28-29.-12. Unionstagung Haut und Gefäße; NOV 9-11, 2011; Baden, SWITZERLAND. [Poster]

 

Hafner, F; Froehlich, H; Gary, T; Henoekl, K; Steidl, K; Pilger, E; Brodmann, M Akut aufgetretene Extremitätenischämie nach Varizensklerosierung - ein Fallbericht
Zeitschrift für Gefäßmedizin. 2011; 8(4):15-15.-Jahrestagung der Österreichischen Gesellchaft für Internistische Angiologie und 6. Sailersymposium; NOV 25-26, 2011; Graz, AUSTRIA. [Poster]

 

Hafner, F; Fröhlich H; Gary, T; Steidl, K; Pilger, E; Brodmann, M Akutes Ischämiesyndrom nach Varizensklerosierung, ein Fallbericht.
VASA. 2011; 40: Suppl. 80: 69-69.-40. Jahrestagung der Deutschen Gesellschaft für Angiologie; SEP 7-10, 2011; Frankfurt am Main, GERMANY. [Poster]
FullText

 

Henokl, K; Gary, T; Feichtinger, P; Deutschmann, H; Pilger, E; Brodmann, M Paradox Embolism in a 46-year-old Woman as the Cause of an acute Abdomen
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A48-A48.-ÖGIM 2011; [Poster]
Web of Science

 

Hoerl, G; Cvirn, G; Schlagenhauf, A; Mathew, E; Tafeit, E; Brodmann, M; Juergens, G; Koestenberger, M; Gary, T Effect of Coagulation on the Development of Stent Restenosis in Patients with peripheral arterial Occlusive Disease
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A47-A47.-ÖGIM 2011; [Poster]
Web of Science

 

Schilcher, G; Ribitsch, W; Otto, R; Portugaller, H; Quehenberger, F; Truschnig-Wilders, M; Zweiker, R; Stiegler, P; Brodmann, M; Weinhandl, K; Rosenkranz, AR; Horina, JH Study protocol: Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: A randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study)
Abstractband ÖGN 2011. 2011; -Jahrestagung der Österreichischen Gesellschaft für Nephrologie (ÖGN); Nov, 4-5, 2011; Gmunden, Austria. [Oral Communication]

 

Schilcher, G; Ribitsch, W; Otto, R; Portugaller, RH; Quehenberger, F; Truschnig-Wilders, M; Zweiker, R; Stiegler, P; Brodmann, M; Rosenkranz, AR; Horina, JH Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: Study protocol of a randomized controlled trial inpatients undergoing intra-arterial angiography (ANTI-CIN Study)
Abstractband der 3.Jahrestagung der DGfN. 2011; -3. Jahrestagung der Deutschen Gesellschaft für Nephrologie; Sept 10-13, 2011; Berlin, Germany. [Poster]

 

Schilcher,G; Ribitsch,W; Otto,R; Portugaller,H; Quehenberger,F; Truschnig-Wilders,M; Zweiker,R; Stiegler,Ph; Brodmann,M; Weinhandl, K; Rosenkranz,AR; Horina, JH; Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial nagiography (ANTI-CIN Study)
Gemeinsame Jahrestagung der Österreischischen Gesellschaft für Hypertensiologie und Nephrologie; NOV 4-5, 2011; Gmunden. 2011. [Oral Communication]

 

Steidl, K; Gary, T; Eller, P; Deutschmann, H; Hafner, F; Nagel, B; Brodmann, M Suspected massive pulmonary embolism in a patient with pulmonal atresia after Fontan-Kreutzer procedure
Vasa, European Journal of Vascular Medicine. 2011; 40(S/81):30-30.-12. Unionstagung Haut und Gefäße; NOV 9-11, 2011; Baden, SWITZERLAND. [Poster]

 

Brodmann, M Thromboseprophylaxe in der Orthopädie-ein Jahr nach der Einführung der neuen Substanzen
Fortbildung Orthopädie; AUG 18, 2010; Graz. 2010. [Oral Communication]

 

Brodmann, M How to do:Diabetes- Vaskuläre Komplikationen; Revaskularisation, was ist gesichert, was ist möglich?
41.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 29-Okt 2, 2010; Salzburg. 2010. [Keynote lecture]

 

Brodmann, M Neue Antikoagulantien im Blickpunkt
Fortbildung des LKH Knittelfeld-Judenburg Verbundes; Jan 20, 2010; Schloß Farrach. 2010. [Keynote lecture]

 

Brodmann, M pAVK- Diagnostik in der Praxis
Ärztekammerfortbildung (10.Seminare); MAR 19-27, 2010; Graz. 2010. [Keynote lecture]

 

Brodmann, M Die arterielle Wunde, Diagnose und Leitfaden zur Therapie
Wundseminar 2010; APR 24, 2010; Hörgas. 2010. [Oral Communication]

 

Brodmann, M Below the knee interventions in diabetic foot syndrome
7th International Congress of Central European Vascular Forum; MAI 27-30, 2010; Timisoara, Romania. 2010. [Oral Communication]

 

Brodmann, M Neue Antikoagulantien, was ist zugelassen?
Fortbildung LKH Verbund Judenburg Knittelfeld; MAR 3, 2010; Knittelfeld. 2010. [Oral Communication]

 

Brodmann, M Beraking News: vom ESC zur Therapie der VTE
41.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 29-Okt 2, 2010; Salzburg. 2010. [Keynote lecture]

 

Brodmann, M Neue Wege in der Antikoagulation-Guidelines und Therapie im Wandel
2nd Anticoagulation Forum ; OKT 16, 2010; St Wolfgang. 2010. [Keynote lecture]

 

Brodmann, M Die arterielle Wunde
Fortbildung Wundmanagement KAGES; OKT 13-15, 2010; Graz. 2010. [Oral Communication]

 

Brodmann, M Neue Antikoagulantien, was ist zugelassen
Fortbildung LKH Hartberg; JAN 20, 2010; Hartberg. 2010. [Oral Communication]

 

Brodmann, M Arterielle Verschlußkrankheit: Invasiv vs. optimale medikamentöse Therapie, Plenarsitzung der ÖGIA
41.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 29-Okt 2, 2010; Salzburg. 2010. [Keynote lecture]

 

Brodmann, M Therapie der Vaskulitis
7. Kardiovaskuläres Symposium am Wilhelminenberg; Jae 15,2011; Wien. 2010. [Keynote lecture]

 

Brodmann, M Konservative Therapie der pAVK
Fortbildungsabend Radiologie Graz; DEZ 14, 2010; Graz. 2010. [Keynote lecture]

 

Brodmann, M Sollte die ABI Messung ein Bestandteil der Gesundenuntersuchung sein? Nein, denn dann ist es schon zu spät
6. Königsbergergefäßdialog; NOV 5-6,2010; Bad Schönau. 2010. [Keynote lecture]

 

Brodmann, M Thrombose- Abklärung und Therapie: Neue Antithrombotika
Jahrestagung der Österreichischen Gesellschaft für Phlebologie und dermatologische Angiologie; OKT 1-2, 2010; Graz. 2010. [Keynote lecture]

 

Brodmann, M Anitplättchensubstanzen beim nephrologischen Patienten
Gemeinsame Jahrestagung der ÖGH und ÖGN; OKT 15-16, 2010; Eisenstadt. 2010. [Keynote lecture]

 

Brodmann, M Emerging PVD
Nucleus Meeting ESC, Imaging Atherosclerosis; Feb 22, 2010; Zuerich. 2010. [Keynote lecture]

 

Brodmann, M Angiologische Ursachen von Beinschmerzen: pAVK und Ischämie
Venalpina VI + 50 Jahre Schweizerische Gesellschaft für Phlebologie ; Jan 23-30, 2010; Pontresina, Schweiz. 2010. [Oral Communication]

 

Brodmann, M The infrapopliteal endovascular procedures-Stenting/PTA. What should we recommend right now?
XXXV Angiological Days 2010; Feb 25-27, 2010; Prag. 2010. [Keynote lecture]

 

Brodmann, M PAVK Begleit-und Nachbehandlung nach Intervention
26. ÖDG Frühjahrstagung; MAI 28-29, 2010; Pörtschach. 2010. [Oral Communication]

 

Brodmann, M RE-VOLUTION in der Prävention und Behandlung
3 Ländertagung Angiologie Basel; SEp 12-15, 2010; Basel, Schweiz. 2010. [Oral Communication]

 

Brodmann, M Blutgefäße und Lunge
Jahrestagung 2010; Österreichische Gesellschaft für Pneumonologie; OKT 7-9, 2010; Graz. 2010. [Oral Communication]

 

Fazekas, Cl; Hafner, F; Gary, T; Froehlich, H; Steidl, K; Brodmann, M Gibt es saisonale Schwankungen der Endothelfunktion bei Patienten mit Raynaud-Phänomen
Wiener klinische Wochenschrift - The Middle European Journal of Medicine2010; 122(17):A3-A4.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 29-OCT 2, 2010; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Fröhlich, H; Hafner, F; Gary, T; Pilger, E; Brodmann, M Automated oscillometric measurement of the ankle-brachial index in comparison to standard doppler technique in vascular patients
VASA2010; 2010(79):-15. Dreiländertagung der Schweizerischen, Deutschen und Österreichischen Gesellschaft für Angiologie; SEP 12-15, 2010; Basel, Schweiz. [Poster]

 

Gary, T; Brodmann, M VTE beim onkologischen Patienten - Therapie und Sekundärprophylaxe
5. Sailersymposium; Jun 25, 2010; Graz. 2010. [Oral Communication]

 

Gary, T; Ina, S; Klara, B; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M Hyperlipidemia is associated with a higher PAP in patients after pulmonary embolism
WIEN KLIN WOCHENSCHR. 2010; 122(17-18): A5-A5. [Poster]
Web of Science

 

Gary, T; Portugaller, H; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M Prospective evaluation of feasibility of the ALN vena cava inferior filter in patients with deep vein thrombosis
Vasa2010; Suppl. 79: 63-63.-15. Dreiländertagung der Schweizerischen, Deutschen und Österreichischen Gesellschaft für Angiologie; SEP 12-15, 2010; Basel, Schweiz. [Oral Communication]

 

Gary, T; Portugaller, R; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M Prospective evaluation of feasibility of the ALN vena cava inferior filter in patients with deep vein thrombosis
EUR HEART J. 2010; 31: 624-624. [Poster]
Web of Science

 

Gary, T; Portugaller, RH; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M Prospektive Feasibility-Studie des ALN Cava Filters in VTE Patienten
Med Klin2010; 105; Suppl. 1: 91-91.-116. Kongreß der Deutschen Gesellschaft für Innere Medizin e.V.; APR 10-14, 2010; Wiesbaden, Deutschland. [Poster]

 

Gary, T; Portugaller, RH; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M Prospective evaluation of feasibility of the ALN vena cava inferior filter in patients with deep vein thrombosis.
Wiener Klinische Wochenschrift 20102010; 122: A4-A5.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEPT 29-OCT 2; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Gary, T; Rief, P; Stojakovic, T; Froehlich, H; Scharnagl, H; Hafner, F; Pilger, E; Brodmann, M Lipoproteins and the development of re-obstruction after stent implantation in the superficial femoral artery in patients with peripheral artery disease.
17. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 7-8, 2010; St. Gilgen, AUSTRIA. 2010. [Oral Communication]

 

Gary, T; Rief, P; Stojakovic, T; Froehlich, H; Scharnagl, H; Hafner, F; Pilger, E; Brodmann, M PARAMETERS OF THE LIPID PROFILE AND ASSOCIATION WITH THE DEVELOPMENT OF RE-OBSTRUCTION AFTER STENT IMPLANTATION IN THE SFA IN PAD-PATIENTS
ATHEROSCLER SUPPL. 2010; 11(2):P292--78th Congress of the European Atherosclerosis Society; JUN 20-23, 2010; Hamburg, GERMANY. Doi: 10.1016/S1567-5688(10)70359-7 [Poster]
Web of Science FullText FullText_MUG

 

Gary, T; Rief, P; Stojakovic, T; Froehlich, H; Scharnagl, H; Hafner, F; Pilger, E; Brodmann, M Lipoproteins and the development of re-obstruction after stentimplantation in the superficial femoral artery in patients with peripheral artery disease
Wiener Klinische Wochenschrift 20102010; 122: A5-A5.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEPT 29-OCT 2; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Gary, T; Rief, P; Stojakovic, T; Froehlich, H; Scharnagl, H; Hafner, F; Pilger, E; Brodmann, M Lipoproteins and the development of re-obstruction after stentimplantation in the superficial femoral artery in patients with peripheral artery disease
Vasa2010; Suppl. 79: 57-57.-15. Dreiländertagung der Schweizerischen, Deutschen und Österreichischen Gesellschaft für Angiologie; SEP 12-15, 2010; Basel, Schweiz. [Oral Communication]

 

Gary, T; Rief, P; Stojakovic, T; Froehlich, H; Scharnagl, H;Hafner, F; Pilger, E; Brodmann, M Parameters of the lipid profile and their association with the development of re-obstruction after stentimplantation in the superficial femoral artery in patients with peripheral arterial disease
Hämostasiologie Jänner 20102010; 30: 118--1.Joint Meeting GTH&NVTH: 54. Jahrestagung der GTH& Symposium van de Nederlandse Vereniging voor Trombose en Hemostase; Feb 24-27, 2010; Nuernberg, Deutschland. [Poster]

 

Gary, T; Starz, I; Belaj, K; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M Hyperlipidemia is associated with a higher PAP in patients after pulmonary embolism
Vasa 2010; Suppl. 79: 61-61.-15. Dreiländertagung der Schweizerischen, Deutschen und Österreichischen Gesellschaft für Angiologie; SEP 12-15, 2010; Basel, Schweiz. [Oral Communication]

 

Gary, T; Starz, I; Belaj, K; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M Hyperlipidämie ist mit erhöhtem PAP nach PAE assoziiert
Med Klin 2010; 105, Suppl. 1: 91-91.-116. Kongreß der Deutschen Gesellschaft für Innere Medizin e.V.; APR 10-14, 2010; Wiesbaden, Deutschland. [Poster]

 

Haas, E; Hafner, F; Froehlich, H; Gary, T; Steidl, K; Brodmann, M Hat die Steroidtherapie einen Einfluss auf die endotheliale Funktion bei Riesenzellarteriitis?
Wiener klinische Wochenschrift - The Middle European Journal of Medicine2010; 122(17):A4-A4.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 29-OCT 2, 2010; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Hafner, F; Froehlich, H; Gary, T; Paetzold, S; Steidl, K; Pilger, E; Brodmann, M BOSENTAN IN ACRAL ISCHEMIA NOT RELATED TO SCLERODERMA
CLIN EXP RHEUMATOL. 2010; 28(2): S159-S160. -1st Systemic Sclerosis World Congress; FEB 11-13, 2010; Florence, ITALY. [Poster]
Web of Science

 

Hafner, F; Fröhlich, H; Gary, T; Steidl, K; Pätzold, S; Seinost, G; Pilger, E; Brodmann, M Der Zusammenhang zwischen der Helicobacter pylori Serologie und dem Auftreten einer Restenose nach endovaskulärer Rekanalisation der Extremitätenarterien
Medizinische Klinik2010; Volume 105, Suppl. 1: 94-94.-116. Kongress der Deutschen Gesellschaft für Innere Medizin (DGIM); APR 10-14, 2010; Wiesbaden, GERMANY. [Poster]

 

Hafner, F; Gary, T; Froehlich, H; Paetzold, S; Steidl, K; Pilger, E; Brodmann, M THE EFFECT OF A SINGLE LINE THERAPY WITH BOSENTAN VERSUS A SEQUENTIAL THERAPY OF PROSTANOIDS AND BOSENTAN IN THE TREATMENT OF DIGITAL SKIN ULCERS IN SEVERE SCLERODERMA
CLIN EXP RHEUMATOL. 2010; 28(2): S160-S160. -1st Systemic Sclerosis World Congress; FEB 11-13, 2010; Florence, ITALY. [Poster]
Web of Science

 

Hafner, F; Steidl, K; Froehlich, H; Gary, T; Paetzold, S; Brodmann, M Der Einsatz von Bosentan bei Vaskulitis-assoziierter kritischer Minderperfusion der Akren
VASA2010; 39, Suppl. 79: 93-93.-15. Dreiländertagung der Schweizerischen, Deutschen und Österreichischen Gesellschaften für Angiologie; SEP 12-15, 2010; Basel, SWITZERLAND. [Poster]

 

Hafner, F; Steidl, K; Froehlich, H; Gary, T; Paetzold, S; Brodmann, M Der Einsatz von Bosentan bei Vaskulitis-assoziierter kritischer Minderperfusion der Akren
Wiener Klinische Wochenschrift - The Middle European Journal of Medicine2010; 122(17):A3-A3.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 29-OCT 2, 2010; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Hafner, F; Steidl, K; Gary, T; Froehlich, H; Brodmann, M Der Einsatz von Bosentan bei Vaskulitis-assoziierter kritischer Minderperfusion der Akren
zfw – Zeitschrift für Wundheilung2010; -13. Jahreskongress der Deutschen Gesellschaft für Wundheilung und Wundbehandlung e.V.; JUN 17-19, 2010; Freiburg, GERMANY. [Poster]

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Graninger, W; Kqiku, X; Scheid, S; Troster, N; Hesse, C; Rubin, L; Olschewski, H The progression towards pulmonary hypertension in systemic sclerosis may be attenuated by "very early" treatment with bosentan
WIEN KLIN WOCHENSCHR. 2010; 122(21-22): A49-A49. [Poster]
Web of Science

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Graninger, W; Kqiku, X; Scheidl, S; Troester, N; Hesse, H; Rubin, L; Olschewski, H The progression towards pulmonary arterial hypertension is attenuated by bosentan in scleroderma patients
Eur Respir J . 2010; Suppl. 54(36):205-205.-ERS Kongress; SEP 18-22, 2010; Barcelona. [Oral Communication]

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Graninger, W; Kqiku, X; Scheidl, S; Tröster, N; Hesse, C; Rubin, L; Olschewski, H The progression towards pulmonary hypertension my be attenuated by " very early" treatment with bosentan
Jahrestagung der Österreichischen Gesellschaft für Pneumonologie; OKT 7-9, 2010; Graz. 2010. [Poster]

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Graninger, W; Kqiku, X; Troester, N; Scheidl, S; Hesse, C; Olschewski, H The progression of early pulmonary vasculopathy in systemic sclerosis may be reversed by bosentan
Pneumologie Update; JUN 17-19, 2010; Igls. 2010. [Poster]

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Graninger, W; Kqiku, X; Troester, N; Scheidl, S; Olschewski, H Early Therapy With Bosentan Reverses Progressing Pulmonary Vasculopathy In Scleroderma Patients
American Journal of Respiratory and Critical Care Medicine Meeting Abstracts. 2010; (181):A3361-A3361.-ATS; MAI 14-20, 2010; New Orleans. [Poster]

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Troester, N; Scheidl, S; Rubin, L; Olschewski, H The progression of early pulmonary vasculopathy in scleroderma is attenuated by bosentan
Cor Vasa. 2010; Suppl 1(52):97-97.-International Conference on Pulmonary Circulation; JUN 2-5, 2010; Prague, Czech Republic. [Poster]

 

Brodmann, M Neue Antikoagulantien-Blick in die Zukunft mit der Erfahrung bewährter Substanzen
53. Jahrestagung der Gesellschaft für Thrombose-und Hämostaseforschung e.V. (GTH) 2009; FEB 4-7,2009; Wien. 2009. [Keynote lecture]

 

Brodmann, M Indications for carotid artery stenting:Comparison sith surgical and medical therapy
18th EUROCHAP 2009; Oct 24-27, 2009; Palermo. 2009. [Keynote lecture]

 

Brodmann, M pAVK-Möglichkeiten und Grenzen
Innere medizin Kompakt; Nov 6-7, 2009; Riegersburg. 2009. [Keynote lecture]

 

Brodmann, M Risiko Thrombose-sind Verbesserungen in der Thromboseprophylaxe sinnvoll, notwendig und möglich?
Bezirksärztefortbildung ; Nov 3, 2009; Straden. 2009. [Keynote lecture]

 

Brodmann, M Sekundärprophylaxe des Patienten mit pAVK-Ich bevorzuge Clopidogrel
5.Köngisberger Gefäßdialog; Nov 6-7, 2010; Bad Schönau. 2009. [Oral Communication]

 

Brodmann, M Thromboseprophylaxe beim internistischen und neurologischen Patienten
Fortbildung im Bezirk; Sep 29, 2009; Langenwang. 2009. [Keynote lecture]

 

Brodmann, M Rekanalisation bei Instentrestenosen mit Silverhawk
Wiener klinische Wochenschrift2009; -Gemeinsame Jahrestagung der gefäßmedizinischen Gesellschaften Österreichs; OCT 1-3, 2009; Bregenz. [Oral Communication]

 

Brodmann, M Entzündliche Gefäßerkrankungen-was tun?
Fortbildung; MAE 25, 2009; LKH Deutschlandsberg. 2009. [Oral Communication]

 

Brodmann, M Ein Blick in die Zukunft; Idrabiotaparinux-innovative Antikoagulation
WWW-Skriptum 06/092009; -Expertenmeeting 2009 "Blutjung"; APR 17-18, 2009; Wien. [Oral Communication]

 

Brodmann, M PAVK- das optimale Therapiekonzept
Fortbildung; JUN 30, 2009; KH der Elisabethinen Graz. 2009. [Keynote lecture]

 

Brodmann, M Sind Verbesserungen in der Thrombosprophylaxe notwendig, sinnvoll und möglich?
Fortbildung; MAI 5, 2009; LKH Bruck/Mur. 2009. [Oral Communication]

 

Brodmann, M Trombinhemmung mit dabigatran-der direkte Ansatz in der Antikoagulation
Gemeinsame Jahrestagung der gefäßmedizinischen Gesellschaften Österreichs; OCT 1-3, 2009; Bregenz. 2009. [Oral Communication]

 

Brodmann, M Thromboseprophylaxe heute/morgen
Fortbildung; Apr 29, 2009; Graz. 2009. [Keynote lecture]

 

Brodmann, M Rekanalisation bei Instentstenosen mit Silverhawk
I.Club Endovascular; APR 24-25, 2009; Bad Tatzmannsdorf, Austria. 2009. [Oral Communication]

 

Brodmann, M Arterielle Diagnostik und Therapie bei chronsichen Wunden
TELEULCUS Projekt; JAE 21-23, 2009; Graz. 2009. [Oral Communication]

 

Brodmann, M pAVK als Markererkrankung für Atherothrombose
WWW Skriptum 6/092009; -Expertenmeeting 2009 " Blutjung"; APR 17-18, 2009; Wien. [Keynote lecture]

 

Brodmann, M Kollagenosen und Pulmonal arterielle Hypertonie
Lungenhochdruck ein Wettlauf mit der Zeit; APR 25, 2009; Wien. 2009. [Oral Communication]

 

Brodmann, M Diagnoseastellung; nicht invasive Methoden bei kritischer Extremitätenischämie und Diabetes
Universum Innere Medizin2009; -40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; AKH Wien. [Oral Communication]

 

Brodmann, M Neue Antithrombotika-Was ist für welche Indikation schon zugelassen?
4. Sailersymposium Graz; JUN 19, 2009; Graz. 2009. [Keynote lecture]

 

Brodmann, M Faktor Xa-Inhibition bei Therapie venöser Thromboembolien-Einblicke in die Zukunft
40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; AKH Wien. 2009. [Oral Communication]

 

Brodmann, M Thrombophilie-wann und wie abklären
CD Room2009; -Tagung Oberlech 2009 der Arbeitsgruppen der ÖGDV; MAE 21-27, 2009; Oberlech, Austria. [Oral Communication]

 

Brodmann, M Orale Thromboseprophylaxe-neue Entwicklungen auf dem Prüfstand
Gemeinsame Jahrestagung der gefäßmedizinischen Gesellschaften Österreichs; OCT 1-3, 2009; Bregenz. 2009. [Oral Communication]

 

Brodmann, M Grenzen der Kompressionstherapie bei Lymphödem, Komorbidität pAVK
14.kongress der Gesellschaft Deutschsprachiger Lymphologen, Lymphologica 2009; Mai 22-23, 2009; Klagenfurt, Austria. 2009. [Oral Communication]

 

Brodmann, M Planung der Patientenrekrutierung-mit Zufall hat das nichts zu tun
Seminar der Gesellschaft für Pharmazeutische Medizin e.v; SEP, 10, 2009; AKH Wien. 2009. [Keynote lecture]

 

Brodmann, M Best and Worst Cases in BTK Interventions
Ischemic Diabetic Foot Treatment II edition; MAE 6-7, 2009; Mailand, Italien. 2009. [Oral Communication]

 

Brodmann, M Prevention of diabetic ulcers
The Diabetic Leg Today; JUN 10-11, 2009; Hamburg, Deutschland. 2009. [Keynote lecture]

 

Brodmann, M Dabigatran, Substanz und Anwendung in der zugelassenen Indikation
Thrombosedialog Fuschl; FEB 28, 2009; Fuschl, Salzburg. 2009. [Oral Communication]

 

Brodmann, M PTA+Life Vascular Stent in der Poplitea (ETAP)
Interventionell Radiologisches Olbert Symposium, IROS 2009; JAN 28-30, 2009; Salzburg. 2009. [Oral Communication]

 

Brodmann, M Thromboseprophylaxe heute und morgen
Fortbildung für Orthopäden und Chirurgen; JAN 20, 2009; LKH Klagenfurt. 2009. [Keynote lecture]

 

Brodmann, M Wundtherapie aus angiologischer Sicht
ReformpooolprojektTeleulcus 2009; JAN 21-23, 2009; Univ.Klinikum Graz. 2009. [Oral Communication]

 

Feichtinger, P; Hafner, F; Gary, T; Brodmann,M; Pilger,E Zentrale PAE und konsekutive paradoxe Embolie in die rechte obere Extremität bei einem Patienten mit Osteogenesis imperfecta Typ V und Vorhofseptumdefekt
CD Room2009; -115. Jahres Tagung der Deutschen Gesellschaft für Innere Medizin, DGIM; APR 18-22, 2009; Wiesbaden, Deutschland. [Poster]

 

Froehlich, H; Gary, T; hafner, F; Pilger, E; Brodmann, M Gesteigerte Endothelzellproliferation durch Clopidogrel
Wiener Klinische Wochenschrift2009; 121. Jahrgang(15):15-15.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; AKH Wien. [Poster]

 

Froehlich, H; Gary, T; Hafner, F; Pilger, E; Brodmann, M Gesteigerte Endothelzellproliferation durch Clopidogrel
Zeitschrift für Gefäßmedizin2009; -Gemeinsame Jahrestagung der gefäßmedizinischen Gesellschaften Österreichs; OCT 1-3, 2009; Bregenz. [Oral Communication]

 

Frohlich, H; Gary, T; Hafner, F; Pilger, M; Brodmann, M Increased Endothelial cell proliferation by Clopidogrel
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A15-A15. [Poster]
Web of Science

 

Gary, T; Hafner, F; Freohlich, H; Pilger, E; Brodmann, M Niedrige Faktor-XII-aktivität und hohe Faktor VII Aktivität als thrombophiler Risikofaktor bei älteren Patienten mit venösen thromboembolischen Ereignissen
CD Room2009; -115. Jahres Tagung der Deutschen Gesellschaft für Innere Medizin, DGIM; APR 18-22, 2009; Wiesbaden, Deutschland. [Poster]

 

Gary, T; Prüller, F; Froehlich, H; Hafner, F; Pilger, E; Brodmann, M Einfluß der endovaskulären Rekanalisation bei Patienten mit peripherer arterieller Verschlußkrankheit auf die Thrombozytenfunktion im Vollblut
Wiener Klinische Wochenschrift. 2009; 121 Jahrgang(15):15--40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19,2009; AKH Wien. [Poster]

 

Gary, T; Prüller, F; Froehlich, H; Hafner, F; Pilger, E; Brodmann, M Influence of endovascular recanalisation in patients with peripheral arterial occlussive disease on the platelet funvtion in whole blood
VASA Supplement 2009; -38. Jahrestagung der Deutschen Gesellschaft für Angiologie; SEp 13-16, 2009; Berlin. [Poster]

 

Gary, T; Prüller, F; Froehlich, H; Hafner, F; Pilger, E; Brodmann,M Influence of endovascular recanalisation in patients with peripheral arterial occlusive disease on the platelet function in whole blood
16.Jahrestagung der AAS; MAI 8-9, 2009; St.Gilgen, Austria. 2009. [Poster]

 

Gary, T; Prüller, F; Froehlich, H; Werner, S; Hafner, F; Pilger, E; Brodmann, M Veränderungen des Gerinnungssystems bei einem Patienten mit tiefer Beinvenenthrombose nach Vipera berus Biss in die rechte Hand
Wiener Klinische Wochenschrift2009; 121 Jahrgang(15):15-16.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; AKH Wien. [Poster]

 

Gary, T; Pruller, F; Frohlich, H; Hafner, E; Pilger, E; Brodmann, M Influence of endovascular Recanalization in Patients with peripheral arterial disease on Platelet function in whole Blood
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A15-A15. [Poster]
Web of Science

 

Gary, T; Prüller, F; Fröhlich, H; Hafner, F; Pilger, E; Brodmann,M Einfluß der endovaskulären Rekanalisation bei Patienten mit pAVK auf die Thrombozytenfunktion im Vollblut
Zeitschrift für Gefäßmedizin2009; -Gemeinsame Jahrestagung der gefäßmedizinischen Gesellschaften Österreichs; OCT 1-3, 2009; Bregenz. [Oral Communication]

 

Gary, T; Pruller, F; Frohlich, H; Werner, F; Hafner, F; Pilger, E; Brodmann, M Changes in the Coagulation in a Patient with Deep vein thrombosis after Vipera berus Bite in the right Hand.
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A15-A16. [Poster]
Web of Science

 

Gary, T; Prüller, F; Fröhlich, H; Werner, S; hafner, F; Pilger, E; Brodmann, M Veränderungen des Gerinnungssystems bei einem Patienten mit tiefer Beinvenenthrombose nach Vipera berus Biß in die rechte Hand
Zeitschrift für Gefäßmedizin2009; -Gemeinsame Jahrestagung der gefäßmedizinischen Gesellschaften Österreichs; OCt 1-3, 2009; Bregenz. [Poster]

 

Gary, T; Seinost, G; Hafner, F; Gorkiewicz, G; Froehlich, H; Pilger,E; Brodmann, M Erdheim Gsell disease as a rare reason for spontaneous rupture of the ascending aorta
"Bail Outs" in the Treatment of Thoaracic Aortic Pathologies; SEP 10-11,2009; Graz, Austria. 2009. [Oral Communication]

 

Gary ,T; Stojakovic, T; Froehlich, H; Scharnagel, H;Hafner, F; Pilger, E; Brodmann, M Reobstruktion nach stentimplantation im Bereich der Arteria femoralis superficialis in Abhängigkeit des lp(a) Spiegels.
CD Room 2009; -115. Jahres Tagung der Deutschen Gesellschaft für Innere Medizin, DGIM; APR 18-22, 2009; Wiesbaden, Deutschland. [Poster]

 

Gary, T; Stojakovic, T; Froehlich, H; Scharnagl, H; Hafner, F; Pilger, E; Brodmann, M Association between plasma lipoprotein(a) concentration and restenosis after stent implantation in the superficial femoral artery.
Hämostaseologie-Kongressausgabe 2009; 29: 77--53. Jahrestagung der Gesellschaft für Thrombose-und Hämostaseforschung e.V. (GTH) 2009; FEB 4-7, 2009; Wien. [Poster]

 

Hafner, F; Brodmann, M; Froehlich, H; gary, T; Pilger, E; Seinost, G Einfluß von Prostanoiden auf die endotheliale (Dys-)Funktion bei Patienten mit lifestylelimitierender Claudicatio intermittens
CD-Room2009; -115. Jahres Tagung der Deutschen Gesellschaft für Innere Medizin, DGIM; APR 18-22, 2009; Wiesbaden, Deutschland. [Poster]

 

Hafner, F; Brodmann, M; Froehlich, H; Gary, T; Pilger, E; Seinost, G Endotheliale (Dys-) Funktion und das Risiko einer Reobstruktion bei Patienten mit endovaskulärer Rekanalisation der Extremitätenarterien
CD Room. 2009; -115. Jahres Tagung der Deutschen Gesellschaft für Innere Medizin, DGIM; APR 18-22,2009; Wiesbaden, Deutschland. [Poster]

 

Hafner, F, Gary, T, Froehlich, H, Pilger, E, Brodmann, M The effect of a single line therapy with bosentan versus a sequential therapy of prostanoids and bosentan in the treatment of digital skin ulcers in severe scleroderma
Ann Rheum Dis 2009. 2009; 68(3):748--EULAR; JUN 10-13, 2009; Kopenhagen, Dänemark. [Poster]

 

Hafner, F; Gary, T; Froehlich, H; Steidl, K; Pilger, E; Brodmann, M Vergleich einer Monotherapie mit Bosenatn gegenüber einer sequentiellen therapie von Prostanoiden und Bosentan bei akralen Nekrosen aufgrund systemsischer Sklerodermie
VASA Supplement2009; -38. Jahrestagung der Deutschen Gesellschaft für Angiologie; SEP 13-16, 2009; Berlin. [Poster]

 

Hafner, F; Gary, T; Froehlich, H; Steidl, K; Pilger, E; Brodmann; M Vergleich einer Monotherapie mit Bosentan gegenüber einer sequentiellen Therapie von Prostanoiden und Bosentan bei akralen Nekrosen aufgrund systemischer Sklerodermie
Wiener Klinische Wochenschrift2009; 121 Jahrgang(15):16-16.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; AKH Wien. [Poster]

 

Hafner, F; Gary, T; Frohlich, H; Steidl, E; Pilger, E; Brodmann, M Comparison of Monotherapy with Bosentan compared with a sequential Therapy of Prostanoids and Bosentan in acral Necrosis due to Systemic Sclerosis
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A16-A16.-ÖGIM 2009; [Poster]
Web of Science

 

Hafner, F; Gary, T; Fröhlich, H; Steidl, K; Pilger, E; Brodmann, M Vergleich einer Monotherapie mit Bosentan gegenüber einer sequentiellen therapie von Prostanoiden und Bosentan bei akralen Nekorsen aufgrund systemischer Sklerodermie
Zeitschrift für Gefäßmedizin. 2009; -Gemeinsame Jahrestagung der gefäßmedizinischen Gesellschaften Österreichs; OCT 1-3, 20009; Bregenz. [Poster]

 

Kovacs G; Maier, R; Aberer, E; Brodmann, M; Graninger, W; Scheidl, S; Hesse, C; Troester, N; Gruenig, E; Olschewski, H Early pulmonary hemodynamical changes in systemic sclerosis. A one-year follow-up.
European Respiratory Journal Supplement2009; 34(53):-ERS; SEP 12-16, 2009; Vienna, AUSTRIA. [Poster]

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Graninger, W; Scheidl, S; Hesse, C; Troester, N; Grunig, E; Olschewski, H Early development of pulmonary vasculopathy in scleroderma patients without manifest pulmonary arterial hypertension. A follow-up study.
WIEN KLIN WOCHENSCHR. 2009; 121(17-18):A48-A48.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie, ÖGP 2009; JUN 11-13, 2009; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Graninger, W; Scheidl, S; Tröster, N; Hesse, C; Grünig, E; Olschewski, H The progression of early pulmonary vasculopathy in systemic sclerosis.
MEMO - magazine of european medical oncology2009; Suppl 04/09: 2--Pneumologie Update; JUN 19-20, 2009; Innsbruck, AUSTRIA. [Oral Communication]

 

Maier, R; Kovacs, G; Stauber, R; Brodmann, M; Fruhwald, FM; Aberer, E; Gruenig, E; Olschewski, H Exercise Doppler echocardiography for screening of patients at risk for pulmonary arterial hypertension.
Eur J Heart Fail 2009; 8(2):1524-1524.- Heart Failure 2009; MAY 30 - JUN 2, 2009; Nice, FRANCE. [Poster]

 

Wiedner, M; Rappl, T; Gary, T; Prandl, EC; Brodmann, M; Scharnagl, E; Versehentliche intraarterielle Injektion als Komplikation bei chronischem i.v.-Drogenabusus.
Abstractband der 47. Jahrestagung der Österreichischen Gesellschaft für Plastische, Ästhetische und Rekonstruktive Chirurgie 2009; -47. Jahrestagung der Österreichischen Gesellschaft für Plastische, Ästhetische und Rekonstruktive Chirurgie ; OKT 8-10, 2009; Schloss Esterházy, Eisenstadt, AUSTRIA. [Oral Communication]
FullText

 

Brodmann, M Stenting of the PA,a don´t.
Friedrich Olbert Symposium;Internationaler Workshop; JAE 16-19, 2008; Muenchen. 2008. [Oral Communication]

 

Brodmann, M VTE Management.
39.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 17-20.9.2008; Graz, Austria. 2008. [Keynote lecture]

 

Brodmann, M Stellenwert der Kapillarmikroskopie in der Diagnostik von Kollagenosen
Fortbildung Kärntner Fachärzte im Sklerodermienetzwerk Kärntnen; AUG 27, 2008; Villach. 2008. [Keynote lecture]

 

Brodmann, M Systemische Therapie digitaler Ulcerationen bei SSc
Expertentreffen Sklerodermie; OCT 22, 2008; Wien. 2008. [Keynote lecture]

 

Brodmann, M Thromboseprophylaxe beim unfallchirurgischen Patienten
Interne Fortbildung LKH Oberwart; DEC 10, 2008; LKH Oberwart. 2008. [Keynote lecture]

 

Brodmann, M Veränderungen der A carotis-Therapie nach Morphologie
Gemeinsame Tagung der ÖGA, ÖGIA und Österreichischen Gesellschaft für Phlebologie und dermatologische Angiologie; NOV 14-15, 2008; Wien. 2008. [Oral Communication]

 

Brodmann, M Interventionen im Unterschenkelbereich
Gemeinsame Tagung der ÖGA, ÖGIA und Österreichischen Gesellschaft für Phlebologie und dermatologische Angiologie; NOV 14-15, 2008; Wien. 2008. [Oral Communication]

 

Brodmann, M pAVK - das optimale Therpiekonzept: Niedergelassen und Klinik Hand in Hand.
39.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; 17.-20.9.2008; Graz, Austria. 2008. [Oral Communication]

 

Brodmann, M PTA der Untersckenkelarterien.
39. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin ; 17.-20.9.2008; Graz, Austria. 2008. [Oral Communication]

 

Brodmann, M Thromboseprophylaxe
Praktikerlehrgang Seggauberg ; 31.5-1.6.2008; Seggauberg. 2008. [Oral Communication]

 

Brodmann, M Diabetes und Beinischämie-Therapiekonzepte aus Sicht des Angiologen.
Meet the Experts; April 25-26, 2008; Baden bei Wien, Austria. 2008. [Oral Communication]

 

Brodmann, M Diabetes und Beinischämie-die endovaskuläre Therapieoption
36.ÖDG-Jahrestagung; NOV 20-22,2008; Baden bei Wien, Austria. 2008. [Oral Communication]

 

Brodmann, M Endovaskuläre Therapie beim Wundpatienten
Ausbildung zum Wundmanager_Klinikum Graz; Oct 22-24, 2008; Graz, Austria. 2008. [Oral Communication]

 

Brodmann, M Biotyliniertes Idraparinoux in der Sekundärprophylaxe bei Schlaganfall und VHFA.
Prüfarztreffen der Borrealistudie; MAE 7, 2008; Wien. 2008. [Keynote lecture]

 

Brodmann, M Thorakales Aortenaneurysma
Fortbildungsabend der Univ.Klinik für Radiologie Graz; JAE 15, 2008; Graz, Austria. 2008. [Oral Communication]

 

Brodmann, M Thromboseprophylaxe unter Berücksichtigung der neuen Antithrombotika
Fortbildung Unfallchirurgie LKH Judenburg; Oct 28, 2008; Judenburg. 2008. [Oral Communication]

 

Brodmann, M Multilevel Treatment in CLI; Below the Knee
Euro PCR 2008; MAI 13-16,2008; Barcelona. 2008. [Oral Communication]

 

Brodmann, M VTE und Kontraindikationen für Antikoagulation-Gibt es Alternativen.
3.Sailersymposium: Was sie über Gerinnung wissen sollten; JUN 20,2008; Graz. 2008. [Oral Communication]

 

Brodmann, M Thromboseprophylaxe bei Schlaganfall.
Fortbildung Krankenhaus Knittelfeld (Neurologie); FEB 12, 2008; Knittelfeld. 2008. [Oral Communication]

 

Brodmann, M Akutmanagement beim Schlaganfall
Fortbildungsabend der Univ.Klinik für Radiologie Graz; Mai 27, 2008; Graz, Austria. 2008. [Oral Communication]

 

Brodmann, M Morbus Takayasu
ESC 2008 (European Society of Cardiology 2008); AUG 30-SEP 3, 2008; Muenchen. 2008. [Keynote lecture]

 

Brodmann, M Dre diabetische Fuß und seine Therapieoptionen.
39.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 17-20.9.2008; Graz, Austria. 2008.

 

Brodmann, M Neue Möglichkeiten einer antithrombotischen Therapie.
Fortbilungskalender der Ärztekammer für Steiermark; Medizin am Kamin; JUN 6,2008; Graz, Austria. 2008. [Oral Communication]

 

Brodmann, M Neue Entwicklungen in der Thromboseprophylaxe; Studienprogramme.
39. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin ; 17.-20.9.2008; Graz, Austria. 2008. [Oral Communication]

 

Brodmann, M; Froehlich, H; Portugaller, H; Dorr, A; Pilger, E Ballon Angioplasty versus Primary Stenting of infrapopliteal arteries in critical extreme ischemia.
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A48-A48.-39.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 17-20.9.2008; Graz, Austria. [Poster]
Web of Science

 

Brodmann, M; Froehlich H, Portugaller HR, Klein E, Dorr A, Pilger E; Ballonangioplastie versus primäres Stenting der infrapoplitealen Arterien bei kritischer Extremitätenischämie-1 Jahres Folow up.
Gefäßmedizin.net. 2008; -9. Unionstagung de Schweizerischen Gesellschaft; OCT 23-25,2008; Basel. [Oral Communication]

 

Brodmann, M; Froehlich, H; Portugaller, HR; Klein, GE; Pilger, E Ballonangioplastie versus primäres Stenting der infrapoplitealen Arterien bei kritischer Extremitätenischämie; 1-Jahres Follow-up.
Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften; NOV 14-15,2008; Wien. 2008. [Poster]

 

Brodmann, M; Hafner, F; Froehlich, H; Pilger, E; Seinost, G Endothelial (Dys-) function and the risk of reobstruction in patients with endovascular recanalization of limb arteries
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A49-A49.-39.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 17-20.9.2008; Graz, Austria. [Poster]
Web of Science

 

Brodmann, M; Hafner, F; Gary, T; Pilger, E; Seinost, G Impact of prostanoids on endothelial (dys-) function in patients with intermittent Claudicatio
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A49-A49.-39.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 17-20.9.2008; Graz, Austria. [Poster]
Web of Science

 

Dunzinger, A; Gary T, Piswanger-Soelkner C, Brodmann M, Lipp RW; GlycoproteinIIb/IIIa receptor scintigraphy for the detection of acute deep vein thrombosis and correlation with other imaging modalities.
Nuklearmedizin 6/20072008; 6/2007: -Radioactive Iostopes in Clinical Medicine and Research; JAE 9-12, 2008; Bad Hofgastein. [Oral Communication]

 

Feichtinger, P; Hafner, F; Gary, T; Brodmann, M; Pilger, E Central PAE and consecutive embolism paradox in the right upper limb in patient with Osteogenesis imperfecta typ V and Vorhof-Septum
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A49-A49.-39.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; [Poster]
Web of Science

 

Feichtinger, P; Hafner F, Gary T, Brodmann M, Pilger E; Zentrale PAE und konsekutive paradoxe Embolie in die rechte obere Extremität bei einem Patienten mit Osteogenesis imperfecta und Vorhofseptumdefekt.
Wiener Klinische Wochenschrift. 2008; -39.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 17.-20.9.2008; Graz, Austria. [Poster]

 

Feichtinger, P; Hafner, F; Gary, Th; Brodmann, M; Pilger, E Zentrale PAE und konsekutive paradoxe Embolie in die rechte obere Extremität bei einem Patienten mit Osteogenesis imperfecta Typ V und Vorhofseptum.
Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften; NOV 14-15,2008; Wien. 2008. [Poster]

 

Gary, T; F. Hafner, G. Seinost, E. Pilger, M. Brodmann; Low factor XII activity as a possible thrombophilic risk factor in elderly patients with venous thrombembolism.
Pathophysiology of Haemosiasis and Thrombosis 36; Supplement 1; June 20082008; -20th International Congress on Thrombosis, Athen; Jun 25-28,2008; Athen, Griechenland. [Poster]

 

Gary, T; Froehlich H, Hafner F, Pilger E, Brodmann M; Low factor XII activity as a possible thrombophilic risk factor in elderly patients with venous thromboembolism.
VASA Supplement2008; -37. Jahrestagung der Deutschen Gesellschaft für Angiologie (DGA); SEP 24-20, 2008; Mannheim, Deutschland. [Poster]

 

Gary, T; Hafner, F; Froehlich, H; Pilger, E; Brodmann, M The low factor XII activity and the high factor VII activity as a thrombophilia risk factor in elderly patients with venous thromboembolic event
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A50-A50.-39.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 17-20.9.2008; Graz, Austria. [Poster]
Web of Science

 

Gary, T; Hafner F, Froehlich H, Pilger E, Brodmann M; Niedrige Faktor XII Aktivität und hohe Faktor VIII Aktivität als thrombophiler Risikofaktor bei älteren Patienten mit venösen thromboembolischen Ereignissen.
Gefäßmedizin.net. 2008; -9.Unionstagung der Schweizerischen Gesellschaften für Gefässkrankheiten; OCT 23-25,2008; Basel. [Oral Communication]

 

Gary, T; Stojakovic, T; Froehlich, H; Pilger, E; Brodmann, M Reobstruction after stent implantation in superficial femoral artery area with correlation on Lp level
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A51-A51.-39.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sep 17-20.9.2008; Graz, Austria. [Poster]
Web of Science

 

Gary, T; Stojakovic T, Froehlich H, Scharnagl H, Hafner F, Pilger E, Brodmann M; Association between Plasma Lipoprotein (a) Concentartion and Restenosis after Stent Implantation in the Superficial Femoral Artery.
vASA Supplement2008; -37.Jahrestagung der Deutschen Gesellschaft für Angiologie (DGA); SEP 24-20, 2008; Mannheim, Deutschland. [Poster]

 

Gary, T; T Stojakovic, H Froehlich, H Scharnagl, F Hafner, M Brodmann; Association Between Plasma Lipoprotein(a) Concentration and Restenosis after Stent Implantation in the Superficial Femoral Artery
AAS (Austrian Atherosclerosis Society) Jahrestagung; Apr 18-19,2008; St Gilgen, Austria. 2008. [Poster]

 

Gray, T; Hafner F, Seinost G, Pilger E, Brodmann M; Low factor XII activity as a possible thrombophilic risk factor in elderly patients with venous thromboembolism.
52. GTH Kongress; FEB 20-23, 2008; Wiesbaden, Deutschland. 2008. [Poster]

 

Hafner, F; Brodmann M, Froehlich H, Gary T, Seinost G, Pilger E; Endotheliale (Dys-)Funktion und das Risiko einer Reobstruktion bei Patienten mit endovaskulärer Rekanalisation der Extremitätenarterien.
Gefäßmedizin.net. 2008; -9.Unionstagung der Schweizerischen Gesellschaften für Gefässkrankheiten; OCT 23-25,2008; Basel. [Oral Communication]

 

Hafner, F; Brodmann, M; Froehlich, H; Gary, Th; Seinost, G; Pilger, E Einfluß von Prostanoiden auf die endotheliale (dys-)Funktion bei Patienten mit lifestylelimitierender Claudicatio intermittens.
Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften; NOV 14-15,2008; Wien. 2008. [Poster]

 

Hafner, F; Brodmann, M; Froehlich, H; Gary,Th; Seinost, G;Pilger, E Enotheliale Dysfunktion und das Risiko einer reobstruktion bei Patienten mit endovaskulärer Rekanalisation der Extremitätenarterien
Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften; NOV 14-15,2008; Wien. 2008. [Poster]

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Salmhofer, W; Fuerst, F; Olschewski, H Association between resting and exercise pulmonary hemodynamics and measures of exercise capacity in patients at risk for pulmonary arterial hypertension.
American Journal of Respiratory and Critical Care Medicine2008; 177: A917-A917.-ATS; MAI 16-21, 2008; Toronto, CANADA. [Poster]

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Salmhofer, W; Graninger, W; Grünig, E; Olschewski, H Resting pulmonary artery pressure predicts exercise capacity in patients with connective tissue disease.
7th International Pulmonary Hypertension Forum; APR 4-6, 2008; Vienna, AUSTRIA. 2008. [Poster]

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Salmhofer, W; Graninger, W; Scheidl, S; Hesse, C; Grünig, E; Olschewski, H Resting and moderate exercise pulmonary pressure as a potential prognostic parameter in patients at risk for pulmonary arterial hypertension.
MEMO - magazine of european medical oncology2008; Suppl 03/08: 30-30.-Pneumologie Update; JUN 20-21, 2008; Innsbruck, AUSTRIA. [Poster]

 

Kovacs, G; Maier, R; Scheidl, S; Hesse, C; Aberer, E; Brodmann, M; Salmhofer, W; Graninger, W; Gruenig, E; Olschewski, H Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension.
Supplement in Vorbereitung2008; -ERS; OKT 4-8, 2008; Berlin, GERMANY. [Oral Communication]

 

Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Brodmann, M; Aberer, E; Gruenig, E; Olschewski, H Stress Doppler echocardiography for screening of patients at risk for pulmonary arterial hypertension.
CIRCULATION. 2008; 118(12):E294-E294.- World Congress of Cardiology; MAY 18-21, 2008; Buenos Aires, ARGENTINA. [Poster]
Web of Science

 

Brodmann, M Fibrinolyse - Chancen und Gefahren: Venöse Thromboembolie.
2. Sailersymposium, Hämostaseologie - update; Jun 15, 2007; Graz. 2007. [Oral Communication]

 

Brodmann, M Zigarette-Nein danke! Nikotin als massiver kardiovaskulärer Risikofaktor
Ärztekammerfortbildung; Nov 15,2007; Fürstenfeld. 2007. [Keynote lecture]

 

Brodmann, M Rezidivierende Bypaßverschlüsse;Lyse und Ballonangioplastie wann immer möglich.
Die komplexe Femoralisläsion im Kreuzfeuer: Stent, Messer-Pille; Dez 7-8,2007; Wien. 2007. [Oral Communication]

 

Brodmann, M Vorsitz: Fibrinolyse - Chancen und Gefahren.
2. Sailersymposium Hämostaseologie - update; Jun 15,2007; Graz. 2007. [Oral Communication]

 

Brodmann, M Nikotin und pAVK-eine unterschätzte Gefahr. Ein Update zur Raucherentwöhnung
Fortbildungsreihe der Medizinischen Gesellschaft für Oberösterreich; JUN 21, 2007; Ried im Innkreis. 2007. [Keynote lecture]

 

Brodmann, M Thromboembolie-Therapie.
Wiener Medizinische Wochenschrift2007; 6-6.-Venalpina V- Phlebologische Fortbildungswoche; JAE 20-27, 2007; Schruns, Vorarlberg. [Oral Communication]

 

Brodmann, M PAH und Kollagenosen.
Fortbildung interdisziplinär LKH Wolfsberg; FEB 21, 2007; Wolfsberg. 2007. [Oral Communication]

 

Brodmann, M Lungenembolie Update
Fortbildungsreihe LKH Feldbach; SEP 13, 2007; LKH Feldbach. 2007. [Oral Communication]

 

Brodmann, M Periphere arterielle Verschlußkrankheit-Fragen des Klinikers
Kardio-Vaskuläre-Radiologie-Neue Horizonte; MAI 10-12, 2007; Pörtschach, Wörthersee. 2007. [Oral Communication]

 

Brodmann, M Pulmonal-arterielle Hypertonie bei Kollagenosen
Fortbildungsveranstaltung - Pulmonal-arterielle Hypertonie bei Kollagenosen; März 20, 2007; Klagenfurt, Elisabethinen Krankenhaus. 2007. [Keynote lecture]

 

Brodmann, M Lungenembolie-Update.
Fortbildung LKH Fürstenfeld; MAI 3, 2007; Fürstenfeld. 2007. [Oral Communication]

 

Brodmann, M Stadiengerechte PAVK-Therapie mit PGE 1.
20 Jahre Prostavasin; MAE 3, 2007; Wien. 2007. [Oral Communication]

 

Brodmann, M Stadiengerechte Therapie der pAVK
Interdisziplinäre Fortbildung LKH Voitsberg; JUN 12, 2007; LKH Voitsberg. 2007. [Keynote lecture]

 

Brodmann, M Stents - Aktuelles zum Thema Stents in der unteren Extremität
7. Wissenschaftliche Sitzung - Wissenschaftliche Gesellschaft der Ärzte in der Steiermark; März 15,2007; Graz, Universitätsklinik,Hörsaal der Pathologie. 2007. [Oral Communication]

 

Brodmann, M Der angiologische Wundpatient, Interventionelle Therapiemöglichkeiten.
Kurs Ärztliches Wundmanagement der Ärztekammer für Steiermark; MAE 9-10,2007; Graz, Austria. 2007. [Oral Communication]

 

Brodmann, M Angiologische Aspekte des diabetischen Fusses
Fortbildung interdisziplinär KH der BHB Eggenberg Graz; MAI 30,2007; KH der BHB Eggenberg Graz. 2007. [Keynote lecture]

 

Brodmann, M Kollagenosen: Vaskulopathie als gemeinsamer Nenner?.
Endothelin Rezeptor Antagonismus -State of the Art:Dualer Wirkansatz heute und morgen; April, 20-22,2007; Salzburg, Castellani Parkhotel. 2007. [Oral Communication]

 

Brodmann, M 1x1 der Diagnostik und Therapie inder Angiologie für die Allgemeinmedizin
18. Grazer Fortbildungstage der Ärztekammer für Steiermark; OKT 11, 2007; Graz, Austria. 2007. [Oral Communication]

 

Brodmann, M The japanese approach for below the knee treatment.
EuroIntervention. 2007; 3(13):-Euro PCR; Mai 22-25,2007; Barcelona, Spanien. [Oral Communication]

 

Brodmann, M Diabetic foot and claudication.
LINC; JAE 24-27, 2007; Leipzig, Deutschland. 2007. [Oral Communication]

 

Brodmann, M Lungenembolie update
Bezirksärztekammerfortbildung Deutschlandsberg; JUN 28,2007; Deutschlandsberg. 2007. [Oral Communication]

 

Brodmann, M Thromboseprophylaxe unter besonderer Berücksichtigung des onkologischen Patienten
Fortbildung LKH Leoben interdisziplinär; JUL 5, 2007; LKH Leoben. 2007. [Oral Communication]

 

Brodmann, M Embolic occlusion of the popliteal artery.
EuroIntervention. 2007; 3(13):-Euro PCR; Mai 22-25,2007; Barcelona, Spanien. [Oral Communication]

 

Brodmann, M Stents im Unterschenkel.
Kliniknachmittag MEDUK 2007; Feb 6, 2007; Graz, Austria. 2007. [Keynote lecture]

 

Brodmann, M Critical Limb Ischemia.
CTO Symposium Kärnten; MAE 29-30, 2007; Klagnefurt. 2007. [Keynote lecture]

 

Brodmann, M Diganostik und Therapie des Morbus Takayasu.
Wissenschaftliche Jahrestagung der ÖGIA; OKT 19-20,2007; Feldkirch, Vorarlberg. 2007. [Oral Communication]

 

Brodmann, M Kollagenosen
Fortbildungsreihe Krankenhaus der BHB Eggenberg Graz; JUN 27, 2007; Krankenhaus der BHB Eggenberg Graz. 2007. [Oral Communication]

 

Brodmann, M Diagnostisches Vorgehen bei venöser Thromboembolie
18. Grazer Fortbildungstage der Ärztekammer für Steiermark; OKT 11, 2007; Graz, Austria. 2007. [Oral Communication]

 

Brodmann, M Vorsitz-Update Thromboseprophylaxe und -therapie
38.Jahrestagung der österreichischen Gesellschaft für Innere Medizin; SEP 27-29, 2007; Innsbruck, AUSTRIA. 2007. [Oral Communication]

 

Brodmann, M Neue Aspekte in der Hypertonie_Gefäße.
2. Österreichische Hochdruckakademie Graz; MAE 10, 2007; Graz, Austria. 2007. [Oral Communication]

 

Brodmann, M Prostanoide im klinischen Einsatz
3.Interdisziplinärer Seminarkongreß; OKT 4-6,2007; Pörtschach, Wörthersee. 2007. [Oral Communication]

 

Brodmann, M Angiologie in der Wundbehandlung-interventionelle Möglichkeiten
Ärztliches Wundmanagement; Dez14-15,2007; Graz. 2007. [Oral Communication]

 

Brodmann, M Update der Lungenembolie unter Berücksichtigung des onkologischen Patienten
Diplomfortbildungsprogramm der ÖAK ; OKT 17, 2007; Knittelfeld. 2007. [Oral Communication]

 

Brodmann, M Vorsitz - Zerebrovaskuläre Erkrankung/Aneurysma.
14. Dreiländertagung der Deutschen, Österreichischen und Schweizerischen GEsellschaften für Angiologie; SEP 9. - 12., 2007; München. 2007. [Oral Communication]

 

Brodmann, M Vorsitz Hauptsitzung der ÖGIA/ÖGA Was Ist zu tun bei?
38. Jahrestagung der österreichischen Gesellschaft für Innere Medizin; SEP 27-29, 2007; Innsbruck, AUSTRIA. 2007. [Oral Communication]

 

Brodmann, M; Dorr, A; Gary, T; Feichtinger, P; Pilger, E Primary Stenting versus ballon angioplasty in the infrapopliteal arteries in CLI (3 months data)
VASA, Supplement. 2007; 36(S/70):141-142.-14. Dreiländertagung der deutschen, österreichischen und schweizerischen Gesellschaften für Angiologie; SEP 9-12,2007; München. [Poster]

 

Brodmann, M; Dorr, A; Gary, T; Seinost, G; Pilger, E Primary stenting versus balloon angioplasty in the infrapopliteal arteries in critical limb ischemia
Cardiovascular and Interventional Radiology. 2007; Supplement: -CIRSE ; SEP 8-12,2007; Athen. [Poster]

 

Brodmann, M; Dorr, A; Portugaller, H; Froehlich, H; Pilger ,E Stentimplantation im Bereich der A. poplitea-eine absolute Kontraindiaktion
VASA, Supplement. 2007; 36(S/70):142-142.-14. Dreiländertagung der deutschen, österreichischen und schweizerischen Gesellschaft für Angiologie ; SEP 9-12,2007; München. [Poster]

 

Brodmann, M; Spary, A; Dorr, A; Gary, T; Hafner, F; Skerget, M; Seinost, G; Lipp, RW; Pilger, E F18-FDG-PET scan for diagnosis and follow-up of retroperitoneal fibrosis
ANN RHEUM DIS. 2007; 66: 375-375.-EULAR 2007; JUN 13-16, 2007; Barcelona. [Poster]
Web of Science

 

Dunzinger, A; Gary, T; Piswanger-Soelkner, JC; Brodmann, M; Lipp, RW Detection of acute deep vein thrombosis in symptomatic patients with Tc99m-apcitide
EUR J NUCL MED MOL IMAGING. 2007; 34: S140-S140.-Annual Congress of the EANM 2007; OCT 13-17,2007; Copenhagen. [Poster]
Web of Science

 

Gary, T; Gries, A; Pilger, E; Seinost , G; Brodmann, M Collagen induces accelerated platelet aggregation as a possible cause for restenosis after stent implantation in PAOD
14. Jahrestagung der Österreichischen Atherosklerosegesellschft - AAS; MAY 11-12, 2007; St. Gilgen/Wolfgangsee. 2007. [Poster]

 

Gary, T; Gries, A; Pilger, E; Seinost, G; Brodmann, M Collagen induced accelerated platelet aggregation as a possible cause for restenosis after stent implantation in paod
ATHEROSCLER SUPPL. 2007; 8(1):145-145.-76th Annual EAS Congress; JUN 10-13,2007; Helsinki. Doi: 10.1016/S1567-5688(07)71530-1 [Poster]
Web of Science FullText FullText_MUG

 

Gary, T; Gries, A; Pilger, E; Seinost, G; Brodmann, M Collagen induced accelerated platelet aggregation as a possible cause for restenosis after stent implantation
VASA, Supplement. 2007; 36(S/70):107-108.-14. Dreiländertagung der deutschen, österreichischen und schweizerischen Gesellschaft für Angiologie; SEP 9-12,2007; München. [Poster]

 

Gary, T; Gries, A; Pilger, E; Seinost, G; Brodmann, M Anti-beta-2-glycoprotein-I: Influence on platelet aggregation in whole blood
VASA, Supplement. 2007; 36(S/70):121-121.-14.Dreiländertagung der deutschen, österreichischen und schweizerischen Gesellschaft für Angiologie; SEP 9-12,2007; München. [Poster]

 

Gary, T; Gries, A; Seinost, G; Pilger, E; Brodmann, M Anti-beta-2-glycoprotein-I: Influence on platelet aggregation in whole blodd.
Haemostasiologie2007; Supplement(1/07):-GTH 2007; FEB 21-24,2007; Dresden. [Poster]

 

Hafner, F; Gary, T; Feichtinger, P; Seinost, G; Pilger, E; Brodmann, M Zystische Adventitiadegeneration der Arteria femoralis communis als seltene Ursache einer Wadenclaudicatio bei einem 28-jährigen Patienten
VASA, Supplement. 2007; 36(S/70):143-144.-14. Dreiländertagung der deutschen, österreichischen und schweizerischen Gesellschaft für Angiologie; SEP 9-12,2007; München. [Poster]

 

Kovacs, G; Maier, R; Aberer, E; Brodmann, M; Scheidl, S; Hesse, C; Salmhofer, W; Furst, F; Olschewski, H The impact of resting and exercise pulmonary hemodynamics on exercise capacity in patients at risk for pulmonary arterial hypertension
WIEN KLIN WOCHENSCHR. 2007; 119(17-18):A19-A19.-Jahrestagung 2007 der Österreichischen Gesellschaft für Pneumologie; OCT 4-6; Salzburg. [Oral Communication]
Web of Science

 

Kovacs, G; Maier, R; Scheidl, S; Hesse, C; Aberer, E; Brodmann, M; Gruenig, E; Olschewski, H Early recognition of pulmonary arterial hypertension in risk patients using exercise stress echocardiography and right heart catheterisation.
ERJ Suppl2007; 2007: 287s-287s.-ERS; SEP 15-19, 2007; Stockholm, SWEDEN. [Oral Communication]

 

Kovacs, G; Maier, R; Scheidl, S; Hesse, C; Aberer, E; Brodmann, M; Gruig, E; Olschewski, H Screening for pulmonary arterial hypertension with exercise-stress-echocardiography and cardiopulmonary exercise testing
CHEST. 2007; 132(4):622S-622S.-CHEST 2007; OCT 20-25, 2007; Chicago, Illinois, USA. [Poster]
Web of Science

 

Kovacs, G; Maier, R; Scheidl, S; Hesse, C; Brodmann, M; Stauber, R; Fürst, F; Aberer, E; Salmhofer, W; Thonhofer, R; Grünig, E; Olschewski, H Die Rolle der Stressechokardiographie und der Spiroergometrie in der Früherkennung der pulmonalarteriellen Hypertonie
Pneumologie Update; JUN 8-9; 2007; innsbruck, AUSTRIA. 2007. [Poster]

 

Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Brodmann, M; Aberer, E; Gruenig, E; Olschewski, H Stress Doppler echocardiography for screening of patients at risk for pulmonary arterial hypertension.
Eur J Echocardiography 2007; 8(Supp):-EUROECHO 2007; DEC 5-8, 2007; Lisbon, PORTUGAL. [Poster]

 

Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Brodmann, M; Aberer, E; Gruenig, E; Olschewski, H Stress Doppler echocardiography for screening of patients at risk for pulmonary arterial hypertension.
Echocardiography Today and Tomorrow; JUN 25-29, 2007; St. Wolfgang, AUSTRIA. 2007. [Poster]

 

Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Brodmann, M; Fruhwald, FM; Aberer, E; Gruenig, E; Olschewski, H Exercise Stress Echocardiography for Screening of Patients at Risk for Pulmonary Arterial Hypertension.
J Kardiol 2007; 14(5-6):171-171.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; MAY 30 - JUN 2, 2007; Salzburg, AUSTRIA. [Poster]

 

Brodmann, M Angiologische Aspekte beim DFS.
-3. Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften Österreichs; Oct.12.-14.2006; Innsbruck, AUSTRIA. [Oral Communication]

 

Brodmann, M Diabetisches Fußsyndrom - Angiologische Aspekte beim DFS
3. Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften Österreichs; Okt, 12-14,2006; Innsbruck. 2006. [Oral Communication]

 

Brodmann, M Venöse Thromboembolie
3. Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften Österreichs; Okt, 12-14,2006; Innsbruck. 2006. [Oral Communication]

 

Brodmann, M Gefäßwand-und Plaqueimaging: The vulnerable patient.
Fortbildung Radiologie, Graz; Jänner 31, 2006; Graz, Austria. 2006. [Oral Communication]

 

Brodmann, M Die Nierenarterienstenose als Zufallsbefund-To stent or not to stent?.
Fortbildungsabend Radiologie Graz; NOV 21,2006; Graz, Austria. 2006. [Oral Communication]

 

Brodmann, M Therapie der venösen Thromboembolie.
-3.Gemeinsame Jahrestagung der Gefässmedizinischen Gesellschaften Österreichs; Oct.12.-14.2006; Innsbruck, AUSTRIA. [Oral Communication]

 

Brodmann, M pAVK-Die verkannte Bedrohung.
Atherothrombose Symposium 2006- das Gefäßkonzept im Blickpunkt; Jänner, 21-22, 2006; Linz, Austria. 2006. [Oral Communication]

 

Brodmann, M Noninvasive Gefäßdiagnostik.
Fortbildungsabend Radiologie Graz; Oct 24,2006; Graz, Austria. 2006. [Oral Communication]

 

Brodmann, M Dilatieren statt amputieren-Diabetische Angiopathie.
Sommersymposium Österreichische Gesellschaft für Internistische Angiologie; Jun 24, 2006; Graz, Austria. 2006. [Oral Communication]
FullText

 

Brodmann, M Zigarette-nein danke!.
2.Königsberger Gefäßdialog; NOV 10-11,2006; Bad Schönau,Austria. 2006. [Oral Communication]

 

Brodmann, M Angiologische Aspekte beim diabetischen Fuß.
51.Ausseer symposium der Wissenscahftlichen Gesellschaft der Ärzte in der Steiermark; Mai 11-13, 2006; Bad Aussee, AUSTRIa. 2006. [Oral Communication]

 

Brodmann, M EVR in the Lower Limb.
-XXII World Congress of the International Union of Angiology; Jun 24-28, 2006; Lissabon, Portugal. [Oral Communication]

 

Brodmann, M MRA Angiography Course-Clinical expectations.
MR Angiography Course, Graz; Jun 2, 2006; Graz, Austria. 2006. [Oral Communication]

 

Brodmann, M Pulmonal-arterielle Hypertonie:eine Herausforderung für Diagnostik und Therapie.
-3.Gemeinsame Jahrestagung der gefäßmedizinischen Gesellschaften Österreichs.; Oct.12.-14.2006; Innsbruck, AUSTRIA. [Oral Communication]

 

Brodmann, M; Dorr, A; Froehlich, H; Stix, A; Portugaller, H; Pilger, E Stentfrakturen-ein Problem in der Arteria femoralis superficialis?.
Zeitschrift für Gefäßmedizin. 3(3):18-18.-3. Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften Österreichs; Oct.12.-14.2006; Innsbruck, AUSTRIA. (ISBN: 1812-9501 ) [Oral Communication]

 

Brodmann, M; Seinost, G; Dorr, A; Pilger, E Reduced endothelial-dependent vasodilatation and reduced endothelial-independent vasodilatation in patients with thromboangitis obliterans.
MED KLIN. 101: A9-A9.-112. Jahrestagung der deutschen Gesellschaft für Innere Medizin; April 22-26, 2006; Wiesbaden, Deutschland. [Poster]
Web of Science

 

Brodmann, M; Skerget, M; Seinost, G; Pilger, E Effect of Therapy with endothelinreceptorantagonist Bosentan on digital ulcers in patients with Crest and scleroderma.
Annals of the Rheumatic Diseases. Supplement II; 65(S II):636-636.-EULAR; 21.-24.6 2006; Amsterdam, Niederlande. (ISBN: 0003-4967 ) [Poster]

 

Brodmann, M; Skerget, M; Spary, A; Seinost, G; Pilger, E Effect of therapy with endothelinerceptorantagonist bosentan on arterial perfusion in patients with crest syndrome ans scleroderma
-34.Kongress der Deutschen Gesellschaft für Rheumatologie; Oct 18 -21, 2006; Wiesbaden, Deutschland. [Oral Communication]

 

Dorr, A; Dimsity, G; Skerget, G; Seinost, G; Pilger, E; Brodmann, M Is there seasonal differences in the flow-mediated vasodilatation of the brachial artery in patients with primary and secondary Raynaud phenomenon.
MED KLIN. 101: A8-A9.-112. Kongress der deutschen Gesellschaft für Innere Medizin; April 22-26, 2006; Wiesbaden, Deutschland. [Poster]
Web of Science

 

Dorr, A; Froehlich, H; Brodmann, M; Protugaller, H; Aschauer, M; Pilger, E Stentimplantation im Bereich der Arteria poplitea-eine absolute Kontraindikation?.
Zeitschrift für Gefäßmedizin. 3(3):19-19.-3. Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften Österreichs; Oct.12.-14.2006; Innsbruck, AUSTRIA. (ISBN: 1812-9501 ) [Oral Communication]

 

Fröhlich, H; Tarmann, M; Seinost, G; Pilger, E; Brodmann, M Frequency of stent fractures in the femoropopliteal artery
Cardiovascular and Interventional Radiology (CVIR). 29(S 1):S 81-S 291.-CIRSE; Sept 9-13 ,2006; Rom, Italien. (ISBN: 0174-1551 ) [Poster]

 

Gries, A; Gary, T; Hafner, F; Brodmann, M; Pilger, E; Seinost, G Anti-beta-2-glycoprotein-I: Einfluß auf die Thromboszytenaggregation im Vollblut.
Zeitschrift für Gefäßmedizin. 3(3):21-21.-3.Gemeinsame Jahrestagung der gefäßmedizinischen Gesellschaften Österreichs; Oct.12.-14.2006; Innsbruck, AUSTRIA. (ISBN: 1812-9501 ) [Oral Communication]

 

Gries A, Gary T, Hafner F, Brodmann M, Pilger E, Seinost G Varia - Anti-beta-2-glycoprotein-I: Einfluss auf die Thrombozytenaggregation im Vollblut
3. Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften Österreichs; Okt,12-14,2006; Innsbruck. 2006. [Oral Communication]

 

Hafner, F; Feichtinger, P; Gary, T; Seinost, G; Pilger, E; Brodmann, M Cystic adventitia degeneration of the Arteria femoralis communis as a rare cause of a calf claudication in a 28-year-old patient
WIEN KLIN WOCHENSCHR. 118(17-1):A41-A41.-37.Jahrestagung, Österreichische Gesellschaft für Innere Medizin; Sept 28-30,2006; Baden, Austria. [Poster]
Web of Science

 

Pilger, E; Brodmann, M; Dorr, A; Froehlich, H; Stix, A; Portugaller, H Periphere arterielle Verschlusskrankheit Stentfrakturen - ein Problem in der Arteria femoralis superficialis?
3. Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften Österreichs; Okt, 12-14,2006; Innsbruck. 2006. [Oral Communication]

 

Pilger E, Dorr A, Froehlich H, Brodmann M, Portugaller H, Aschauer M Periphere arterielle Verschlusskrankheit - Stentimplantationen im Bereich der Arteria poplitea - eine absolute Kontraindikation?
3. Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften Österreichs; Okt,12-14,2006; Innsbruck. 2006. [Oral Communication]

 

Pilger E, Spary A, Dorr A, Seinost G, Brodmann M Frequenzverhalten nach Carotisstentimplantationen vorstehender antihypertensiver Therapie.
3. Gemeinsame Jehrestagung der Gefäßmedizinischen Gesellschaften Österreichs; Okt, 12-14,2006; Innsbruck. 2006. [Oral Communication]

 

Skerget, M; Dorr, A; Hafner, F; Seinost, G; Pilger, E; Brodmann, M Tongue necrosis - Initial manifestation of temporal arteritis .
-34.Kongress der Deutschen Gesellschaft für Rheumatologie ; Oct 18 -21, 2006; Wiesbaden, Deutschland. [Poster]

 

Skerget, M; Spary, A; Seinost, G; Pilger, E; Brodmann, M Der Effekt des Endothelinantagonisten Bosentan auf die arterielle Perfusion bei Patienten mit Sklerodermie.
Zeitschrift für Gefäßmedizin. 3(3):26-26.-3. Gemeinsame Jahrestagung der gefäßmedizinischen Gesellschaften Österreichs; Oct.12.-14.2006; Innsbruck, AUSTRIA. (ISBN: 1812-9501 ) [Oral Communication]

 

Skerget, M; Spary, A; Seinost, G; Pilger, E; Brodmann, M The effect of the endothelin antagonist Bosenatan on arterial perfusion in patients with sclerodermia
WIEN KLIN WOCHENSCHR. 118(17-1):A46-A46.-37.Jahrestagung, Österreichische Gesellschaft für Innere Medizin; Sept 28-30,2006; Baden, Austria. [Poster]
Web of Science

 

Skerget M, Spary A, Seinost G, Pilger E, Brodmann M Varia - Der Effekt des Endothelinantagonisten Bosenatan auf die arterielle Perfusion bei Patienten mit Sklerodermie.
3. Gemeinsame Jahrestagung der Gefäßmedizinischen Gesellschaften Österreichs; Okt, 12-14,2006; Innsbruck. 2006. [Oral Communication]

 

Skerget, M; Wimmer, G; Thaller, E; März, W; Meinitzer, A; Spary, A; Brodmann, M; Bratschko, RO; Pilger, E; Seinost, G Führt eine verminderte Ratio von L-Arginin und asymetrischem Dimethylarginin bei parodontalen Erkrankungen zu einer endothelialen Dysfunktion?
-DGIM; 22.04.-26.04.06; Wiesbaden, Deutschland. [Poster]

 

Skerget, M; Wimmer, G; Thaller, E; Marz, W; Spary, A; Brodmann, M; Bratschko, R; Pilger, E; Seinost, G Does a reduced ratio of L-arginine and asymmetric dimethyl arginine in parodontal diseases lead to an endothelial dysfunction?
MED KLIN. 101: A9-A10.-112. Jahrestagung der deutschen Gesellschaft für Innere Medizin; April 22-26, 2006; Wiesbaden, Deutschland. [Poster]
Web of Science

 

Spary, A; Dorr, A; Pilger, E; Seinost, G; Brodmann, M Frequenzverhalten nach Carotisstentimplantation unter vorbestehender antihypertensiver Therapie.
Vasa. Vasa Supplement S/69; 35 (S/69):61-61.-35.Jahrestagung der Deutschen Gesellschaft für Angiologie; 6.-9.September 2006; Dresden, Deutschland. (ISBN: 0301-1526 ) [Poster]

 

Spary, A; Dorr, A; Pilger, E; Seinost, G; Brodmann, M Frequency behaviour after carotis stent implantation under pre-existing antihypertensive treatment
WIEN KLIN WOCHENSCHR. 118(17-1):A46-A47.-37.Jahrestagung, Österreichische Gesellschaft für Innere Medizin; Sept 28-30,2006; Baden, Austria. [Poster]
Web of Science

 

Mueller, T; Graninger, WB; Yazdani-Biuki,B; Breinschek, HP; Pilger, E; Brodmann, M; Is high sensitive C-reactive protein or coeruloplasmin helpful in the diagnosis of giant cell arthritis?.
[AB0170] Ann Rheum Dis2005; 64(3):-EULAR; JUN 8-11, 2005; Vienna, AUSTRIA. [Poster]

 

Yazani-Biuki, B; Brezinschek, R; Brickmann, K; Brodmann, M; Pilger, E; Graninger, WB; Brezinschek, HP; Diminished growth Factor levels in connective tissue disorders compares to Osteoarthritis.
[AB0192] Ann Rheum Dis2005; 64(3):-EULAR; JUN 8-11, 2005; Vienna, AUSTRIA. [Poster]

 

Yazdani-Biuki, BJ; Mueller, T; Brezinschek, H; Graninger, WB; Pilger, E; Brodmann, M Seasonal variation in acute phase proteins in patients with primary Raynaud's phenomenon
ANN RHEUM DIS 2005 64: 300-300. [Poster]
Web of Science

 

Brodmann, M; Seinost, G; Skerget, M; Dimsity, H; Pilger, E Impaired endothelial dependent vasodilatation in patients giant cell arteriitis
ANN RHEUM DIS 2004 63: 319-320.
Web of Science

 

Cichocki,L;Gugl,A;Renner,W;Gasser,R;Brodmann,M;Gasser,S;Klein,W;Pilger,E Heme oxygenase-1 length polymorphism is not a predictor of clinical signs of restenosis in patients with peripheral arterial disease and percutaneous transluminal angioplasty.
12th Alpe Adria Cardiology Meeting; April 29 - May 1, 2004; Cividale del Friuli, ITALY. 2004. [Poster]

 

Deutschmann, H; Brodmann, M; Schöllnast, H; Seinost, G; Tiessenhausen, K; Preidler, KW; Pilger, E; Szolar, DH Periphere arterielle Verschlusskrankheit: Vergleich der kontrastverstärkten 3D Magnetresonanzangiographie mittels Panoramatisch mit der konventionellen digitalen Subtraktionsangiographie.
RÖFO. 2004; 176: S134-S134.-Deutscher Röntgenkongress; Mai 19-21, 2004; Wiesbaden, GERMANY. [Oral Communication]

 

Brodmann, M; Passath, A; Lipp, RW; Stark, G; Pabst, E; Seinost, G; Pilger, E F18-FDG-PET as helpful tool in the diagnosis of giant cell arteriitis
ANN RHEUM DIS 2003 62: 447-447.
Web of Science

 

Deutschmann, HA; Schoellnast, H;Brodmann, M;Reittner, P;Preidler, KW;Szolar, DHM Evaluation of iliac and peripheral arteries: Comparison of contrast enhanced 3D panoramic-table MR angiography with conventional digital subtraction angiography.
European Radiology. 2003; 13: 290-290.-European Congress of Radiology; MAR 7-11, 2003; Vienna, AUSTRIA. [Oral Communication]

 

Renner, W; Brodmann, M; Winkler, M; Wascher, TC; Pilger, E The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with peripheral arterial disease
In: Clement, D; Rieger, H editor(s).PROCEEDINGS OF THE 14TH CONGRESS OF THE EUROPEAN CHAPTER OF THE INTERNATIONAL UNION OF ANGIOLOGY; MAY 23-26, 2001; COLOGNE, GERMANY. 40128 BOLOGNA: MONDUZZI EDITORE; 2001. p.85-88.

 

Brodmann, M; Lischnig, U; Friedl, I; Lueger, A; Scherr, D; Pilger, E; Stark, G Effect of nifedipin and verapamil on the peripheral vascular resistance
Abstract Book2000; -19th World Congress of the International Union of Angiology 2000; MAY 1-5, 2000; Gent, BELGIUM. [Oral Communication]

 

Brodmann, M; Lischnig, U; Scherr, D; Lueger, A; Pilger, E; Stark, G Vergleich der Wirkung von Prostaglandin E1, Prostazyklin und Adenosin auf den peripheren arteriellen Gefäßwiderstand
Abstract Book2000; -29. Jahrestagung der DGA 2000; SEP 10-13, 2000; Frankfurt, GERMANY. [Poster]

 

Brodmann, M; Lueger, A; Scherr, D; Lischnig, U; Pilger, E; Stark, G Effekte von Nifedipin und Verapamil auf den Gefäßwiderstand peripherer Extremitätenarterien
Abstract Book2000; -29. Jahrestagung der DGA 2000; SEP 10-13, 2000; Frankfurt, GERMANY. [Poster]

 

Brodmann, M; Lueger, A; Scherr, D; Lischnig, U; Pilger, E; Stark, G Effekte von Nifedipin und Verapamil auf den Gefäßwiderstand peripherer Extremitätenarterien
Acta Med Austriaca 20002000; 27(S1):A39--ÖGIM 2000; OCT 4-7, 2000; Wien, AUSTRIA. [Poster]

 

Lueger, A; Brodmann, M; Scherr, D; Stark, G Eine neue Methode zur Evaluierung elektrophysiologischer Parameter an isolierten Mausherzen
Acta Med Austriaca 20002000; 27(S1):A26--ÖGIM 2000; OCT 4-7, 2000; Wien, AUSTRIA. [Poster]

 

Lueger, A; Stark, G; Brodmann, M; Scherr, D; Gasser, R; Tritthart, H A new high resolution ECG recording technique for evaluation of cardiac conduction and refractoriness in isolated perfused mice hearts
J Heart Fail 20002000; 6(1):63--7th World Congress on Heart Failure 2000; JUL 9-12, 2000; Vancouver, CANADA. [Poster]

 

Stark, G; Brodmann, M; Lueger, A; Scherr, D; Lang, B; Lischnig, U Magnesium mindert unerwünschte elektrophysiologische Effekte von Erythromycin am Herzen
Acta Med Austriaca 20002000; 27(S1):A28--ÖGIM 2000; OCT 4-7, 2000; Wien, AUSTRIA. [Poster]

 

Brodmann, M; Lueger, A; Scherr, D; Stelzer, I; Friedl, I; Pilger, E; Stark, G Effekte von Nifedipin und Verapamil auf den Gefäßwiderstand peripherer Extremitätenarterien
Abstract Band1999; -Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Angiologie und der Arbeitsgruppe Phlebologie der ÖGDV 1999; NOV 11-13, 1999; Salzburg, AUSTRIA. [Oral Communication]

 

↑ Top of page / Navigation